
<html lang="en"     class="pb-page"  data-request-id="39ddac98-6cdd-4a1c-aca9-fab3645939a1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-14;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01314;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy" /></meta><meta name="dc.Creator" content="Ruomeng  Qiu" /></meta><meta name="dc.Creator" content="Yonghui  Wang" /></meta><meta name="dc.Description" content="The recent success of PD-1/PD-L1 antibodies for advanced cancer treatment has led to the conclusion that activating the immune system can be employed to fight cancer. These results also encourage t..." /></meta><meta name="Description" content="The recent success of PD-1/PD-L1 antibodies for advanced cancer treatment has led to the conclusion that activating the immune system can be employed to fight cancer. These results also encourage t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 7, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01314" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01314" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01314" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01314" /></link>
        
    
    

<title>Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01314" /></meta><meta property="og:title" content="Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0022.jpeg" /></meta><meta property="og:description" content="The recent success of PD-1/PD-L1 antibodies for advanced cancer treatment has led to the conclusion that activating the immune system can be employed to fight cancer. These results also encourage the development of small molecule immunomodulators for cancer immunotherapy. RORγt is a key transcription factor mediating Th17 cell differentiation and IL-17 production, which is able to activate CD8+ T cells and elicit antitumor efficacy. Since RORγt agonists have been shown to increase basal activity of RORγt and promote Th17 cell differentiation, development of RORγt agonists could provide a unique approach to cancer immunotherapy. In this review, we summarize RORγt sterol and synthetic agonists, analyze the common ground of their mode of actions, and discuss the potential role of RORγt agonists as small molecule therapeutics for cancer immunotherapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01314"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01314">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01314&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01314&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01314&amp;href=/doi/10.1021/acs.jmedchem.7b01314" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5794-5804</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01306" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b01689" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ruomeng Qiu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruomeng Qiu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruomeng++Qiu">Ruomeng Qiu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Yonghui Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yonghui Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, China</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +86 21 5198 0118. E-mail: <a href="/cdn-cgi/l/email-protection#84fdebeae3ecf1edf3e5eae3c4e2f1e0e5eaaae1e0f1aae7ea"><span class="__cf_email__" data-cfemail="1f66707178776a76687e71785f796a7b7e71317a7b6a317c71">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yonghui++Wang">Yonghui Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0262-2431" title="Orcid link">http://orcid.org/0000-0002-0262-2431</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01314&amp;href=/doi/10.1021%2Facs.jmedchem.7b01314" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5794–5804</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 7, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 September 2017</li><li><span class="item_label"><b>Published</b> online</span>7 February 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 July 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01314" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01314</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5794%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRuomeng%2BQiu%252C%2BYonghui%2BWang%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D14%26contentID%3Dacs.jmedchem.7b01314%26title%3DRetinoic%2BAcid%2BReceptor-Related%2BOrphan%2BReceptor%2B%25CE%25B3t%2B%2528ROR%25CE%25B3t%2529%2BAgonists%2Bas%2BPotential%2BSmall%2BMolecule%2BTherapeutics%2Bfor%2BCancer%2BImmunotherapy%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5804%26publicationDate%3DJuly%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01314"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3055</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01314" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ruomeng&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Yonghui&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5794-5804&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01314&quot;},&quot;abstract&quot;:&quot;The recent success of PD-1/PD-L1 antibodies for advanced cancer treatment has led to the conclusion that activating the immune system can be employed to fight cancer. These results also encourage the development of small molecule immunomodulators for cancer immunotherapy. RORγt is a key transcription factor mediating Th17 cell differentiation and IL-17 production, which is able to activate CD8+ T cells and elicit antitumor efficacy. Since RORγt agonists have been shown to increase basal activity of RORγt and promote Th17 cell differentiation, development of RORγt agonists could provide a unique approach to cancer immunotherapy. In this review, we summarize RORγt sterol and synthetic agonists, analyze the common ground of their mode of actions, and discuss the potential role of RORγt agonists as small molecule therapeutics for cancer immunotherapy.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01314&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01314" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01314&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01314" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01314&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01314" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01314&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01314&amp;href=/doi/10.1021/acs.jmedchem.7b01314" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01314" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01314" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01314%26sid%3Dliteratum%253Aachs%26pmid%3D29412659%26genre%3Darticle%26aulast%3DQiu%26date%3D2018%26atitle%3DRetinoic%2BAcid%2BReceptor-Related%2BOrphan%2BReceptor%2B%25CE%25B3t%2B%2528ROR%25CE%25B3t%2529%2BAgonists%2Bas%2BPotential%2BSmall%2BMolecule%2BTherapeutics%2Bfor%2BCancer%2BImmunotherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D14%26spage%3D5794%26epage%3D5804%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/jmcmar.2018.61.issue-14/20180726/jmcmar.2018.61.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The recent success of PD-1/PD-L1 antibodies for advanced cancer treatment has led to the conclusion that activating the immune system can be employed to fight cancer. These results also encourage the development of small molecule immunomodulators for cancer immunotherapy. RORγt is a key transcription factor mediating Th17 cell differentiation and IL-17 production, which is able to activate CD8<sup>+</sup> T cells and elicit antitumor efficacy. Since RORγt agonists have been shown to increase basal activity of RORγt and promote Th17 cell differentiation, development of RORγt agonists could provide a unique approach to cancer immunotherapy. In this review, we summarize RORγt sterol and synthetic agonists, analyze the common ground of their mode of actions, and discuss the potential role of RORγt agonists as small molecule therapeutics for cancer immunotherapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43453" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43453" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer immunotherapy has generated inspiring clinical success recently after decades of research effort.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Harnessing the human body’s own immune system, cancer immunotherapy has been widely recognized as a revolutionary approach to fight cancer, either as a standalone treatment or combined with surgery, radiotherapy, chemotherapy, and other established targeted therapy.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4−7)</a></div><div class="NLM_p">In spite of contributions by other immune cell subtypes, CD8<sup>+</sup> T cells have arisen as the prominent component in most antitumor immunity settings.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, one of the challenges that remain is tumor immune escape, as the activity of CD8<sup>+</sup> T cells is down regulated in the tumor microenvironment.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Multiple immunotherapeutic strategies including cytokines, vaccine, adoptive cell transfer, and checkpoint blockades are aimed at reactivating, improving, and maintaining responses by antitumor CD8<sup>+</sup> T-cells.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11−14)</a> The recently approved antibody drugs, nivolumab and pembrolizumab as PD-1 inhibitors and atezolizumab, avelumab, and durvalumab as PD-L1 inhibitors,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> have demonstrated significant efficacy and are expected to be blockbusters in the future.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Yet considering that small molecule therapeutics offer unique complementary advantages and are potentially synergistic with biologics, it is of great interest to develop alternative pathways available for small molecule intervention to boost the antitumor activity of CD8<sup>+</sup> T cells.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a></div><div class="NLM_p">T helper 17 (Th17) cells, one of T-cell subsets differentiated from naive CD4<sup>+</sup> T cells, are characterized by unique transcription factors and IL-17 production.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Previously, Th17 cells have been well described as an essential inflammatory effector and shown to promote inflammation in various autoimmune diseases.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> Recent studies show that Th17 cells and IL-17 expression are broadly distributed in human tumors.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22−25)</a> It has been demonstrated that Th17 cells are actively involved in tumor immunology processes and have potential antitumor efficacy by eliciting remarkable activation of CD8<sup>+</sup> T cells, which makes Th17 cells a potential source of targets for cancer immunotherapy.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a></div><div class="NLM_p">Retinoic acid receptor-related orphan receptor γt (RORγt) belongs to the nuclear receptor (NR) superfamily, which has provided a rich source of targets appropriate for small molecule therapeutic development of various human diseases.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> RORγt is specifically expressed by Th17 cells and is the key transcription factor to drive naive CD4<sup>+</sup> T cells differentiated into Th17 cells.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Since RORγt agonists have been shown to increase basal activity of RORγt and promote Th17 cell differentiation, development of RORγt agonists could provide a unique approach to cancer immunotherapy.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Although there have been quite a few research articles in recent years on RORγt modulators, there are no reviews focusing exclusively on RORγt agonists. This review covers the reported RORγt sterol and synthetic agonists, their mode of actions (MOAs), and their potential role in cancer immunotherapy. Discovery progress from the first natural RORγ ligands to the most recently identified Th17 cell endogenous agonist of the orphan receptor RORγ has been summarized. Furthermore, we have elaborated on the published synthetic small molecule RORγt agonists, their structural insights, and the common ground of their MOAs. Finally, we discuss the potential of small molecule RORγt agonists as novel therapeutics for cancer immunotherapy.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">1.1.  NR Superfamily and MOA</h3><div class="NLM_p">The NR superfamily consists of 48 transcription factors in human, including the receptors for steroid hormones, lipophilic vitamins, thyroid hormone, and cholesterol metabolites.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Approximately half of NRs are defined as orphan receptors since their ligands have not been identified. The NRs regulate a wide spectrum of physiological processes, and fairly all the NRs with identified ligands are developable targets for drug discovery.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> NR modulators have proven to be a rich source of pharmaceuticals, and in 2009 it was estimated that NR drugs accounted for approximately 13% of all pharmaceutical sales in the U.S. and an appreciable share of global sales.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p last">Nuclear receptors share a highly conserved domain that is divided into six subregions (regions A–F) based on sequence similarity. The structure consists of AF1 (activation function 1) region (A/B region), followed by zinc-finger DBD (DNA binding domain) (C region), hinge domain (D region), LBD (ligand binding domain) containing the AF2 (activation function 2) region (E region). Some receptors contain a region from LBD to the C-terminal, making up the F region. The ability of NR LBDs to trigger the transcriptional network is modulated by helix 12 at the C-terminal.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Helix 12 is a crucial component of the NR LBDs because its ligand-induced reorientation contributes to the surfaces in a critical manner, recruiting or expelling coactivators/corepressors and regulating the level of transcriptional activity. Several cocrystal structures of NR LBDs have revealed that the interactions of ligands with helix 12 significantly determine AF2 stability. Besides, helix 12 has intermediary positions (rather than simply being active or inactive), suggesting that ligands can be designed to have different degrees of agonism/inverse agonism. Therefore, chemistry can generate not only receptor-specific ligands but also full or partial agonists/inverse agonists, leading to NR-based drug development.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.2.  RORγt</h3><div class="NLM_p">The retinoic acid receptor-related orphan receptor γ (RORγ or NR1F3) is a key NR of the ROR family, identified after RORα (RORa or NR1F1) and RORβ (RORb or NR1F2).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> RORα is most widely expressed in multiple organs, such as the liver, kidney, thymus, and brain.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> RORβ expression is restricted to the central nervous system.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> RORγ exists in two distinct isoforms, RORγ (RORγ1) and RORγt (RORγ2), and share the identical sequence through DBD to the LBD at the C terminus and only differ in their N-terminal sequences by only 24 amino acids.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> The mRNA for RORγ is widely observed in many tissues, but RORγt isoform is mainly expressed in the immune system, especially in thymus.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">RORγt is a key transcription factor for Th17 cell differentiation and IL-17 production.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Other transcription factors, including STAT3, BATF, IRF4, RUNX1, and IκBζ, also play an important role in pharmacological processes of Th17 cell differentiation. In terms of small molecule drug discovery, RORγt contains a typical-NR ligand binding domain (LBD) that binds and interacts with small molecule ligands, making it an attractive therapeutic target.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">2.  RORγt Agonists and Their Mode of Actions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.1.  Sterol RORγt Agonists</h3><div class="NLM_p">During exploration of RORγ endogenous ligands and their role in Th17 cell differentiation, a myriad of sterols as RORγ natural ligands have been discovered, most of which serve as RORγ agonists.<a onclick="showRef(event, 'ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref46">(43−46)</a></div><div class="NLM_p">In 2010, Jin et al. reported four RORγ sterol agonists (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> These were the first discovered RORγ natural ligands that led to the first determined RORγ structure. To explore cholesterol and its hydroxycholesterol derivatives’ role in RORγ, the interaction of RORγ with coactivator SRC1 (SRC1-2) either with or without cholesterol and hydroxycholesterols (HCs) was monitored in an AlphaScreen biochemical assay. RORα showed a high basal interaction with the SRC1-2 coactivator as a proof of concept. Ligands <b>1</b> (cholesterol), <b>2</b> (20α-hydroxycholesterol), <b>3</b> (22R-hydroxycholesterol), and <b>4</b> (25-hydroxycholesterol) also strongly enhanced the interaction of RORγ with coactivators instead of corepressors. Besides, the EC<sub>50</sub> of the tested hydroxycholesterols were around 0.02–0.04 μM against RORγ, compared with the EC<sub>50</sub> of 0.02 μM for cholesterol, which was previously identified as a natural ligand of RORα. These results suggested that endogenous hydroxycholesterols played an important role in modulating RORγ-dependent biological processes.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. First reported RORγ natural ligands as RORγ agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additionally, the crystal structures of <b>2</b>, <b>3</b>, and <b>4</b> with RORγ LBD were resolved (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The cocrystal complex revealed that RORγ LBD contained 12 α-helices and two short β-strands that were folded into a typical three-layer helix sandwich. The coactivator (SRC2-2) adopted a two α-helix that directed hydrophobic side chains toward RORγ coactivator binding surface. The C-terminal AF2 was positioned in the active conformation, consistent with the agonist activity results of AlphaScreen assays. These structures revealed the binding modes of hydroxycholesterols with RORγ LBD and provided the typical coactivator-recruiting conformation of RORγ.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) <b>4</b> with RORγ LBD. (B) overlay of <b>2</b> (gray), <b>3</b> (green), and <b>4</b> (blue). PDB codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KYT">3KYT</a> (RORγ/<b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0J">3L0J</a> (RORγ/<b>3</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0L">3L0L</a> (RORγ/<b>4</b>). Blue dashes represent hydrogen bond interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2014, Soroosh et al. discovered a series of oxysterols as RORγt agonists (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In a RORγ-LBD Gal4 reporter assay, several oxysterols showed significant agonism activity, with <b>5</b> (27-hydroxycholesterol), <b>7</b> (7β, 27-hydroxycholesterol), and <b>8</b> (7-keto, 27-hydroxycholesterol) having the best potency and efficacy. The direct binding of oxysterols with RORγ LBD was identified by a thermal shift assay and a <sup>3</sup>H-labeled 25-hydroxycholesterol binding assay, and promotion of coactivator recruitment and reduction of corepressor binding were observed. In murine and human primary cells, <b>7</b> and <b>6</b> (7α, 27-HC) promoted Th17 cell differentiation in a RORγt-dependent manner. More importantly, these two oxysterols, <b>6</b> and <b>7</b>, were found to be specifically produced by Th17 cells. In vivo administration of <b>7</b> observed enhanced IL-17 production in mice. In CYP27A1-deficient mice, which lacked an essential enzyme for generation of these oxysterols, a significant reduction of IL-17 producing cells was observed, and it was phenotypically similar to RORγt knockout mice. These results suggested that naturally generated oxysterols acted as RORγ agonists, and the author speculates that oxysterols may potentially serve as RORγt endogenous ligands to drive IL-17 dependent immune responses.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Oxysterol RORγt agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2015, Santori et al. showed that sterols were essential and sufficient to trigger the RORγ-dependent transcriptional network and that the RORγt ligand is a cholesterol biosynthetic intermediate in mammalian cells.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> To map the RORγ ligand biosynthetic pathway, 78 cholesterol biosynthetic intermediates were tested in a RORγ reporter assay in insect cells, and 46 of them were bioactive. Combined with overexpression, RNA interference, and genetic deletion of metabolic enzymes to investigate the RORγ-dependent transcriptional network, it was proven that the RORγ ligands could be cholesterol biosynthetic intermediates (CBIs) as lanosterol downstream and zymosterol upstream. Lipid molecules bound to RORγ were analyzed by LC/MS/MS, and they had consistent molecular weights with CBIs. In addition, CBIs stabilized the RORγ LBD and promoted coactivator recruitment, which was consistent with a previous study. This study suggested that possible endogenous ligands of RORγ were methylated CBIs or related metabolites, which is a major step toward the identification of RORγ endogenous ligands.</div><div class="NLM_p">Furthermore, the cocrystal complex of <b>9</b> (4α-carboxy-4β-methyl-zymosterol, 4ACD8) with RORγ was obtained (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4S14">4S14</a>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In the RORγ-<b>9</b> cocrystal structure, helix 12 showed an agonism-like conformation, packed tightly to the LBD surface, and directly interacted with the coactivator. The cocrystal structure displayed a well-organized arrangement of 4ACD8 (<b>9</b>) in the RORγ LBD with the carboxy group of <b>9</b> interacting with RORγ residues (Q286, L287). These interactions ensured the universal binding affinity of CBIs to RORγ, similar to those of previously studied RORγ agonists.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Chemical structure of 4ACD8 (<b>9</b>); (B) RORγt-<b>9</b> cocrystal structure; (C) key interactions of RORγ LBD with <b>9</b> (blue dashes represent hydrogen bond interactions).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2015, Hu et al. confirmed that <b>11</b>, a sterol produced after CYP51 demethylation, is an endogenous RORγ agonist (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> To identify whether precursors of cholesterol bind to RORγ and induce coactivator recruitment, a set of sterols was tested in RORγ coactivator recruitment profiling with ursolic acid added. Among these sterols, <b>10</b> and <b>11</b>, two late-stage cholesterol precursors significantly promoted coactivator recruitment with EC<sub>50</sub> values of 0.11 μM and 0.08 μM, respectively. In addition, <b>10</b> and <b>11</b> boosted IL-17 production in Th17 cell differentiation. Levels of selected sterols in Th17 cells were measured by LC/MS/MS. Only cholesterol and desmosterol were detectable among the tested sterols. Since cholesterol was unable to be generated by enzymes expressed in Th17 cells, it can be confirmed that desmosterol is an endogenous ligand in Th17 cells.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of <b>10</b> (zymosterol) and <b>11</b> (desmosterol).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.2.  Synthetic RORγt Agonists</h3><div class="NLM_p">In 2010, Scripps Florida disclosed compound <b>13</b>, the first published synthetic small molecule as a RORγ agonist (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a><b>13</b> was discovered from a series of compounds derived from <b>12</b>, the previously identified inverse agonist of RORα/RORγ. By slightly changing from <i>N-</i>phenylbenzenesulfonamide to <i>N-</i>phenylbenzamide, <b>12</b> and <b>13</b> displayed opposite activity and different degrees of selectivity. <b>13</b> functioned as a RORα/γ agonist, while <b>12</b> functioned as a RORα/γ inverse agonist; in addition, <b>12</b> has promiscuous activity by modulating RORα, RORγ, LXR, and FXR, while <b>13</b> selectively modulated RORα/γ receptors, which indicated a high potential of <b>13</b> to be a chemical probe for RORα/γ function. In the AlphaScreen assay, <b>13</b> functioned as a ROR agonist on full-length RORα/γ. The agonism of <b>13</b> was further confirmed in HepG2 cells at 10 μM. The pharmacodynamics (PD) profile of <b>13</b> was also evaluated by ip administration at 10 mg/kg in mice, and increasing G6 Pase and FGF21 mRNA levels were detected in harvested mice livers, which was consistent with the fact that <b>13</b> functioned as a RORα/γ agonist. It is worth mentioning that <b>13</b> activates the receptor beyond the normal level, along with <b>12</b>, indicating the possibility of developing synthetic small molecules to suppress or further activate ROR receptors.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of <b>12</b> (T0901317) and <b>13</b> (SR1078).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2012, GSK accidentally discovered a class of aryl amides as RORγ agonists while screening for RORγ small molecule inhibitors (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The representative three aryl amide compounds (<b>14</b>–<b>16</b>) displayed their activities with an EC<sub>50</sub> of ∼0.1 μM in IL-17 reporter assay. The three agonists also elevated thermal stability by ∼3 °C, indicating that these compounds directly bind to RORγ. Compound <b>15</b> promoted IL-17 production in a mouse Th17 cell differentiation assay with the maximum response of 220% at 3 μM, which further confirmed that RORγ activation and downstream biological effects were induced by these compounds.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Aryl amides as RORγ agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2014, Wang and colleagues at GSK discovered a novel series of tertiary amines ranging from RORγt agonist to inverse agonists (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> SAR explorations starting from inverse agonist <b>17</b> yielded a tertiary amine <b>18</b> as a potent RORγt agonist with an EC<sub>50</sub> of 0.02 μM in a RORγ dual FRET assay. A cocrystal structure of <b>18</b> with the RORγ LBD was obtained (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NIE">4NIE</a>), and the overall binding mode was essentially the same as previously predicted (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Two hydrogen bond interactions of the sulfonyl group with Arg367 and the linker amide with a backbone carbonyl residue were observed. Furthermore, the sulfonylphenyl ring and the middle phenyl ring formed π–π stacking interactions with Phe377 and Phe378, respectively. Notably, the left-hand side (LHS) benzyl group occupied the hydrophobic pocket around Trp317 and Tyr502, the key site for stabilizing helix 12.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Discovery of tertiary amines as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) RORγ cocrystal structure with agonist <b>18</b>; (B) key interactions of RORγ LBD with <b>18</b> (blue dashes represent hydrogen bond interactions, and pink dashes represent π–π stacking interactions).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initiated from agonist <b>18</b>, a series of tertiary amines with different sizes of 4-substituted moieties on LHS phenyl ring were designed, synthesized, and biologically evaluated in both a RORγ dual FRET assay and FRET assay. As the size of the substitution increased (compounds <b>18</b>–<b>20</b>), maximum activation of the compounds decreased as indicated in a RORγ dual FRET assay. When the size of the LHS substituents was further enlarged, compound <b>21</b> did not affect the basal activity of RORγt and could be regarded as a neutral antagonist. Futhermore, compounds <b>22</b>–<b>24</b> could be considered inverse agonists according to the increased level of inhibition indicated in the RORγ FRET assay.</div><div class="NLM_p">The activity results together with the cocrystal structure revealed a typical RORγ mode of action. The strong association between substituent bulkiness and the inhibition level could be interpreted as differing sizes of LHS moieties push away helix 12 to different degrees, thus influencing the ability of coactivator and corepressor recruitment at different levels. Notably, in contrast to the stepwise inhibition variation, the potency was barely influenced by substituent size. Further evaluation of <b>23</b> was performed by peptide recruitment in a RORγ dual FRET assay. Consequently, neither coactivator nor corepressor was recruited by RORγ LBD. This was the first discovery that a certain RORγt inverse agonist did not recruit corepressors. These results need to be studied further.</div><div class="NLM_p">In 2015, Wang and colleagues reported a novel series of thiazole amides as RORγt modulators (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Several partial agonists were identified, and the resolved cocrystal structure of <b>27</b> with the RORγ LBD provided structural insights into the mode of action. On the basis of the structure of HTS hit <b>17</b>, a set of compounds with different 5-substitutions on the thiazole ring were evaluated in both RORγ FRET and dual FRET assays. Small alkyl moieties such as Me (<b>25</b>) and Et (<b>26</b>) did not affect RORγt activity as seen in either FRET or dual FRET assays. However, the bulky group such as phenyl (<b>27</b>) showed decreased maximum inhibition in RORγ FRET assay. Furthermore, <b>27</b> behaved as a partial agonist, and it activated RORγt with a pEC<sub>50</sub> of 5.5, achieving 150% maximum activation seen in RORγ dual FRET assay. When 5-substituted moieties were changed into benzyl (<b>28</b>) and phenoxy (<b>29</b>), the compounds became inverse agonists. These results indicated a correlation between RORγt partial agonism activity and the bulky phenyl moiety on this thiazole amide scaffold.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Thiazole amides as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A cocrystal structure of RORγ LBD with <b>27</b> was obtained (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XT9">4XT9</a>) and showed similar interactions to the previously reported tertiary amine RORγt agonist (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The sulfonyl group formed hydrogen bonds with Arg367 and Leu287, and amide NH formed hydrogen bonds with the backbone carbonyl of Phe377, respectively (blue dash in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). π–π stacking interactions between two phenyl rings of <b>27</b> and Phe377 and Phe388 were observed. The thiazole ring also had a π–π stacking interaction with Phe378 (pink dash in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). The 5-thiazole phenyl group occupied the hydrophobic space near AF2 domain and thus stabilized the AF2 domain toward coactivator recruitment. The overlay of <b>27</b> with the full RORγt agonist 20-hydroxycholesterol showed that the 5-phenyl only partially occupied the hydrophobic pocket which made <b>27</b> a partial agonist. When a CH<sub>2</sub> or O linker was added into the thiazole ring and 5-phenyl group, it pushed the phenyl group away from the hydrophobic site and thus may not be sufficient for AF2 domain stabilization, making <b>28</b> and <b>29</b> inverse agonists. Besides, addition of 2-methoxy group on the phenyl group led <b>30</b> to be a partial agonist because the 2-methoxy moiety of <b>30</b> occupied more space in the hydrophobic site around the AF2 domain. It was demonstrated that different sizes of substituted moieties influenced the stability of helix 12, resulting in a functional switch only by minor structure changes.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Co-crystal structure of RORγ LBD with <b>27</b>; (B) key interactions of RORγ LBD with <b>27</b> (blue dashes represent hydrogen bond interactions, and pink dashes represent π–π stacking interactions).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2014, Genentech reported divergent modes of action resulting from minor structural changes from phenylsulfonamides to benzylsulfonamides (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In the process of optimization, parallel synthesis yielded the pair of benzylsulfonamide <b>32</b> and phenylsulfonamide <b>33</b>, which was derived from inverse agonist <b>31</b>. In a RORγ SRC1 recruitment assay, benzylsulfonamide <b>32</b> exhibited inverse agonist activity with an IC<sub>50</sub> of 0.015 μM, while phenylsulfonamide <b>33</b> showed agonist activity with an EC<sub>50</sub> of 0.25 μM.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Sulfonamides as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cocrystal structures of inverse agonist <b>31</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WQP">4WQP</a>) and agonist <b>33</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WPF">4WPF</a>) with the human RORγ LBD were solved (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). From an overlay of the two complexes, it was found that the two ligands almost identically overlapped from the acetyl group through the middle phenyl ring. The compounds then oriented divergently. The terminal phenyl group of the agonist ligand <b>33</b> interacted with Trp317, His479, and Tyr502, stabilizing helix 12 in an agonist-like conformation, while the benzyl group of the inverse agonist <b>31</b> disrupted the His479-Tyr502 hydrogen bond near helix 12. This observation provided an explanation for <b>31</b> behaving in an inverse agonist manner. Moreover, in the inverse agonist <b>31</b> complex, the helix 11 C-terminal bent inward by 16°, while aromatic side chains rotated and the pocket apex was repacked in the absence of helix 12. Trp317 and Phe486 also reorientated and the filled pockets formed following these changes. These switch-like motions explained how inverse agonist <b>31</b> interfered with helix 11 and helix 12, leading to inverse agonism activity.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Cocrystal structure inverse agonist <b>31</b> (purple) and agonist <b>33</b> (green) with RORγ LBD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2016, a series of benzoxazepine benzamides as RORγt modulators were disclosed by AstraZeneca (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The opposite behaviors induced by slightly modified compounds were also observed. In a cofactor recruitment assay, most compounds behaved as potent and selective RORγt inverse agonists, whereas five compounds behaved as RORγt agonists, promoting coactivator recruitment with efficacy up to 58% at a concentration of 1 μM. The soaked-in crystal structures of inverse agonist <b>34</b> and agonist <b>35</b> with RORγ-LBD were solved (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APJ">5APJ</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APH">5APH</a>, respectively). However, the binding modes were similar and could not provide a solid explanation for the different mode of actions (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>A). To identify the potential triggers for the inverse agonism of compound <b>34</b>, cocrystallization with the RORγ LBD without a coactivator peptide was carried out (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APK">5APK</a>) (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>B). In this way, a different binding mode of inverse agonist <b>34</b> was identified. The NH of the benzamide group formed a hydrogen bond interaction with His479, effectively disturbing the His479-Tyr502 agonist lock, which was a crucial interaction for maintaining the agonist conformation. Additionally, an induced fit binding mode was discovered, in which helix 11 residues formed a pocket around the halogen-substituted benzamide group. The induced-fit binding like mode of action has never been observed in previously reported inverse agonist cocrystal structures, and the detailed mechanism of achieving inverse agonism required further exploration.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Benzoxazepine benzamides as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (A) Superposition of soak-in crystal structures of <b>34</b> (purple) and <b>35</b> (green). (B) Superposition of cocrystal structure of <b>34</b> (red) and soak-in crystal structure of <b>35</b> (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2016, Biogen reported benzoxazinone as RORγt modulators including an inverse agonist <b>36</b> and an agonist <b>37</b> (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Having similar chemical scaffold, <b>36</b> was only three atoms larger compared to the benzo[1,4]oxazine-3-one ring of <b>37</b>. To investigate how minor differences lead to inverse agonism, an X-ray crystallography study was carried out and their cocrystal structures with full-length or partial proteolyzed RORγ were solved (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IXK">5IXK</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IZ0">5IZ0</a>, respectively) (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>). The agonist-bound construct showed that the agonist conformation was stabilized by His479-Tyr502 hydrogen bond, which was critical for agonist conformation. Next, cocrystallization with the inverse agonist <b>36</b> and RORγ518 was attempted but did not produce any crystals. By use of RORγ518 with proteolyzed AF2 helix, the inverse agonist-bound construct was obtained. Together with the cocrystal structure of <b>37</b>, it can be concluded that the agonist conformation of the cocrystal structure of <b>37</b> would be perturbed by Met358 and pushed by BIO399 into Phe506 of AF2 domain, suggesting that Met358 positioning is crucial for triggering RORγ inverse agonism.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Benzoxazinones as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Overlay of inverse agonist <b>36</b> (BIO399, purple) and agonist <b>37</b> (BIO592, green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2016, Scripps reported <b>38</b>, discovered from SAR exploration of the first identified RORγt agonist <b>13</b> (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Using desmosterol as a control for agonism, the efficacy of <b>13</b> as a RORγt agonist was determined in a Gal4 reporter assay. In the same system, <b>38</b> resulted in a further increase in the expression of IL-17. Unexpectedly, treatment with <b>38</b> also led to a decrease in the expression of PD-1 without impact on the expression of granzyme B (cytotoxicity marker). Together, these results suggested that treatment with <b>38</b> may enhance protective immunity by regulating the expression of IL-17 and PD-1 while maintaining the cytotoxic ability of these cells. And this hypothesis was also validated by a Th17 cell differentiation assay using Jurkat T cells. The discovery of dual function of anti-PD-1 and T cell activation of RORγt agonists may provide a unique approach to cancer immunotherapy.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. <b>13</b> and its analog <b>38</b> (SR0987).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To study the mode of action in view of structural insights, hydrogen/deuterium exchange (HDX) mass spectrometry was applied with desmosterol, <b>13</b>, and <b>38</b>. When treated with either <b>13</b> or <b>38</b>, protection to solvent exchange was also observed in helix 12 but was not observed with desmosterol. This phenomenon was consistent with the stabilized conformation of helix 12 in previously reported cocrystallization structures, and it provided an explanation for why <b>38</b> acted as a RORγt agonist.</div><div class="NLM_p">Doebelin et al. from the Scripps Institute reported a series of <i>N-</i>arylsulfonylindolines as RORγ agonists (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The first RORγ agonist was accidentally discovered by N-methylation of the amide linker of inverse agonist <b>39</b>. Similar to previously reported mode of action studies, the linker played a major role in deciding specific pharmacology wherein a potent RORγ inverse agonist could be converted into a RORγ agonist, while the binding affinity was not much influenced. After SAR exploration of multiple linkers, ether (-CH<sub>2</sub>O-) was identified as preferred linker to exhibit RORγ agonism. Further optimization had minor effects on in vitro activity. HDX data were able to delineate the structural mechanism for the switch in pharmacology from an inverse agonist <b>39</b> to an agonist <b>40</b> through increased helix 12 stabilization, a phenomenon that was constantly observed in nuclear receptors. These RORγ agonists had poor metabolic stability probably caused by the high lipophilicity. Yet considering adequate plasma exposure following ip dosing, these compounds may be used as tools to investigate RORγ activation in animal tumor models.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. <i>N-</i>Arylsulfonylindolines as RORγ agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2015, Lycera disclosed three patents claiming RORγt agonists.<a onclick="showRef(event, 'ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57">(55−57)</a> The patents provided sulfonamido and related compounds, methods of boosting RORγ activity and/or enhancing the amount of IL-17 in a subject, and methods of treating various medical disorders especially aiming at various cancers. In patent WO2015131035 A1, three sulfonamido compounds (<b>41</b>–<b>43</b>) were listed as potent RORγt agonists (<a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>) with average EC<sub>50</sub> values under 0.5 μM in a TR-FRET assay and a Gal4 reporter assay. Adoptive transfer of Tc17 to mice EG7 tumor model and Tc17/Th17/both to mice B16F10 tumor model was exemplified, demonstrating RORγt agonist suppressing tumor growth through T-cell activation. Additionally, obvious antitumor efficacy was observed at the compound concentration of 5 μM to 10 μM.</div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Exemplary RORγt agonists in patent WO2015131035 A1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Two patents were published in 2016 by Lycera which particularly provided dihydro-2<i>H</i>-benzo[<i>b</i>][1,4]oxazine sulfonamide and related compounds (e.g., <b>46</b> and <b>47</b>) as follow-up to the 2015 patents (e.g., <b>44</b> and <b>45</b>).<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> Compared to WO2015131035 and WO2015171610, the exemplary compounds in WO2016201225 and WO2016179343 have similar core structures but with different left-side linkers or right-side substituents (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>). Exemplary compounds were tested in a TR-FRET assay and a Gal4 RORγ assay, and the most potent compounds were less than 0.5 μM with the maximum response of greater than 200%.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Representative RORγt agonists in Lycera’s patents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In June of 2015, Celgene paid Lycera $105 million to partner with Lycera’s anticancer T-cell technology, which was assumed by emerging evidence as orally available RORγ agonists.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In January 2017, the RORγ agonist named LYC-55176 from Lycera entered into phase 2A trial (NCT02929862) and was orally dosed as a single agent for locally advanced or metastatic solid tumors.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In addition to Lycera, several pharmaceutical companies have begun to initiate anticancer RORγ agonist projects (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Collectively, it can be concluded that synthetic RORγ agonists potentially serve as novel small molecule therapeutics for cancer immunotherapy.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Current Active Projects of Anticancer RORγt Agonists<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">drug name</th><th class="colsep0 rowsep0" align="center">active company</th><th class="colsep0 rowsep0" align="center">active indication</th><th class="colsep0 rowsep0" align="center">status</th><th class="colsep0 rowsep0" align="center">added date</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RORγt agonist (cancer)</td><td class="colsep0 rowsep0" align="left">Nuevolution</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">discovery</td><td class="colsep0 rowsep0" align="left">Jan 24, 2017</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RORγ agonists (oral, cancer)</td><td class="colsep0 rowsep0" align="left">Celgene Corp</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">discovery</td><td class="colsep0 rowsep0" align="left">Nov 08, 2016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RORγ agonists (cancer)</td><td class="colsep0 rowsep0" align="left">Aurigene</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">discovery</td><td class="colsep0 rowsep0" align="left">Dec 18, 2015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">INV-71</td><td class="colsep0 rowsep0" align="left">Innovimmune</td><td class="colsep0 rowsep0" align="left">cancer</td><td class="colsep0 rowsep0" align="left">discovery</td><td class="colsep0 rowsep0" align="left">Jan 20, 2017</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LYC-55716</td><td class="colsep0 rowsep0" align="left">Lycera Corp</td><td class="colsep0 rowsep0" align="left">advanced solid tumor</td><td class="colsep0 rowsep0" align="left">phase 2A</td><td class="colsep0 rowsep0" align="left">Jan 05, 2017</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data retrieved from Cortellis, Thomson Reuters.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">3.  Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15864" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15864" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The NR superfamily has been considered attractive targets involved in various human diseases. Since NRs contain a conserved ligand-binding domain, they are ideal receptors for development of small molecuar ligands. As a member of the NR superfamily, many RORγt small molecule modulators have been discovered, including endogenous sterol ligands and synthetic small molecule modulators. In recent years, substantial progress has been made in the discovery of RORγt agonists, even though some studies may not be focused on agonists at first. Sterols, as first identified RORγ ligands, led to determination of the RORγ structure and initiated progress toward the identification of endogenous RORγ agonists. Synthetic RORγt agonists have been unexpectedly discovered through agonist/inverse agonist conversion, and their crystallization structures revealed similar mode of actions. Stabilization of a hydrophobic pocket formed around Trp317 and Tyr502 near helix 12 is crucial in recruiting coactivators and functioning in an agonist-like manner. Minor structural changes to synthetic ligands, such as enlarging substituents or changing linkers, pushed the hydrophobic pocket and disrupted the His479-Tyr502 lock, resulting in a functional switch between agonist and inverse agonist. In general, together with discovered RORγt modulators, recent progress of RORγt structural insights has provided key principles guiding structure-based design for discovery of synthetic RORγt agonists.</div><div class="NLM_p last">Since Th17 cell differentiation and IL-17 have been demonstrated to elicit an antitumor effect by activating CD8<sup>+</sup> T cells, RORγt, as the key lineage transcription factor to initiate the Th17 cell differentiation and IL-17 production, is considered a potential target for cancer immunotherapy. Moreover, several synthetic RORγt agonists have been shown to inhibit PD-1 expression on Th17 cells and regulate other pathways favorable to antitumor immunity. A recent paper reported that a RORγ antagonist has an antitumor effect on prostate cancer by acting on upstream of the androgen receptor (AR), yet this is resulted from a distinct mechanism.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> In theory, there is also the potential risk that RORγt agonists could cause autoimmune disorders, resulting from increased levels of IL-17. However, no experimental findings or clinical evidence has been reported for this side effect so far.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Therefore, along with LYC-55716 entering into phase 2A study, the development of RORγt agonists may provide a promising approach toward novel small molecule therapeutics for cancer immunotherapy.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01314" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yonghui Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0262-2431" title="Orcid link">http://orcid.org/0000-0002-0262-2431</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dfa6b0b1b8b7aab6a8beb1b89fb9aabbbeb1f1babbaaf1bcb1"><span class="__cf_email__" data-cfemail="b9c0d6d7ded1ccd0ced8d7def9dfccddd8d797dcddcc97dad7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruomeng Qiu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry,
School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Ruomeng Qiu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=BIO-d156e1312-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ruomeng Qiu</b> is a graduate student in medicinal chemistry under the supervision of Professor Yonghui Wang at Fudan University. She earned her B.S. degree from the School of Pharmacy at Fudan University in 2015. Her research interests include discovery of novel RORγt agonists for cancer immunotherapy and phenotypic drug discovery of small molecular IL-17 suppressors.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Yonghui Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=BIO-d156e1317-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yonghui Wang</b> obtained his Ph.D. in Organic Chemistry from Virginia Tech in 1997 and had his postdoctoral training in physical and synthetic organic chemistry at Harvard University from 1997 to 2001. He then worked at GlaxoSmithKline R&D as a principal scientist, investigator, and associate director for more than 12 years. Since 2014, he has become a professor at the School of Pharmacy at Fudan University, China. His current research focuses on small molecule drug discovery for autoimmune diseases and cancer immunotherapy. He has published more than 50 scientific papers and is co-inventor of 30 PCT international patents.</p></figure></div><div class="ack" id="ACK-d156e1322-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank all the present and past members of the working group that were not actively involved in this publication for the help with some of the ideas and for the stimulating discussions: Ting Tang, Yafei Huang, Mingcheng Yu, Nannan Sun, Wei Fu. We thank Professor Di Zhu for helpful discussions. We are grateful to Tony Wang and Caitlin Wang for the proofreading of the manuscript. This work was supported by National Science Foundation of China (Grant 81573276) and Shanghai Biopharmaceutical Science and Technology Supporting Plan (Grant 15431900300).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AF2</td><td class="NLM_def"><p class="first last">activation function 2</p></td></tr><tr><td class="NLM_term">CBI</td><td class="NLM_def"><p class="first last">cholesterol biosynthetic intermediate</p></td></tr><tr><td class="NLM_term">CYP51</td><td class="NLM_def"><p class="first last">cytochrome P450, family 51</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">HC</td><td class="NLM_def"><p class="first last">hydroxycholesterol</p></td></tr><tr><td class="NLM_term">HDX</td><td class="NLM_def"><p class="first last">hydrogen/deuterium exchange</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">IL-17</td><td class="NLM_def"><p class="first last">interleukin 17</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand binding domain</p></td></tr><tr><td class="NLM_term">LHS</td><td class="NLM_def"><p class="first last">left-hand side</p></td></tr><tr><td class="NLM_term">MOA</td><td class="NLM_def"><p class="first last">mode of action</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">nuclear receptor</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PD-1</td><td class="NLM_def"><p class="first last">programmed death 1</p></td></tr><tr><td class="NLM_term">PD-L1</td><td class="NLM_def"><p class="first last">programmed death ligand 1</p></td></tr><tr><td class="NLM_term">RORγt</td><td class="NLM_def"><p class="first last">retinoic acid receptor-related orphan receptor γt</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SRC</td><td class="NLM_def"><p class="first last">steroid receptor coactivator</p></td></tr><tr><td class="NLM_term">Th17 cell</td><td class="NLM_def"><p class="first last">T helper 17 cell</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Inflammation and cancer: back to Virchow?</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(00)04046-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2FS0140-6736%2800%2904046-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=11229684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsVKltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=539-545&author=F.+Balkwillauthor=A.+Mantovani&title=Inflammation+and+cancer%3A+back+to+Virchow%3F&doi=10.1016%2FS0140-6736%2800%2904046-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and cancer: back to Virchow?</span></div><div class="casAuthors">Balkwill, F.; Mantovani, A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9255</span>),
    <span class="NLM_cas:pages">539-545</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The response of the body to a cancer is not a unique mechanism but has many parallels with inflammation and wound healing.  This article reviews the links between cancer and inflammation and discusses the implications of these links for cancer prevention and treatment.  We suggest that the inflammatory cells and cytokines found in tumors are more likely to contribute to tumor growth, progression, and immunosuppression than they are to mount an effective host anti-tumor response.  Moreover cancer susceptibility and severity may be assocd. with functional polymorphisms of inflammatory cytokine genes, and deletion or inhibition of inflammatory cytokines inhibits development of exptl. cancer.  If genetic damage is the "match that lights the fire" of cancer, some types of inflammation may provide the "fuel that feeds the flames".  Over the past 10 yr information about the cytokine and chemokine network has led to development of a range of cytokine/chemokine antagonists targeted at inflammatory and allergic diseases.  The first of these to enter the clinic, tumor necrosis factor antagonists, have shown encouraging efficacy.  In this article the authors have provided a rationale for the use of cytokine and chemokine blockade, and further investigation of non-steroidal anti-inflammatory drugs, in the chemoprevention and treatment of malignant diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIap2mRKsiZLVg90H21EOLACvtfcHk0ljCqfe17DXTTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsVKltb0%253D&md5=a3568a66d36e057bf811ac3dedbf0199</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2800%2904046-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252800%252904046-0%26sid%3Dliteratum%253Aachs%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DInflammation%2520and%2520cancer%253A%2520back%2520to%2520Virchow%253F%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D539%26epage%3D545%26doi%3D10.1016%2FS0140-6736%2800%2904046-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. S.</span></span> <i>A Commotion in the Blood: Life, Death, and the Immune System</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Henry Holt</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1997</span>; pp  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">14</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=14-14&author=S.+S.+Hall&title=A+Commotion+in+the+Blood%3A+Life%2C+Death%2C+and+the+Immune+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DS.%2BS.%26btitle%3DA%2520Commotion%2520in%2520the%2520Blood%253A%2520Life%252C%2520Death%252C%2520and%2520the%2520Immune%2520System%26pub%3DHenry%2520Holt%26date%3D1997%26spage%3D14%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coley, W. B.,  II</span></span> <span> </span><span class="NLM_article-title">Contribution to the knowledge of sarcoma</span>. <i>Ann. Surg.</i> <span class="NLM_year" style="font-weight: bold;">1891</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1097/00000658-189112000-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1097%2F00000658-189112000-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=17859590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A280%3ADC%252BD2srksVKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1891&pages=199-220&author=W.+B.+Coley&title=Contribution+to+the+knowledge+of+sarcoma&doi=10.1097%2F00000658-189112000-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">II. Contribution to the Knowledge of Sarcoma</span></div><div class="casAuthors">Coley W B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of surgery</span>
        (<span class="NLM_cas:date">1891</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-220</span>
        ISSN:<span class="NLM_cas:issn">0003-4932</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRo-f4FsyvzhTQLBVDQn4bCfW6udTcc2eZuIk5_yk4uKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srksVKlsg%253D%253D&md5=41f295141a7469993cfd74031506e71d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00000658-189112000-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000658-189112000-00015%26sid%3Dliteratum%253Aachs%26aulast%3DColey%26aufirst%3DW.%2BB.%26atitle%3DContribution%2520to%2520the%2520knowledge%2520of%2520sarcoma%26jtitle%3DAnn.%2520Surg.%26date%3D1891%26volume%3D14%26spage%3D199%26epage%3D220%26doi%3D10.1097%2F00000658-189112000-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couzin-Frankel, J.</span></span> <span> </span><span class="NLM_article-title">Breakthrough of the year 2013. cancer immunotherapy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1433</span>, <span class="refDoi"> DOI: 10.1126/science.342.6165.1432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1126%2Fscience.342.6165.1432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=24357284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=1432-1433&author=J.+Couzin-Frankel&title=Breakthrough+of+the+year+2013.+cancer+immunotherapy&doi=10.1126%2Fscience.342.6165.1432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer immunotherapy</span></div><div class="casAuthors">Couzin-Frankel, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6165</span>),
    <span class="NLM_cas:pages">1432-1433</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxASV1j-6kL7Vg90H21EOLACvtfcHk0lihgoMlH6ufvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotF2qsg%253D%253D&md5=2e0995fd567c5b59f40c46981da0bef4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.342.6165.1432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.342.6165.1432%26sid%3Dliteratum%253Aachs%26aulast%3DCouzin-Frankel%26aufirst%3DJ.%26atitle%3DBreakthrough%2520of%2520the%2520year%25202013.%2520cancer%2520immunotherapy%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D1432%26epage%3D1433%26doi%3D10.1126%2Fscience.342.6165.1432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennert, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, G. J.</span></span> <span> </span><span class="NLM_article-title">Combination cancer immunotherapy and new immunomodulatory targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1038/nrd4591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnrd4591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=26228759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=561-584&author=K.+M.+Mahoneyauthor=P.+D.+Rennertauthor=G.+J.+Freeman&title=Combination+cancer+immunotherapy+and+new+immunomodulatory+targets&doi=10.1038%2Fnrd4591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Combination cancer immunotherapy and new immunomodulatory targets</span></div><div class="casAuthors">Mahoney, Kathleen M.; Rennert, Paul D.; Freeman, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-584</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting immune checkpoints such as programmed cell death protein 1 (PD1), programmed cell death 1 ligand 1 (PDL1) and cytotoxic T lymphocyte antigen 4 (CTLA4) has achieved noteworthy benefit in multiple cancers by blocking immunoinhibitory signals and enabling patients to produce an effective antitumor response.  Inhibitors of CTLA4, PD1 or PDL1 administered as single agents have resulted in durable tumor regression in some patients, and combinations of PD1 and CTLA4 inhibitors may enhance antitumor benefit.  Numerous addnl. immunomodulatory pathways as well as inhibitory factors expressed or secreted by myeloid and stromal cells in the tumor microenvironment are potential targets for synergizing with immune checkpoint blockade.  Given the breadth of potential targets in the immune system, crit. questions to address include which combinations should move forward in development and which patients will benefit from these treatments.  This Review discusses the leading drug targets that are expressed on tumor cells and in the tumor microenvironment that allow enhancement of the antitumor immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwi7ChUpfjArVg90H21EOLACvtfcHk0lihgoMlH6ufvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ&md5=b0b598b2a7c62794b4f03c4cea196a97</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4591%26sid%3Dliteratum%253Aachs%26aulast%3DMahoney%26aufirst%3DK.%2BM.%26aulast%3DRennert%26aufirst%3DP.%2BD.%26aulast%3DFreeman%26aufirst%3DG.%2BJ.%26atitle%3DCombination%2520cancer%2520immunotherapy%2520and%2520new%2520immunomodulatory%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D561%26epage%3D584%26doi%3D10.1038%2Fnrd4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pop, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyengar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannan, R.</span></span> <span> </span><span class="NLM_article-title">Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1007/s00262-016-1914-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1007%2Fs00262-016-1914-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27743027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yitbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=281-298&author=D.+Ishiharaauthor=L.+Popauthor=T.+Takeshimaauthor=P.+Iyengarauthor=R.+Hannan&title=Rationale+and+evidence+to+combine+radiation+therapy+and+immunotherapy+for+cancer+treatment&doi=10.1007%2Fs00262-016-1914-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment</span></div><div class="casAuthors">Ishihara, Dan; Pop, Laurentiu; Takeshima, Tsuguhide; Iyengar, Puneeth; Hannan, Raquibul</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-298</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cancer immunotherapy exploits the immune system's ability to differentiate between tumor target cells and host cells.  Except for limited success against a few tumor types, most immunotherapies have not achieved the desired clin. efficacy until recently.  The field of cancer immunotherapy has flourished with a variety of new agents for clin. use, and remarkable progress has been made in the design of effective immunotherapeutic regimens.  Furthermore, the therapeutic outcome of these novel agents is enhanced when combined with conventional cancer treatment modalities including radiotherapy (RT).  An increasing no. of studies have demonstrated the abscopal effect, an immunol. response occurring in cancer sites distant from irradiated areas.  The present work reviews studies on the combination between RT and immunotherapy to induce synergistic and abscopal effects involved in cancer immunomodulation.  Further insight into the complex interactions between the immune system and cancer cells in the tumor microenvironment, and their modulation by RT, may reveal the abscopal effect as a clin. relevant and reproducible event leading to improved cancer outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7j6Vr1ziOIrVg90H21EOLACvtfcHk0lihgoMlH6ufvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yitbjP&md5=e04b45ff25872d8794b712abf8606cc1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00262-016-1914-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-016-1914-6%26sid%3Dliteratum%253Aachs%26aulast%3DIshihara%26aufirst%3DD.%26aulast%3DPop%26aufirst%3DL.%26aulast%3DTakeshima%26aufirst%3DT.%26aulast%3DIyengar%26aufirst%3DP.%26aulast%3DHannan%26aufirst%3DR.%26atitle%3DRationale%2520and%2520evidence%2520to%2520combine%2520radiation%2520therapy%2520and%2520immunotherapy%2520for%2520cancer%2520treatment%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2017%26volume%3D66%26spage%3D281%26epage%3D298%26doi%3D10.1007%2Fs00262-016-1914-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilgelm, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, A.</span></span> <span> </span><span class="NLM_article-title">Combinatorial approach to cancer immunotherapy: strength in numbers</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1189/jlb.5RI0116-013RR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1189%2Fjlb.5RI0116-013RR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27256570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSks7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2016&pages=275-290&author=A.+E.+Vilgelmauthor=D.+B.+Johnsonauthor=A.+Richmond&title=Combinatorial+approach+to+cancer+immunotherapy%3A+strength+in+numbers&doi=10.1189%2Fjlb.5RI0116-013RR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial approach to cancer immunotherapy: strength in numbers</span></div><div class="casAuthors">Vilgelm, Anna E.; Johnson, Douglas B.; Richmond, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-290</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">Immune-checkpoint blockade therapy with antibodies targeting CTLA-4 and PD-1 has revolutionized melanoma treatment by eliciting responses that can be remarkably durable and is now advancing to other malignancies.  However, not all patients respond to immune-checkpoint inhibitors.  Extensive preclin. evidence suggests that combining immune-checkpoint inhibitors with other anticancer treatments can greatly improve the therapeutic benefit.  The first clin. success of the combinatorial approach to cancer immunotherapy was demonstrated using a dual-checkpoint blockade with CTLA-4 and PD-1 inhibitors, which resulted in accelerated FDA approval of this therapeutic regimen.  In this review, we discuss the combinations of current and emerging immunotherapeutic agents in clin. and preclin. development and summarize the insights into potential mechanisms of synergistic anti-tumor activity gained from animal studies.  These promising combinatorial partners for the immune-checkpoint blockade include therapeutics targeting addnl. inhibitory receptors of T cells, such as TIM-3, LAG-3, TIGIT, and BTLA, and agonists of T cell costimulatory receptors 4-1BB, OX40, and GITR, as well as agents that promote cancer cell recognition by the immune system, such as tumor vaccines, IDO inhibitors, and agonists of the CD40 receptor of APCs.  We also review the therapeutic potential of regimens combining the immune-checkpoint blockade with therapeutic interventions that have been shown to enhance immunogenicity of cancer cells, including oncolytic viruses, RT, epigenetic therapy, and senescence-inducing therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph3E1E6MXDzLVg90H21EOLACvtfcHk0lgxuklFwvmatg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSks7zP&md5=ae79677e8207f81fa81cb99e619fc642</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1189%2Fjlb.5RI0116-013RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.5RI0116-013RR%26sid%3Dliteratum%253Aachs%26aulast%3DVilgelm%26aufirst%3DA.%2BE.%26aulast%3DJohnson%26aufirst%3DD.%2BB.%26aulast%3DRichmond%26aufirst%3DA.%26atitle%3DCombinatorial%2520approach%2520to%2520cancer%2520immunotherapy%253A%2520strength%2520in%2520numbers%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2016%26volume%3D100%26spage%3D275%26epage%3D290%26doi%3D10.1189%2Fjlb.5RI0116-013RR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, R. M.</span></span> <span> </span><span class="NLM_article-title">Targeting CD8<sup>+</sup> T-cell tolerance for cancer immunotherapy</span>. <i>Immunotherapy</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">852</span>, <span class="refDoi"> DOI: 10.2217/imt.14.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.2217%2Fimt.14.51" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=833-852&author=S.+R.+Jacksonauthor=J.+Yuanauthor=R.+M.+Teague&title=Targeting+CD8%2B+T-cell+tolerance+for+cancer+immunotherapy&doi=10.2217%2Fimt.14.51"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2217%2Fimt.14.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fimt.14.51%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BR.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DTeague%26aufirst%3DR.%2BM.%26atitle%3DTargeting%2520CD8%252B%2520T-cell%2520tolerance%2520for%2520cancer%2520immunotherapy%26jtitle%3DImmunotherapy%26date%3D2014%26volume%3D6%26spage%3D833%26epage%3D852%26doi%3D10.2217%2Fimt.14.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thor Straten, P.</span></span> <span> </span><span class="NLM_article-title">Immune-suppressive properties of the tumor microenvironment</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1148</span>, <span class="refDoi"> DOI: 10.1007/s00262-013-1434-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1007%2Fs00262-013-1434-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=23666510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSmtbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=1137-1148&author=J.+C.+Beckerauthor=M.+H.+Andersenauthor=D.+Schramaauthor=P.+Thor+Straten&title=Immune-suppressive+properties+of+the+tumor+microenvironment&doi=10.1007%2Fs00262-013-1434-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Immune-suppressive properties of the tumor microenvironment</span></div><div class="casAuthors">Becker, Juergen C.; Andersen, Mads Hald; Schrama, David; thor Straten, Per</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1137-1148</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Solid tumors are more than an accumulation of cancer cells.  Indeed, cancerous cells create a permissive microenvironment by exploiting non-transformed host cells.  Thus, solid tumors rather resemble abnormal organs composed of the cancerous cells itself and the stroma providing the supportive framework.  The stroma can be divided into the extracellular matrix consisting of proteoglycans, hyaluronic acid, and fibrous proteins, as well as stromal cells including mesenchymal and immune cells; moreover, it contains various peptide factors and metabolites.  Here, we will focus on immune-modulating capacities of the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLtWHRmIPq_rVg90H21EOLACvtfcHk0liM30zlw531Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSmtbvM&md5=78f0a9179a7864d6be5153e99274d369</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00262-013-1434-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-013-1434-6%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DJ.%2BC.%26aulast%3DAndersen%26aufirst%3DM.%2BH.%26aulast%3DSchrama%26aufirst%3DD.%26aulast%3DThor%2BStraten%26aufirst%3DP.%26atitle%3DImmune-suppressive%2520properties%2520of%2520the%2520tumor%2520microenvironment%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2013%26volume%3D62%26spage%3D1137%26epage%3D1148%26doi%3D10.1007%2Fs00262-013-1434-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wayteck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breckpot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smedt, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raemdonck, K.</span></span> <span> </span><span class="NLM_article-title">A personalized view on cancer immunotherapy</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2013.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.canlet.2013.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=24051308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOgsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2014&pages=113-125&author=L.+Wayteckauthor=K.+Breckpotauthor=J.+Demeesterauthor=S.+C.+De+Smedtauthor=K.+Raemdonck&title=A+personalized+view+on+cancer+immunotherapy&doi=10.1016%2Fj.canlet.2013.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A personalized view on cancer immunotherapy</span></div><div class="casAuthors">Wayteck, Laura; Breckpot, Karine; Demeester, Jo; De Smedt, Stefaan C.; Raemdonck, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-125</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Recent progress in cancer immunotherapy has resulted in complete responses in patients refractory to current std. cancer therapies.  However, due to tumor heterogeneity and inter-individual variations in anti-tumor immunity, only subsets of patients experience clin. benefit.  This review highlights the implementation of a personalized approach to enhance treatment efficacy and reduce side effects, including the identification of tumor-specific antigens for cancer vaccination and adoptive T cell therapies.  Furthermore, together with the current advances and promising clin. outcomes of combination cancer (immuno-)therapies, the screening for predictive biomarkers in a patient-specific manner is emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtw-Tgp9wkh7Vg90H21EOLACvtfcHk0liM30zlw531Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOgsbbF&md5=072e789986a14c4f74cdd0b52eed984a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DWayteck%26aufirst%3DL.%26aulast%3DBreckpot%26aufirst%3DK.%26aulast%3DDemeester%26aufirst%3DJ.%26aulast%3DDe%2BSmedt%26aufirst%3DS.%2BC.%26aulast%3DRaemdonck%26aufirst%3DK.%26atitle%3DA%2520personalized%2520view%2520on%2520cancer%2520immunotherapy%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D352%26spage%3D113%26epage%3D125%26doi%3D10.1016%2Fj.canlet.2013.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstein, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surh, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprent, J.</span></span> <span> </span><span class="NLM_article-title">Selective stimulation of T cell subsets with antibody-cytokine immune complexes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">1924</span>– <span class="NLM_lpage">1927</span>, <span class="refDoi"> DOI: 10.1126/science.1122927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1126%2Fscience.1122927" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2006&pages=1924-1927&author=O.+Boymanauthor=M.+Kovarauthor=M.+P.+Rubinsteinauthor=C.+D.+Surhauthor=J.+Sprent&title=Selective+stimulation+of+T+cell+subsets+with+antibody-cytokine+immune+complexes&doi=10.1126%2Fscience.1122927"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1122927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1122927%26sid%3Dliteratum%253Aachs%26aulast%3DBoyman%26aufirst%3DO.%26aulast%3DKovar%26aufirst%3DM.%26aulast%3DRubinstein%26aufirst%3DM.%2BP.%26aulast%3DSurh%26aufirst%3DC.%2BD.%26aulast%3DSprent%26aufirst%3DJ.%26atitle%3DSelective%2520stimulation%2520of%2520T%2520cell%2520subsets%2520with%2520antibody-cytokine%2520immune%2520complexes%26jtitle%3DScience%26date%3D2006%26volume%3D311%26spage%3D1924%26epage%3D1927%26doi%3D10.1126%2Fscience.1122927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pardoll, D. M.</span></span> <span> </span><span class="NLM_article-title">The blockade of immune checkpoints in cancer immunotherapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1038/nrc3239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnrc3239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=22437870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVegtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=252-64&author=D.+M.+Pardoll&title=The+blockade+of+immune+checkpoints+in+cancer+immunotherapy&doi=10.1038%2Fnrc3239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The blockade of immune checkpoints in cancer immunotherapy</span></div><div class="casAuthors">Pardoll, Drew M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">252-264</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Among the most promising approaches to activating therapeutic antitumor immunity is the blockade of immune checkpoints.  Immune checkpoints refer to a plethora of inhibitory pathways hardwired into the immune system that are crucial for maintaining self-tolerance and modulating the duration and amplitude of physiol. immune responses in peripheral tissues in order to minimize collateral tissue damage.  It is now clear that tumors co-opt certain immune-checkpoint pathways as a major mechanism of immune resistance, particularly against T cells that are specific for tumor antigens.  Because many of the immune checkpoints are initiated by ligand-receptor interactions, they can be readily blocked by antibodies or modulated by recombinant forms of ligands or receptors.  Cytotoxic T-lymphocyte-assocd. antigen 4 (CTLA4) antibodies were the first of this class of immunotherapeutics to achieve US Food and Drug Administration (FDA) approval.  Preliminary clin. findings with blockers of addnl. immune-checkpoint proteins, such as programmed cell death protein 1 (PD1), indicate broad and diverse opportunities to enhance antitumor immunity with the potential to produce durable clin. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosDPsOq8t6CrVg90H21EOLACvtfcHk0liMEhLtao3WFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVegtrw%253D&md5=d278a058ffb1ccd3f678c1ae3ac0e55e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrc3239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3239%26sid%3Dliteratum%253Aachs%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26atitle%3DThe%2520blockade%2520of%2520immune%2520checkpoints%2520in%2520cancer%2520immunotherapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D252%26epage%3D64%26doi%3D10.1038%2Fnrc3239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restifo, N. P.</span></span> <span> </span><span class="NLM_article-title">Adoptive cell transfer as personalized immunotherapy for human cancer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1126/science.aaa4967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1126%2Fscience.aaa4967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=25838374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1Wmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=62-68&author=S.+A.+Rosenbergauthor=N.+P.+Restifo&title=Adoptive+cell+transfer+as+personalized+immunotherapy+for+human+cancer&doi=10.1126%2Fscience.aaa4967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Adoptive cell transfer as personalized immunotherapy for human cancer</span></div><div class="casAuthors">Rosenberg, Steven A.; Restifo, Nicholas P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6230</span>),
    <span class="NLM_cas:pages">62-68</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Adoptive cell therapy (ACT) is a highly personalized cancer therapy that involves administration to the cancer-bearing host of immune cells with direct anticancer activity.  ACT using naturally occurring tumor-reactive lymphocytes has mediated durable, complete regressions in patients with melanoma, probably by targeting somatic mutations exclusive to each cancer.  These results have expanded the reach of ACT to the treatment of common epithelial cancers.  In addn., the ability to genetically engineer lymphocytes to express conventional T cell receptors or chimeric antigen receptors has further extended the successful application of ACT for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbfkkwt9K57Vg90H21EOLACvtfcHk0liMEhLtao3WFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1Wmurk%253D&md5=5e1f436aab5b0a6cf53eb4f50e3bb143</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaa4967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaa4967%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DS.%2BA.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26atitle%3DAdoptive%2520cell%2520transfer%2520as%2520personalized%2520immunotherapy%2520for%2520human%2520cancer%26jtitle%3DScience%26date%3D2015%26volume%3D348%26spage%3D62%26epage%3D68%26doi%3D10.1126%2Fscience.aaa4967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palucka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banchereau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span> <span> </span><span class="NLM_article-title">Designing vaccines based on biology of human dendritic cell subsets</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2010.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.immuni.2010.10.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=464-478&author=K.+Paluckaauthor=J.+Banchereauauthor=I.+Mellman&title=Designing+vaccines+based+on+biology+of+human+dendritic+cell+subsets&doi=10.1016%2Fj.immuni.2010.10.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2010.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2010.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DPalucka%26aufirst%3DK.%26aulast%3DBanchereau%26aufirst%3DJ.%26aulast%3DMellman%26aufirst%3DI.%26atitle%3DDesigning%2520vaccines%2520based%2520on%2520biology%2520of%2520human%2520dendritic%2520cell%2520subsets%26jtitle%3DImmunity%26date%3D2010%26volume%3D33%26spage%3D464%26epage%3D478%26doi%3D10.1016%2Fj.immuni.2010.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>Cortellis,
Thomson Reuters Database. <a href="https://cortellis.thomsonreuterslifesciences.com/" class="extLink">https://cortellis.thomsonreuterslifesciences.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cortellis%2C%0AThomson+Reuters+Database.+https%3A%2F%2Fcortellis.thomsonreuterslifesciences.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collin, M.</span></span> <span> </span><span class="NLM_article-title">Immune checkpoint inhibitors: a patent review (2010–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1080/13543776.2016.1176150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1080%2F13543776.2016.1176150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27054314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1SlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=555-564&author=M.+Collin&title=Immune+checkpoint+inhibitors%3A+a+patent+review+%282010%E2%80%932015%29&doi=10.1080%2F13543776.2016.1176150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Immune checkpoint inhibitors: a patent review (2010-2015)</span></div><div class="casAuthors">Collin, Matthieu</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-564</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Immune checkpoint inhibitors, like anti-PD-1/PD-L1 antibodies, are revolutionizing therapeutic concepts in the treatment of cancer.  Said class of drugs will represent a multi-billion dollar market over the coming decade.  Many companies have therefore developed important patent activities in the field.: The present review gives an overview of the patent literature during the period 2010-2015 in the field of immune checkpoint inhibitors.  In particular, the review presents a selection of international patent applications related to inhibitors of PD-1/PD-L1, CTLA-4, IDO, TIM3, LAG3, TIGIT, BTLA, VISTA, ICOS, KIRs and CD39.: Immune checkpoint inhibitors are now widely accepted as a key component of the therapeutic strategies in cancer.  This fervent activity creates a maze of third-party patents that pose considerable risks for both newcomers and established companies.  We can thus anticipate that the no. of patent conflicts and disputes will increase in the near future.  Treatments will involve combination therapy comprising at least one immune checkpoint inhibitor and companies will multiply patent filings in this field.  Finally, we can expect that patents related to biomarkers that will render a patient eligible to a treatment with an immune checkpoint inhibitor will have tremendous com. value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMoVL42Yd6VrVg90H21EOLACvtfcHk0lgbKNiuolVNMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1SlsbY%253D&md5=a23ba11a0c4b42243e327dccb46259b5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F13543776.2016.1176150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2016.1176150%26sid%3Dliteratum%253Aachs%26aulast%3DCollin%26aufirst%3DM.%26atitle%3DImmune%2520checkpoint%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D555%26epage%3D564%26doi%3D10.1080%2F13543776.2016.1176150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smothers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoos, A.</span></span> <span> </span><span class="NLM_article-title">Big opportunities for small molecules in immuno-oncology</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1038/nrd4596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnrd4596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=26228631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KiurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=603-622&author=J.+L.+Adamsauthor=J.+Smothersauthor=R.+Srinivasanauthor=A.+Hoos&title=Big+opportunities+for+small+molecules+in+immuno-oncology&doi=10.1038%2Fnrd4596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Big opportunities for small molecules in immuno-oncology</span></div><div class="casAuthors">Adams, Jerry L.; Smothers, James; Srinivasan, Roopa; Hoos, Axel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">603-622</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The regulatory approval of ipilimumab (Yervoy) in 2011 ushered in a new era of cancer immunotherapies with durable clin. effects.  Most of these breakthrough medicines are monoclonal antibodies that block protein-protein interactions between T cell checkpoint receptors and their cognate ligands.  In addn., genetically engineered autologous T cell therapies have also recently demonstrated significant clin. responses in haematol. cancers.  Conspicuously missing from this class of therapies are traditional small-mol. drugs, which have previously served as the backbone of targeted cancer therapies.  Modulating the immune system through a small-mol. approach offers several unique advantages that are complementary to, and potentially synergistic with, biol. modalities.  This Review highlights immuno-oncol. pathways and mechanisms that can be best or solely targeted by small-mol. medicines.  Agents aimed at these mechanisms - modulation of the immune response, trafficking to the tumor microenvironment and cellular infiltration - are poised to significantly extend the scope of immuno-oncol. applications and enhance the opportunities for combination with tumor-targeted agents and biol. immunotherapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBZyGzN4ec8bVg90H21EOLACvtfcHk0lgbKNiuolVNMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KiurvE&md5=b6c9d41ae81a8c504ee6aac209ea0509</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrd4596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4596%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DSmothers%26aufirst%3DJ.%26aulast%3DSrinivasan%26aufirst%3DR.%26aulast%3DHoos%26aufirst%3DA.%26atitle%3DBig%2520opportunities%2520for%2520small%2520molecules%2520in%2520immuno-oncology%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D603%26epage%3D622%26doi%3D10.1038%2Fnrd4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, H.</span></span> <span> </span><span class="NLM_article-title">Cancer immunotherapy: selected targets and small-molecule modulators</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1002%2Fcmdc.201500566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=26836578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=450-466&author=H.+Weinmann&title=Cancer+immunotherapy%3A+selected+targets+and+small-molecule+modulators&doi=10.1002%2Fcmdc.201500566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators</span></div><div class="casAuthors">Weinmann, Hilmar</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">450-466</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">There is a significant amt. of excitement in the scientific community around cancer immunotherapy, as this approach has renewed hope for many cancer patients owing to some recent successes in the clinic.  Currently available immuno-oncol. therapeutics under clin. development and on the market are mostly biologics (antibodies, proteins, engineered cells, and oncolytic viruses).  However, modulation of the immune system with small mols. offers several advantages that may be complementary and potentially synergistic to the use of large biologicals.  Therefore, the discovery and development of novel small-mol. modulators is a rapidly growing research area for medicinal chemists working in cancer immunotherapy.  This review provides a brief introduction into recent trends related to selected targets and pathways for cancer immunotherapy and their small-mol. pharmacol. modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXRleizKnn77Vg90H21EOLACvtfcHk0ljlRI4p9pMvkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSiurg%253D&md5=0cf24fb364c8f87d912da8267fa9eb98</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500566%26sid%3Dliteratum%253Aachs%26aulast%3DWeinmann%26aufirst%3DH.%26atitle%3DCancer%2520immunotherapy%253A%2520selected%2520targets%2520and%2520small-molecule%2520modulators%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D450%26epage%3D466%26doi%3D10.1002%2Fcmdc.201500566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatton, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangan, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C. T.</span></span> <span> </span><span class="NLM_article-title">Interleukin 17-producing CD4<sup>+</sup> effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1123</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1038/ni1254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fni1254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=16200070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFamsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1123-1132&author=L.+E.+Harringtonauthor=R.+D.+Hattonauthor=P.+R.+Manganauthor=H.+Turnerauthor=T.+L.+Murphyauthor=K.+M.+Murphyauthor=C.+T.+Weaver&title=Interleukin+17-producing+CD4%2B+effector+T+cells+develop+via+a+lineage+distinct+from+the+T+helper+type+1+and+2+lineages&doi=10.1038%2Fni1254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages</span></div><div class="casAuthors">Harrington, Laurie E.; Hatton, Robin D.; Mangan, Paul R.; Turner, Henrietta; Murphy, Theresa L.; Murphy, Kenneth M.; Weaver, Casey T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1123-1132</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CD4+ T cells producing interleukin 17 (IL-17) are assocd. with autoimmunity, although the precise mechanisms that control their development are undefined.  Here the authors present data that challenge the idea of a shared developmental pathway with T helper type 1 (TH1) or TH2 lineages and instead favor the idea of a distinct effector lineage the authors call 'TH-17'.  The development of TH-17 cells from naive precursor cells was potently inhibited by interferon-γ (IFN-γ) and IL-4, whereas committed TH-17 cells were resistant to suppression by TH1 or TH2 cytokines.  In the absence of IFN-γ and IL-4, IL-23 induced naive precursor cells to differentiate into TH-17 cells independently of the transcription factors STAT1, T-bet, STAT4 and STAT6.  These findings provide a basis for understanding how inhibition of IFN-γ signaling enhances development of pathogenic TH-17 effector cells that can exacerbate autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo6A2C_tQswLVg90H21EOLACvtfcHk0ljlRI4p9pMvkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFamsb7J&md5=de4b453a239c0c221684e2c6227dd555</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fni1254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1254%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DL.%2BE.%26aulast%3DHatton%26aufirst%3DR.%2BD.%26aulast%3DMangan%26aufirst%3DP.%2BR.%26aulast%3DTurner%26aufirst%3DH.%26aulast%3DMurphy%26aufirst%3DT.%2BL.%26aulast%3DMurphy%26aufirst%3DK.%2BM.%26aulast%3DWeaver%26aufirst%3DC.%2BT.%26atitle%3DInterleukin%252017-producing%2520CD4%252B%2520effector%2520T%2520cells%2520develop%2520via%2520a%2520lineage%2520distinct%2520from%2520the%2520T%2520helper%2520type%25201%2520and%25202%2520lineages%26jtitle%3DNat.%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D1123%26epage%3D1132%26doi%3D10.1038%2Fni1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakae, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nambu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishigame, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakuta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakura, Y.</span></span> <span> </span><span class="NLM_article-title">IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.177.1.566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.4049%2Fjimmunol.177.1.566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=16785554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2ntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2006&pages=566-573&author=Y.+Komiyamaauthor=S.+Nakaeauthor=T.+Matsukiauthor=A.+Nambuauthor=H.+Ishigameauthor=S.+Kakutaauthor=K.+Sudoauthor=Y.+Iwakura&title=IL-17+plays+an+important+role+in+the+development+of+experimental+autoimmune+encephalomyelitis&doi=10.4049%2Fjimmunol.177.1.566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis</span></div><div class="casAuthors">Komiyama, Yutaka; Nakae, Susumu; Matsuki, Taizo; Nambu, Aya; Ishigame, Harumichi; Kakuta, Shigeru; Sudo, Katsuko; Iwakura, Yoichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">566-573</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">IL-17 is a proinflammatory cytokine that activates T cells and other immune cells to produce a variety of cytokines, chemokines, and cell adhesion mols.  This cytokine is augmented in the sera and/or tissues of patients with contact dermatitis, asthma, and rheumatoid arthritis.  The authors previously demonstrated that IL-17 is involved in the development of autoimmune arthritis and contact, delayed, and airway hypersensitivity in mice.  As the expression of IL-17 is also augmented in multiple sclerosis, the authors examd. the involvement of this cytokine in these diseases using IL-17-/- murine disease models.  They found that the development of exptl. autoimmune encephalomyelitis (EAE), the rodent model of multiple sclerosis, was suppressed in IL-17-/- mice; these animals exhibited delayed onset, reduced max. severity scores, ameliorated histol. changes, and early recovery.  T cell sensitization against myelin oligodendrocyte glycoprotein was reduced in IL-17-/- mice upon sensitization.  The major producer of IL-17 upon treatment with myelin oligodendrocyte glycoprotein were CD4+ T cells rather than CD8+ T cells, and adoptive transfer of IL-17-/- CD4+ T cells inefficiently induced EAE in recipient mice.  Notably, IL-17-producing T cells were increased in IFN-γ-/- cells, while IFN-γ-producing cells were increased in IL-17-/- cells, suggesting that IL-17 and IFN-γ mutually regulate IFN-γ and IL-17 prodn.  Thus, IL-17 rather than IFN-γ plays a crucial role in the development of EAE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP-YRfRiE4_rVg90H21EOLACvtfcHk0lg4d0eVGMSWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2ntbg%253D&md5=84f23ee506e146b036aeefc289dbdc33</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.177.1.566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.177.1.566%26sid%3Dliteratum%253Aachs%26aulast%3DKomiyama%26aufirst%3DY.%26aulast%3DNakae%26aufirst%3DS.%26aulast%3DMatsuki%26aufirst%3DT.%26aulast%3DNambu%26aufirst%3DA.%26aulast%3DIshigame%26aufirst%3DH.%26aulast%3DKakuta%26aufirst%3DS.%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DIwakura%26aufirst%3DY.%26atitle%3DIL-17%2520plays%2520an%2520important%2520role%2520in%2520the%2520development%2520of%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D177%26spage%3D566%26epage%3D573%26doi%3D10.4049%2Fjimmunol.177.1.566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tesmer, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. A.</span></span> <span> </span><span class="NLM_article-title">Th17 cells in human disease</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00628.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1111%2Fj.1600-065X.2008.00628.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=18613831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=87-113&author=L.+A.+Tesmerauthor=S.+K.+Lundyauthor=S.+Sarkarauthor=D.+A.+Fox&title=Th17+cells+in+human+disease&doi=10.1111%2Fj.1600-065X.2008.00628.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Th17 cells in human disease</span></div><div class="casAuthors">Tesmer, Laura A.; Lundy, Steven K.; Sarkar, Sujata; Fox, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-113</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Our understanding of the role of T cells in human disease is undergoing revision as a result of the discovery of T-helper 17 (Th17) cells, a unique CD4+ T-cell subset characterized by prodn. of interleukin-17 (IL-17).  IL-17 is a highly inflammatory cytokine with robust effects on stromal cells in many tissues.  Recent data in humans and mice suggest that Th17 cells play an important role in the pathogenesis of a diverse group of immune-mediated diseases, including psoriasis, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and asthma.  Initial reports also propose a role for Th17 cells in tumorigenesis and transplant rejection.  Important differences, as well as many similarities, are emerging when the biol. of Th17 cells in the mouse is compared with corresponding phenomena in humans.  As our understanding of human Th17 biol. grows, the mechanisms underlying many diseases are becoming more apparent, resulting in a new appreciation for both previously known and more recently discovered cytokines, chemokines, and feedback mechanisms.  Given the strong assocn. between excessive Th17 activity and human disease, new therapeutic approaches targeting Th17 cells are highly promising, but the potential safety of such treatments may be limited by the role of these cells in normal host defenses against infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1z_YfE_Dmz7Vg90H21EOLACvtfcHk0lg4d0eVGMSWLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGls7s%253D&md5=f8a6314e2868e3be4f072bda3a038697</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00628.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00628.x%26sid%3Dliteratum%253Aachs%26aulast%3DTesmer%26aufirst%3DL.%2BA.%26aulast%3DLundy%26aufirst%3DS.%2BK.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DD.%2BA.%26atitle%3DTh17%2520cells%2520in%2520human%2520disease%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D87%26epage%3D113%26doi%3D10.1111%2Fj.1600-065X.2008.00628.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kryczek, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altuwaijri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeliga, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolls, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span> <span> </span><span class="NLM_article-title">Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">6730</span>– <span class="NLM_lpage">6733</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.178.11.6730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.4049%2Fjimmunol.178.11.6730" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=6730-6733&author=I.+Kryczekauthor=S.+Weiauthor=L.+Zouauthor=S.+Altuwaijriauthor=W.+Szeligaauthor=J.+Kollsauthor=A.+Changauthor=W.+Zou&title=Cutting+edge%3A+Th17+and+regulatory+T+cell+dynamics+and+the+regulation+by+IL-2+in+the+tumor+microenvironment&doi=10.4049%2Fjimmunol.178.11.6730"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.178.11.6730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.178.11.6730%26sid%3Dliteratum%253Aachs%26aulast%3DKryczek%26aufirst%3DI.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DAltuwaijri%26aufirst%3DS.%26aulast%3DSzeliga%26aufirst%3DW.%26aulast%3DKolls%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DZou%26aufirst%3DW.%26atitle%3DCutting%2520edge%253A%2520Th17%2520and%2520regulatory%2520T%2520cell%2520dynamics%2520and%2520the%2520regulation%2520by%2520IL-2%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D6730%26epage%3D6733%26doi%3D10.4049%2Fjimmunol.178.11.6730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kryczek, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vatan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeliga, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlayson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeone, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welling, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coukos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span> <span> </span><span class="NLM_article-title">Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">1141</span>– <span class="NLM_lpage">1149</span>, <span class="refDoi"> DOI: 10.1182/blood-2009-03-208249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1182%2Fblood-2009-03-208249" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=1141-1149&author=I.+Kryczekauthor=M.+Banerjeeauthor=P.+Chengauthor=L.+Vatanauthor=W.+Szeligaauthor=S.+Weiauthor=E.+Huangauthor=E.+Finlaysonauthor=D.+Simeoneauthor=T.+H.+Wellingauthor=A.+Changauthor=G.+Coukosauthor=R.+Liuauthor=W.+Zou&title=Phenotype%2C+distribution%2C+generation%2C+and+functional+and+clinical+relevance+of+Th17+cells+in+the+human+tumor+environments&doi=10.1182%2Fblood-2009-03-208249"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-03-208249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-03-208249%26sid%3Dliteratum%253Aachs%26aulast%3DKryczek%26aufirst%3DI.%26aulast%3DBanerjee%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DP.%26aulast%3DVatan%26aufirst%3DL.%26aulast%3DSzeliga%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DFinlayson%26aufirst%3DE.%26aulast%3DSimeone%26aufirst%3DD.%26aulast%3DWelling%26aufirst%3DT.%2BH.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DCoukos%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DW.%26atitle%3DPhenotype%252C%2520distribution%252C%2520generation%252C%2520and%2520functional%2520and%2520clinical%2520relevance%2520of%2520Th17%2520cells%2520in%2520the%2520human%2520tumor%2520environments%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D1141%26epage%3D1149%26doi%3D10.1182%2Fblood-2009-03-208249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muranski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulos, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touloukian, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gattinoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrzesinski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerstann, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feigenbaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restifo, N. P.</span></span> <span> </span><span class="NLM_article-title">Tumor-specific Th17-polarized cells eradicate large established melanoma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-11-120998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1182%2Fblood-2007-11-120998" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=362-373&author=P.+Muranskiauthor=A.+Boniauthor=P.+A.+Antonyauthor=L.+Cassardauthor=K.+R.+Irvineauthor=A.+Kaiserauthor=C.+M.+Paulosauthor=D.+C.+Palmerauthor=C.+E.+Touloukianauthor=K.+Ptakauthor=L.+Gattinoniauthor=C.+Wrzesinskiauthor=C.+S.+Hinrichsauthor=K.+W.+Kerstannauthor=L.+Feigenbaumauthor=C.+C.+Chanauthor=N.+P.+Restifo&title=Tumor-specific+Th17-polarized+cells+eradicate+large+established+melanoma&doi=10.1182%2Fblood-2007-11-120998"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-11-120998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-11-120998%26sid%3Dliteratum%253Aachs%26aulast%3DMuranski%26aufirst%3DP.%26aulast%3DBoni%26aufirst%3DA.%26aulast%3DAntony%26aufirst%3DP.%2BA.%26aulast%3DCassard%26aufirst%3DL.%26aulast%3DIrvine%26aufirst%3DK.%2BR.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DPalmer%26aufirst%3DD.%2BC.%26aulast%3DTouloukian%26aufirst%3DC.%2BE.%26aulast%3DPtak%26aufirst%3DK.%26aulast%3DGattinoni%26aufirst%3DL.%26aulast%3DWrzesinski%26aufirst%3DC.%26aulast%3DHinrichs%26aufirst%3DC.%2BS.%26aulast%3DKerstann%26aufirst%3DK.%2BW.%26aulast%3DFeigenbaum%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DC.%2BC.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26atitle%3DTumor-specific%2520Th17-polarized%2520cells%2520eradicate%2520large%2520established%2520melanoma%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D362%26epage%3D373%26doi%3D10.1182%2Fblood-2007-11-120998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odunsi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. F.</span></span> <span> </span><span class="NLM_article-title">Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">15505</span>– <span class="NLM_lpage">15510</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710686105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1073%2Fpnas.0710686105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=15505-15510&author=Y.+Miyaharaauthor=K.+Odunsiauthor=W.+Chenauthor=G.+Pengauthor=J.+Matsuzakiauthor=R.+F.+Wang&title=Generation+and+regulation+of+human+CD4%2B+IL-17-producing+T+cells+in+ovarian+cancer&doi=10.1073%2Fpnas.0710686105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710686105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710686105%26sid%3Dliteratum%253Aachs%26aulast%3DMiyahara%26aufirst%3DY.%26aulast%3DOdunsi%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DG.%26aulast%3DMatsuzaki%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%2BF.%26atitle%3DGeneration%2520and%2520regulation%2520of%2520human%2520CD4%252B%2520IL-17-producing%2520T%2520cells%2520in%2520ovarian%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D15505%26epage%3D15510%26doi%3D10.1073%2Fpnas.0710686105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Orozco, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muranski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restifo, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overwijk, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span> <span> </span><span class="NLM_article-title">T helper 17 cells promote cytotoxic T cell activation in tumor immunity</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2009.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.immuni.2009.09.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=787-798&author=N.+Martin-Orozcoauthor=P.+Muranskiauthor=Y.+Chungauthor=X.+O.+Yangauthor=T.+Yamazakiauthor=S.+Luauthor=P.+Hwuauthor=N.+P.+Restifoauthor=W.+W.+Overwijkauthor=C.+Dong&title=T+helper+17+cells+promote+cytotoxic+T+cell+activation+in+tumor+immunity&doi=10.1016%2Fj.immuni.2009.09.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2009.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2009.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Orozco%26aufirst%3DN.%26aulast%3DMuranski%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%2BO.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHwu%26aufirst%3DP.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26aulast%3DOverwijk%26aufirst%3DW.%2BW.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DT%2520helper%252017%2520cells%2520promote%2520cytotoxic%2520T%2520cell%2520activation%2520in%2520tumor%2520immunity%26jtitle%3DImmunity%26date%3D2009%26volume%3D31%26spage%3D787%26epage%3D798%26doi%3D10.1016%2Fj.immuni.2009.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulos, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heemskerk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrzesinski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borman, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muranski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restifo, N. P.</span></span> <span> </span><span class="NLM_article-title">Type 17 CD8<sup>+</sup> T cells display enhanced antitumor immunity</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1182/blood-2009-02-203935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1182%2Fblood-2009-02-203935" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=596-599&author=C.+S.+Hinrichsauthor=A.+Kaiserauthor=C.+M.+Paulosauthor=L.+Cassardauthor=L.+Sanchez-Perezauthor=B.+Heemskerkauthor=C.+Wrzesinskiauthor=Z.+A.+Bormanauthor=P.+Muranskiauthor=N.+P.+Restifo&title=Type+17+CD8%2B+T+cells+display+enhanced+antitumor+immunity&doi=10.1182%2Fblood-2009-02-203935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-02-203935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-02-203935%26sid%3Dliteratum%253Aachs%26aulast%3DHinrichs%26aufirst%3DC.%2BS.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DCassard%26aufirst%3DL.%26aulast%3DSanchez-Perez%26aufirst%3DL.%26aulast%3DHeemskerk%26aufirst%3DB.%26aulast%3DWrzesinski%26aufirst%3DC.%26aulast%3DBorman%26aufirst%3DZ.%2BA.%26aulast%3DMuranski%26aufirst%3DP.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26atitle%3DType%252017%2520CD8%252B%2520T%2520cells%2520display%2520enhanced%2520antitumor%2520immunity%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D596%26epage%3D599%26doi%3D10.1182%2Fblood-2009-02-203935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maglich, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, L.</span></span> <span> </span><span class="NLM_article-title">The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">4051</span>– <span class="NLM_lpage">4058</span>, <span class="refDoi"> DOI: 10.1093/nar/gkg444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1093%2Fnar%2Fgkg444" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=4051-4058&author=J.+M.+Maglichauthor=J.+A.+Caravellaauthor=M.+H.+Lambertauthor=T.+M.+Willsonauthor=J.+T.+Mooreauthor=L.+Ramamurthy&title=The+first+completed+genome+sequence+from+a+teleost+fish+%28Fugu+rubripes%29+adds+significant+diversity+to+the+nuclear+receptor+superfamily&doi=10.1093%2Fnar%2Fgkg444"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkg444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkg444%26sid%3Dliteratum%253Aachs%26aulast%3DMaglich%26aufirst%3DJ.%2BM.%26aulast%3DCaravella%26aufirst%3DJ.%2BA.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DMoore%26aufirst%3DJ.%2BT.%26aulast%3DRamamurthy%26aufirst%3DL.%26atitle%3DThe%2520first%2520completed%2520genome%2520sequence%2520from%2520a%2520teleost%2520fish%2520%2528Fugu%2520rubripes%2529%2520adds%2520significant%2520diversity%2520to%2520the%2520nuclear%2520receptor%2520superfamily%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D4051%26epage%3D4058%26doi%3D10.1093%2Fnar%2Fgkg444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepelley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17<sup>+</sup> T helper cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.cell.2006.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=16990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1121-1133&author=+Ivanovauthor=B.+S.+McKenzieauthor=L.+Zhouauthor=C.+E.+Tadokoroauthor=A.+Lepelleyauthor=J.+J.+Lafailleauthor=D.+J.+Cuaauthor=D.+R.+Littman&title=The+orphan+nuclear+receptor+RORgammat+directs+the+differentiation+program+of+proinflammatory+IL-17%2B+T+helper+cells&doi=10.1016%2Fj.cell.2006.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span></div><div class="casAuthors">Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease.  The authors show here that the orphan nuclear receptor RORγt is the key transcription factor that orchestrates the differentiation of this effector cell lineage.  RORγt induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4+ T helper cells and is required for their expression in response to IL-6 and TGF-β, the cytokines known to induce IL-17.  Th17 cells are constitutively present throughout the intestinal lamina propria, express RORγt, and are absent in mice deficient for RORγt or IL-6.  Mice with RORγt-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells.  Together, these studies suggest that RORγt is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsJd6RyFqWrVg90H21EOLACvtfcHk0liUjNIBO2CLoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE&md5=4f5693603c30dca4f6a2d0994aeaf9b0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DLepelley%26aufirst%3DA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520RORgammat%2520directs%2520the%2520differentiation%2520program%2520of%2520proinflammatory%2520IL-17%252B%2520T%2520helper%2520cells%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D1121%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2006.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmarajan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebelin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Synthetic RORgammat agonists enhance protective immunity</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1012</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00899</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00899" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1012-1018&author=M.+R.+Changauthor=V.+Dharmarajanauthor=C.+Doebelinauthor=R.+D.+Garcia-Ordonezauthor=S.+J.+Novickauthor=D.+S.+Kuruvillaauthor=T.+M.+Kameneckaauthor=P.+R.+Griffin&title=Synthetic+RORgammat+agonists+enhance+protective+immunity&doi=10.1021%2Facschembio.5b00899"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00899%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DDharmarajan%26aufirst%3DV.%26aulast%3DDoebelin%26aufirst%3DC.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DNovick%26aufirst%3DS.%2BJ.%26aulast%3DKuruvilla%26aufirst%3DD.%2BS.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DSynthetic%2520RORgammat%2520agonists%2520enhance%2520protective%2520immunity%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D1012%26epage%3D1018%26doi%3D10.1021%2Facschembio.5b00899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumbley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundasen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojetin, D. J.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptors and their selective pharmacologic modulators</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">778</span>, <span class="refDoi"> DOI: 10.1124/pr.112.006833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1124%2Fpr.112.006833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=23457206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslCisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=710-778&author=T.+P.+Burrisauthor=L.+A.+Soltauthor=Y.+Wangauthor=C.+Crumbleyauthor=S.+Banerjeeauthor=K.+Griffettauthor=T.+Lundasenauthor=T.+Hughesauthor=D.+J.+Kojetin&title=Nuclear+receptors+and+their+selective+pharmacologic+modulators&doi=10.1124%2Fpr.112.006833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptors and their selective pharmacologic modulators</span></div><div class="casAuthors">Burris, Thomas P.; Solt, Laura A.; Wang, Yongjun; Crumbley, Christine; Banerjee, Subhashis; Griffett, Kristine; Lundasen, Thomas; Hughes, Travis; Kojetin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">710-778, 69 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors are ligand-activated transcription factors and include the receptors for steroid hormones, lipophilic vitamins, sterols, and bile acids.  These receptors serve as targets for development of myriad drugs that target a range of disorders.  Classically defined ligands that bind to the ligand-binding domain of nuclear receptors, whether they are endogenous or synthetic, either activate receptor activity (agonists) or block activation (antagonists) and due to the ability to alter activity of the receptors are often termed receptor "modulators".  The complex pharmacol. of nuclear receptors has provided a class of ligands distinct from these simple modulators where ligands display agonist/partial agonist/antagonist function in a tissue or gene selective manner.  This class of ligands is defined as selective modulators.  Here, we review the development and pharmacol. of a range of selective nuclear receptor modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodFD-Tf1vBUrVg90H21EOLACvtfcHk0ljjVguzvyUORw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslCisrY%253D&md5=33c34757a837d2a80674fbe5c1660fe2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.006833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.006833%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCrumbley%26aufirst%3DC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DGriffett%26aufirst%3DK.%26aulast%3DLundasen%26aufirst%3DT.%26aulast%3DHughes%26aufirst%3DT.%26aulast%3DKojetin%26aufirst%3DD.%2BJ.%26atitle%3DNuclear%2520receptors%2520and%2520their%2520selective%2520pharmacologic%2520modulators%26jtitle%3DPharmacol.%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D710%26epage%3D778%26doi%3D10.1124%2Fpr.112.006833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Germain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacquet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, V.</span></span> <span> </span><span class="NLM_article-title">Overview of nomenclature of nuclear receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1124/pr.58.4.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1124%2Fpr.58.4.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=17132848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1ajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=685-704&author=P.+Germainauthor=B.+Staelsauthor=C.+Dacquetauthor=M.+Speddingauthor=V.+Laudet&title=Overview+of+nomenclature+of+nuclear+receptors&doi=10.1124%2Fpr.58.4.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of nomenclature of nuclear receptors</span></div><div class="casAuthors">Germain, Pierre; Staels, Bart; Dacquet, Catherine; Spedding, Michael; Laudet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-704</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Nuclear receptor pharmacol. has, to a certain extent, led the way, compared with other receptor systems, in the appreciation that ligands may exert very diverse pharmacol., based on their individual chem. structure and the allosteric changes induced in the receptor/accessory protein complex.  This can lead to very selective pharmacol. effects, which may not necessarily be predicted from the experience with other agonists/partial agonists/antagonists.  If this is the case, then drug discovery may be back to drug-specific pharmacol. (where each drug may have an original profile), rather than specific-drug pharmacol. (where agents specific for a receptor have a distinct profile).  As functional selectivity is indeed a crucial mechanism to be considered when going through the drug discovery development process, then initial screens using reconstituted systems may not show the appropriate pharmacol., simply because the required stoichiometry of corepressors and coactivators may not be present to select the best compds.; therefore, multiple effector systems are necessary to screen for differential activation, and, even then, screening with in vivo pathophysiol. models may ultimately be required for the selection process-a massive but necessary task for pharmacologists.  Thus, the characterization of nuclear receptors and their assocd. proteins and the ligands that interact with them will remain a challenge to pharmacologists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXeD8Bz5rVrVg90H21EOLACvtfcHk0ljjVguzvyUORw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1ajtA%253D%253D&md5=264d69bdcd7b9f01f2d6ef3b73b78c60</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.4.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.4.2%26sid%3Dliteratum%253Aachs%26aulast%3DGermain%26aufirst%3DP.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DLaudet%26aufirst%3DV.%26atitle%3DOverview%2520of%2520nomenclature%2520of%2520nuclear%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D685%26epage%3D704%26doi%3D10.1124%2Fpr.58.4.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORgamma or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.%0AP.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+nuclear+receptor+retinoic+acid+receptor-related+orphan+receptor-gamma+%28RORgamma+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520nuclear%2520receptor%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-gamma%2520%2528RORgamma%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busby, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.chembiol.2011.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=22284354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=51-59&author=T.%0AP.+Burrisauthor=S.+A.+Busbyauthor=P.+R.+Griffin&title=Targeting+orphan+nuclear+receptors+for+treatment+of+metabolic+diseases+and+autoimmunity&doi=10.1016%2Fj.chembiol.2011.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity</span></div><div class="casAuthors">Burris, Thomas P.; Busby, Scott A.; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-59</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The nuclear receptor (NR) superfamily is composed of 48 members in humans and includes receptors for steroid hormones, thyroid hormone, various lipids and oxysterols.  This superfamily has been a rich source of drug targets for myriad diseases including inflammation, cancer, and metabolic disorders.  Approx. half of the superfamily have well characterized natural ligands whereas the remaining receptors are considered orphan receptors and remain a focus of a no. of investigators assessing their ability to be regulated by ligands.  Here, we review recent discoveries that yield important insight into the druggability of three orphan nuclear receptors: the retinoic acid receptor-like orphan receptors (RORs), peroxisome proliferator-activated receptor γ (PPARγ), and liver receptor homolog-1 (LRH-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWjganOqGf87Vg90H21EOLACvtfcHk0ljS5Rl42y9sMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GjtLY%253D&md5=d110458f889d2faccd4a9c6f0c5fcf0d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DBusby%26aufirst%3DS.%2BA.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DTargeting%2520orphan%2520nuclear%2520receptors%2520for%2520treatment%2520of%2520metabolic%2520diseases%2520and%2520autoimmunity%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D51%26epage%3D59%26doi%3D10.1016%2Fj.chembiol.2011.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Action of RORs and their ligands in (patho)physiology</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.tem.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=22789990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWgur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=619-627&author=L.+A.+Soltauthor=T.+P.+Burris&title=Action+of+RORs+and+their+ligands+in+%28patho%29physiology&doi=10.1016%2Fj.tem.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Action of RORs and their ligands in (patho)physiology</span></div><div class="casAuthors">Solt, Laura A.; Burris, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">619-627</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The retinoic-acid-receptor-related orphan receptors (RORs) are members of the nuclear receptor (NR) superfamily whose activity has been implicated in several physiol. and pathol. processes.  The RORs, specifically RORα and RORγ, are considered to be master regulators of TH17 cells, a recently described subset of CD4+ T helper cells that have been demonstrated to have a pathol. role in autoimmune disease.  As with most members of the NR superfamily, RORs are ligand-regulated, suggesting that their activity can be modulated by synthetic ligands.  Recent advances in the field have established that selective inhibition of the RORs is a viable therapeutic approach for not only the treatment of autoimmune disorders but also ROR-mediated metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU_NvOEtj6cbVg90H21EOLACvtfcHk0ljS5Rl42y9sMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWgur%252FJ&md5=a1d5b61ffa1b224265d1cd90d60e9620</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DAction%2520of%2520RORs%2520and%2520their%2520ligands%2520in%2520%2528patho%2529physiology%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D23%26spage%3D619%26epage%3D627%26doi%3D10.1016%2Fj.tem.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrebrock, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FitzHugh, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Berkel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birren, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruglyak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span> <span> </span><span class="NLM_article-title">Disruption of the nuclear hormone receptor RORalpha in staggerer mice</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1038/379736a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2F379736a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=736-739&author=B.+A.+Hamiltonauthor=W.+N.+Frankelauthor=A.+W.+Kerrebrockauthor=T.+L.+Hawkinsauthor=W.+FitzHughauthor=K.+Kusumiauthor=L.+B.+Russellauthor=K.+L.+Muellerauthor=V.+van+Berkelauthor=B.+W.+Birrenauthor=L.+Kruglyakauthor=E.+S.+Lander&title=Disruption+of+the+nuclear+hormone+receptor+RORalpha+in+staggerer+mice&doi=10.1038%2F379736a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2F379736a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379736a0%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DB.%2BA.%26aulast%3DFrankel%26aufirst%3DW.%2BN.%26aulast%3DKerrebrock%26aufirst%3DA.%2BW.%26aulast%3DHawkins%26aufirst%3DT.%2BL.%26aulast%3DFitzHugh%26aufirst%3DW.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DRussell%26aufirst%3DL.%2BB.%26aulast%3DMueller%26aufirst%3DK.%2BL.%26aulast%3Dvan%2BBerkel%26aufirst%3DV.%26aulast%3DBirren%26aufirst%3DB.%2BW.%26aulast%3DKruglyak%26aufirst%3DL.%26aulast%3DLander%26aufirst%3DE.%2BS.%26atitle%3DDisruption%2520of%2520the%2520nuclear%2520hormone%2520receptor%2520RORalpha%2520in%2520staggerer%2520mice%26jtitle%3DNature%26date%3D1996%26volume%3D379%26spage%3D736%26epage%3D739%26doi%3D10.1038%2F379736a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinmayr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conquet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondi-Reig, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhaye-Bouchaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auclair, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crepel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Andre, M.</span></span> <span> </span><span class="NLM_article-title">Staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">3960</span>– <span class="NLM_lpage">3965</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.7.3960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1073%2Fpnas.95.7.3960" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3960-3965&author=M.+Steinmayrauthor=E.+Andreauthor=F.+Conquetauthor=L.+Rondi-Reigauthor=N.+Delhaye-Bouchaudauthor=N.+Auclairauthor=H.+Danielauthor=F.+Crepelauthor=J.+Marianiauthor=C.+Soteloauthor=M.+Becker-Andre&title=Staggerer+phenotype+in+retinoid-related+orphan+receptor+alpha-deficient+mice&doi=10.1073%2Fpnas.95.7.3960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.7.3960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.7.3960%26sid%3Dliteratum%253Aachs%26aulast%3DSteinmayr%26aufirst%3DM.%26aulast%3DAndre%26aufirst%3DE.%26aulast%3DConquet%26aufirst%3DF.%26aulast%3DRondi-Reig%26aufirst%3DL.%26aulast%3DDelhaye-Bouchaud%26aufirst%3DN.%26aulast%3DAuclair%26aufirst%3DN.%26aulast%3DDaniel%26aufirst%3DH.%26aulast%3DCrepel%26aufirst%3DF.%26aulast%3DMariani%26aufirst%3DJ.%26aulast%3DSotelo%26aufirst%3DC.%26aulast%3DBecker-Andre%26aufirst%3DM.%26atitle%3DStaggerer%2520phenotype%2520in%2520retinoid-related%2520orphan%2520receptor%2520alpha-deficient%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D3960%26epage%3D3965%26doi%3D10.1073%2Fpnas.95.7.3960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gawlas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmayr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Andre, M.</span></span> <span> </span><span class="NLM_article-title">A novel isoform of the orphan nuclear receptor RORbeta is specifically expressed in pineal gland and retina</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1016/S0378-1119(98)00348-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2FS0378-1119%2898%2900348-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1998&pages=277-283&author=E.+Andreauthor=K.+Gawlasauthor=M.+Steinmayrauthor=M.+Becker-Andre&title=A+novel+isoform+of+the+orphan+nuclear+receptor+RORbeta+is+specifically+expressed+in+pineal+gland+and+retina&doi=10.1016%2FS0378-1119%2898%2900348-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0378-1119%2898%2900348-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-1119%252898%252900348-5%26sid%3Dliteratum%253Aachs%26aulast%3DAndre%26aufirst%3DE.%26aulast%3DGawlas%26aufirst%3DK.%26aulast%3DSteinmayr%26aufirst%3DM.%26aulast%3DBecker-Andre%26aufirst%3DM.%26atitle%3DA%2520novel%2520isoform%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520RORbeta%2520is%2520specifically%2520expressed%2520in%2520pineal%2520gland%2520and%2520retina%26jtitle%3DGene%26date%3D1998%26volume%3D216%26spage%3D277%26epage%3D283%26doi%3D10.1016%2FS0378-1119%2898%2900348-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer’s patches</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1034/j.1600-065X.2003.00074.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1034%2Fj.1600-065X.2003.00074.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=12969312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFyrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2003&pages=81-90&author=G.+Eberlauthor=D.+R.+Littman&title=The+role+of+the+nuclear+hormone+receptor+RORgammat+in+the+development+of+lymph+nodes+and+Peyer%E2%80%99s+patches&doi=10.1034%2Fj.1600-065X.2003.00074.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches</span></div><div class="casAuthors">Eberl, Gerard; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-90</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The nuclear hormone receptor retinoic acid-related orphan receptor (ROR)γt is required for the development of lymph nodes (LNs) and Peyer's patches (PPs), as these organs are absent in RORγt-deficient mice.  During fetal life, RORγt is expressed exclusively in lymphoid tissue-inducer (LTi) cells, a cell type that localizes in developing LNs and PPs.  LTi cells express surface lymphotoxin α1β2 that activates specialized mesenchymal cells to produce chemokines, upregulate adhesion mols. and induce further maturation of lymphoid organs.  RORγt inhibits nuclear factor of activated T-cell (NFAT) function in cell lines and induces the expression of Bcl-xL and p27kip1 in the adult thymus, suggesting that RORγt prevents cell activation, cell-cycle progression, and apoptosis.  We propose that RORγt, together with the inhibitor of basic helix-loop-helix transcription factor Id2, ensures generation and survival of fetal LTi cells necessary for the development of LNs and PPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQF5WmEPV1QbVg90H21EOLACvtfcHk0lgEWijk50CQlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFyrt7k%253D&md5=7a1566b2570a0ae10edd9ff06160f298</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2003.00074.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2003.00074.x%26sid%3Dliteratum%253Aachs%26aulast%3DEberl%26aufirst%3DG.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520role%2520of%2520the%2520nuclear%2520hormone%2520receptor%2520RORgammat%2520in%2520the%2520development%2520of%2520lymph%2520nodes%2520and%2520Peyer%25E2%2580%2599s%2520patches%26jtitle%3DImmunol.%2520Rev.%26date%3D2003%26volume%3D195%26spage%3D81%26epage%3D90%26doi%3D10.1034%2Fj.1600-065X.2003.00074.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isono, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita-Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span> <span> </span><span class="NLM_article-title">Inhibiting RORgammat/Th17 axis for autoimmune disorders</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.drudis.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=24792721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1205-1211&author=F.+Isonoauthor=S.+Fujita-Satoauthor=S.+Ito&title=Inhibiting+RORgammat%2FTh17+axis+for+autoimmune+disorders&doi=10.1016%2Fj.drudis.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting RORγt/Th17 axis for autoimmune disorders</span></div><div class="casAuthors">Isono, Fujio; Fujita-Sato, Saori; Ito, Shuichiro</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1205-1211</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent success reported in late-stage clin. trials for the treatment of psoriasis by antibodies directed against interleukin (IL)-17 or its receptor has validated and strongly supports the development of inhibitors of the IL-17 pathway as a new therapeutic modality in chronic inflammation and autoimmunity.  These results also encourage the drug discovery of orally available small mols. that can modulate down the prodn. of IL-17 by Th17 cells (the major IL-17 producers) or the downstream signaling of the IL-17 receptor.  Here, we review these strategies with an emphasis on inhibiting the retinoic-acid-related orphan nuclear receptor RORγt, which is the master regulator of Th17 cells and a promising therapeutic target for the treatment of multiple autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQi4K-X9vSobVg90H21EOLACvtfcHk0lgEWijk50CQlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D&md5=aaa82e8d21bcd0c879b0219a7b84e126</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DIsono%26aufirst%3DF.%26aulast%3DFujita-Sato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DS.%26atitle%3DInhibiting%2520RORgammat%252FTh17%2520axis%2520for%2520autoimmune%2520disorders%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1205%26epage%3D1211%26doi%3D10.1016%2Fj.drudis.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennert, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1038/ni1022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fni1022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=14691482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWhtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=64-73&author=G.+Eberlauthor=S.+Marmonauthor=M.+J.+Sunshineauthor=P.+D.+Rennertauthor=Y.+Choiauthor=D.+R.+Littman&title=An+essential+function+for+the+nuclear+receptor+RORgamma%28t%29+in+the+generation+of+fetal+lymphoid+tissue+inducer+cells&doi=10.1038%2Fni1022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells</span></div><div class="casAuthors">Eberl, Gerard; Marmon, Shana; Sunshine, Mary-Jean; Rennert, Paul D.; Choi, Yongwon; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-73</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lymphoid tissue inducer (LTi) cells are assocd. with early development of lymph nodes and Peyer's patches.  The authors show here that during fetal life the nuclear hormone receptor RORγt is expressed exclusively in and is required for the generation of LTi cells.  RORγt+ LTi cells provide essential factors, among which lymphotoxin-α1β2 is necessary but not sufficient for activation of the mesenchyma in lymph node and Peyer's patch anlagen.  This early LTi cell-mediated activation of lymph node and Peyer's patch mesenchyma forms the necessary platform for the subsequent development of mature lymphoid tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5WJaoOUVHLVg90H21EOLACvtfcHk0ljyWldFUKTMlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWhtr3N&md5=537f5f89b071b5b5a710d80a476d1b52</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fni1022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1022%26sid%3Dliteratum%253Aachs%26aulast%3DEberl%26aufirst%3DG.%26aulast%3DMarmon%26aufirst%3DS.%26aulast%3DSunshine%26aufirst%3DM.%2BJ.%26aulast%3DRennert%26aufirst%3DP.%2BD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DAn%2520essential%2520function%2520for%2520the%2520nuclear%2520receptor%2520RORgamma%2528t%2529%2520in%2520the%2520generation%2520of%2520fetal%2520lymphoid%2520tissue%2520inducer%2520cells%26jtitle%3DNat.%2520Immunol.%26date%3D2004%26volume%3D5%26spage%3D64%26epage%3D73%26doi%3D10.1038%2Fni1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huh, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of RORgammat: targeting Th17 cells and other applications</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">2232</span>– <span class="NLM_lpage">2237</span>, <span class="refDoi"> DOI: 10.1002/eji.201242740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1002%2Feji.201242740" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=2232-2237&author=J.+R.+Huhauthor=D.+R.+Littman&title=Small+molecule+inhibitors+of+RORgammat%3A+targeting+Th17+cells+and+other+applications&doi=10.1002%2Feji.201242740"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Feji.201242740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.201242740%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DJ.%2BR.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520RORgammat%253A%2520targeting%2520Th17%2520cells%2520and%2520other%2520applications%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2012%26volume%3D42%26spage%3D2232%26epage%3D2237%26doi%3D10.1002%2Feji.201242740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martynowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1210%2Fme.2009-0507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=20203100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=923-929&author=L.+Jinauthor=D.+Martynowskiauthor=S.+Zhengauthor=T.+Wadaauthor=W.+Xieauthor=Y.+Li&title=Structural+basis+for+hydroxycholesterols+as+natural+ligands+of+orphan+nuclear+receptor+RORgamma&doi=10.1210%2Fme.2009-0507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ</span></div><div class="casAuthors">Jin, Lihua; Martynowski, Dariusz; Zheng, Songyang; Wada, Taira; Xie, Wen; Li, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The retinoic acid-related orphan receptor γ (RORγ) has important roles in development and metabolic homeostasis.  Although the biol. functions of RORγ have been studied extensively, no ligands for RORγ have been identified, and no structure of RORγ has been reported.  In this study, we showed that hydroxycholesterols promote the recruitment of coactivators by RORγ using biochem. assays.  We also report the crystal structures of the RORγ ligand-binding domain bound with hydroxycholesterols.  The structures reveal the binding modes of various hydroxycholesterols in the RORγ pocket, with the receptors all adopting the canonical active conformation.  Mutations that disrupt the binding of hydroxycholesterols abolish the constitutive activity of RORγ.  Our observations suggest an important role for the endogenous hydroxycholesterols in modulating RORγ-dependent biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-ndP3ZSYebVg90H21EOLACvtfcHk0li-0hFIvAXZIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D&md5=1651fa21702f2a06451377fa11aa80bc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0507%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMartynowski%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520for%2520hydroxycholesterols%2520as%2520natural%2520ligands%2520of%2520orphan%2520nuclear%2520receptor%2520RORgamma%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D923%26epage%3D929%26doi%3D10.1210%2Fme.2009-0507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandridge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tootoonchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milla, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12163</span>– <span class="NLM_lpage">12168</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322807111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1073%2Fpnas.1322807111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12163-12168&author=P.+Sorooshauthor=J.+Wuauthor=X.+Xueauthor=J.+Songauthor=S.+W.+Suttonauthor=M.+Sabladauthor=J.+Yuauthor=M.+I.+Nelenauthor=X.+Liuauthor=G.+Castroauthor=R.+Lunaauthor=S.+Crawfordauthor=H.+Banieauthor=R.+A.+Dandridgeauthor=X.+Dengauthor=A.+Bittnerauthor=C.+Kueiauthor=M.+Tootoonchiauthor=N.+Rozenkrantsauthor=K.+Hermanauthor=J.+Gaoauthor=X.+V.+Yangauthor=K.+Sachenauthor=K.+Ngoauthor=W.+P.+Fung-Leungauthor=S.+Nguyenauthor=A.+de+Leon-Tabaldoauthor=J.+Blevittauthor=Y.+Zhangauthor=M.+D.+Cummingsauthor=T.+Raoauthor=N.+S.+Maniauthor=C.+Liuauthor=M.+McKinnonauthor=M.+E.+Millaauthor=A.+M.+Fourieauthor=S.+Sun&title=Oxysterols+are+agonist+ligands+of+RORgammat+and+drive+Th17+cell+differentiation&doi=10.1073%2Fpnas.1322807111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322807111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322807111%26sid%3Dliteratum%253Aachs%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DLuna%26aufirst%3DR.%26aulast%3DCrawford%26aufirst%3DS.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DDandridge%26aufirst%3DR.%2BA.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DBittner%26aufirst%3DA.%26aulast%3DKuei%26aufirst%3DC.%26aulast%3DTootoonchi%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DHerman%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%2BV.%26aulast%3DSachen%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DFung-Leung%26aufirst%3DW.%2BP.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3Dde%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DBlevitt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DRao%26aufirst%3DT.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DMilla%26aufirst%3DM.%2BE.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DOxysterols%2520are%2520agonist%2520ligands%2520of%2520RORgammat%2520and%2520drive%2520Th17%2520cell%2520differentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12163%26epage%3D12168%26doi%3D10.1073%2Fpnas.1322807111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santori, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Pavert, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglass, E. F.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaver, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haubrich, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorbek, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konijn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosales, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mebius, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nes, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">Identification of natural RORgamma ligands that regulate the development of lymphoid cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2015.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.cmet.2015.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=25651181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFals7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=286-297&author=F.+R.+Santoriauthor=P.+Huangauthor=S.+A.+van+de+Pavertauthor=E.+F.+Douglassauthor=D.+J.+Leaverauthor=B.+A.+Haubrichauthor=R.+Keberauthor=G.+Lorbekauthor=T.+Konijnauthor=B.+N.+Rosalesauthor=D.+Rozmanauthor=S.+Horvatauthor=A.+Rahierauthor=R.+E.+Mebiusauthor=F.+Rastinejadauthor=W.+D.+Nesauthor=D.+R.+Littman&title=Identification+of+natural+RORgamma+ligands+that+regulate+the+development+of+lymphoid+cells&doi=10.1016%2Fj.cmet.2015.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Natural RORγ Ligands that Regulate the Development of Lymphoid Cells</span></div><div class="casAuthors">Santori, Fabio R.; Huang, Pengxiang; van de Pavert, Serge A.; Douglass, Eugene F.; Leaver, David J.; Haubrich, Brad A.; Keber, Rok; Lorbek, Gregor; Konijn, Tanja; Rosales, Brittany N.; Rozman, Damjana; Horvat, Simon; Rahier, Alain; Mebius, Reina E.; Rastinejad, Fraydoon; Nes, W. David; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">286-297</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mice deficient in the nuclear hormone receptor RORγt have defective development of thymocytes, lymphoid organs, Th17 cells, and type 3 innate lymphoid cells.  RORγt binds to oxysterols derived from cholesterol catabolism, but it is not clear whether these are its natural ligands.  Here, we show that sterol lipids are necessary and sufficient to drive RORγt-dependent transcription.  We combined overexpression, RNAi, and genetic deletion of metabolic enzymes to study RORγ-dependent transcription.  Our results are consistent with the RORγt ligand(s) being a cholesterol biosynthetic intermediate (CBI) downstream of lanosterol and upstream of zymosterol.  Anal. of lipids bound to RORγ identified mols. with mol. wts. consistent with CBIs.  Furthermore, CBIs stabilized the RORγ ligand-binding domain and induced coactivator recruitment.  Genetic deletion of metabolic enzymes upstream of the RORγt-ligand(s) affected the development of lymph nodes and Th17 cells.  Our data suggest that CBIs play a role in lymphocyte development potentially through regulation of RORγt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxQ633DcL_x7Vg90H21EOLACvtfcHk0li-Rx0SiuJKpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFals7Y%253D&md5=6a4dbea10a38202f6e2253964f8f244e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2015.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2015.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DSantori%26aufirst%3DF.%2BR.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3Dvan%2Bde%2BPavert%26aufirst%3DS.%2BA.%26aulast%3DDouglass%26aufirst%3DE.%2BF.%26aulast%3DLeaver%26aufirst%3DD.%2BJ.%26aulast%3DHaubrich%26aufirst%3DB.%2BA.%26aulast%3DKeber%26aufirst%3DR.%26aulast%3DLorbek%26aufirst%3DG.%26aulast%3DKonijn%26aufirst%3DT.%26aulast%3DRosales%26aufirst%3DB.%2BN.%26aulast%3DRozman%26aufirst%3DD.%26aulast%3DHorvat%26aufirst%3DS.%26aulast%3DRahier%26aufirst%3DA.%26aulast%3DMebius%26aufirst%3DR.%2BE.%26aulast%3DRastinejad%26aufirst%3DF.%26aulast%3DNes%26aufirst%3DW.%2BD.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DIdentification%2520of%2520natural%2520RORgamma%2520ligands%2520that%2520regulate%2520the%2520development%2520of%2520lymphoid%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2015%26volume%3D21%26spage%3D286%26epage%3D297%26doi%3D10.1016%2Fj.cmet.2015.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendling, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span></span> <span> </span><span class="NLM_article-title">Sterol metabolism controls T(H)17 differentiation by generating endogenous RORgamma agonists</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnchembio.1714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=25558972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=141-147&author=X.+Huauthor=Y.+Wangauthor=L.+Y.+Haoauthor=X.+Liuauthor=C.+A.+Leschauthor=B.+M.+Sanchezauthor=J.+M.+Wendlingauthor=R.+W.+Morganauthor=T.+D.+Aicherauthor=L.+L.+Carterauthor=P.+L.+Toogoodauthor=G.+D.+Glick&title=Sterol+metabolism+controls+T%28H%2917+differentiation+by+generating+endogenous+RORgamma+agonists&doi=10.1038%2Fnchembio.1714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists</span></div><div class="casAuthors">Hu, Xiao; Wang, Yahong; Hao, Ling-Yang; Liu, Xikui; Lesch, Chuck A.; Sanchez, Brian M.; Wendling, Jay M.; Morgan, Rodney W.; Aicher, Tom D.; Carter, Laura L.; Toogood, Peter L.; Glick, Gary D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-147</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor γ (RORγt) controls the differentiation of naive CD4+ T cells into the TH17 lineage, which are crit. cells in the pathogenesis of autoimmune diseases.  Here the authors report that during TH17 differentiation, cholesterol biosynthesis and uptake programs are induced, whereas their metab. and efflux programs are suppressed.  These changes result in the accumulation of the cholesterol precursor, desmosterol, which functions as a potent endogenous RORγ agonist.  Generation of cholesterol precursors is essential for TH17 differentiation as blocking cholesterol synthesis with chem. inhibitors at steps before the formation of active precursors reduces differentiation.  Upon activation, metabolic changes also lead to prodn. of specific sterol-sulfate conjugates that favor activation of RORγ over the TH17-inhibiting sterol receptor LXR.  Thus, TH17 differentiation is orchestrated by coordinated sterol synthesis, mobilization and metab. to selectively activate RORγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKonRBn05nmbVg90H21EOLACvtfcHk0liwOPTauLL2GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislOltQ%253D%253D&md5=e82af9d561a1e4683a86b815cb734971</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1714%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DL.%2BY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLesch%26aufirst%3DC.%2BA.%26aulast%3DSanchez%26aufirst%3DB.%2BM.%26aulast%3DWendling%26aufirst%3DJ.%2BM.%26aulast%3DMorgan%26aufirst%3DR.%2BW.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DGlick%26aufirst%3DG.%2BD.%26atitle%3DSterol%2520metabolism%2520controls%2520T%2528H%252917%2520differentiation%2520by%2520generating%2520endogenous%2520RORgamma%2520agonists%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D141%26epage%3D147%26doi%3D10.1038%2Fnchembio.1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuhant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istrate, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORalpha and RORgamma</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1029</span>– <span class="NLM_lpage">1034</span>, <span class="refDoi"> DOI: 10.1021/cb100223d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100223d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1029-1034&author=Y.+Wangauthor=N.+Kumarauthor=P.+Nuhantauthor=M.+D.+Cameronauthor=M.+A.+Istrateauthor=W.+R.+Roushauthor=P.+R.+Griffinauthor=T.+P.+Burris&title=Identification+of+SR1078%2C+a+synthetic+agonist+for+the+orphan+nuclear+receptors+RORalpha+and+RORgamma&doi=10.1021%2Fcb100223d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcb100223d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100223d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DNuhant%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DIstrate%26aufirst%3DM.%2BA.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DIdentification%2520of%2520SR1078%252C%2520a%2520synthetic%2520agonist%2520for%2520the%2520orphan%2520nuclear%2520receptors%2520RORalpha%2520and%2520RORgamma%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1029%26epage%3D1034%26doi%3D10.1021%2Fcb100223d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisely, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span> <span> </span><span class="NLM_article-title">Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor gamma (RORgamma) by a class of aryl amide compounds</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1124/mol.112.078667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1124%2Fmol.112.078667" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=583-590&author=W.+Zhangauthor=J.+Zhangauthor=L.+Fangauthor=L.+Zhouauthor=S.+Wangauthor=Z.+Xiangauthor=Y.+Liauthor=B.+Wiselyauthor=G.+Zhangauthor=G.+Anauthor=Y.+Wangauthor=S.+Leungauthor=Z.+Zhong&title=Increasing+human+Th17+differentiation+through+activation+of+orphan+nuclear+receptor+retinoid+acid-related+orphan+receptor+gamma+%28RORgamma%29+by+a+class+of+aryl+amide+compounds&doi=10.1124%2Fmol.112.078667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.078667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.078667%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWisely%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DAn%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DZ.%26atitle%3DIncreasing%2520human%2520Th17%2520differentiation%2520through%2520activation%2520of%2520orphan%2520nuclear%2520receptor%2520retinoid%2520acid-related%2520orphan%2520receptor%2520gamma%2520%2528RORgamma%2529%2520by%2520a%2520class%2520of%2520aryl%2520amide%2520compounds%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D583%26epage%3D590%26doi%3D10.1124%2Fmol.112.078667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxdorf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of tertiary amine and indole derivatives as potent RORγt inverse agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1021/ml4003875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=65-68&author=T.+Yangauthor=Q.+Liuauthor=Y.+Chengauthor=W.+Caiauthor=Y.+Maauthor=L.+Yangauthor=Q.+Wuauthor=L.+A.+Orband-Millerauthor=L.+Zhouauthor=Z.+Xiangauthor=M.+Huxdorfauthor=W.+Zhangauthor=J.+Zhangauthor=J.+N.+Xiangauthor=S.+Leungauthor=Y.+Qiuauthor=Z.+Zhongauthor=J.+D.+Elliottauthor=X.+Linauthor=Y.+Wang&title=Discovery+of+tertiary+amine+and+indole+derivatives+as+potent+ROR%CE%B3t+inverse+agonists&doi=10.1021%2Fml4003875"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fml4003875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003875%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DHuxdorf%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520tertiary%2520amine%2520and%2520indole%2520derivatives%2520as%2520potent%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D65%26epage%3D68%26doi%3D10.1021%2Fml4003875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5293</span>– <span class="NLM_lpage">5302</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.bmc.2015.07.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5293-5302&author=Y.+Wangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Maauthor=L.+Yangauthor=L.+Zhouauthor=Z.+Xiangauthor=Z.+Chengauthor=S.+Luauthor=L.+A.+Orband-Millerauthor=W.+Zhangauthor=Q.+Wuauthor=K.+Zhangauthor=Y.+Liauthor=J.+N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+N-%284-aryl-5-aryloxy-thiazol-2-yl%29-amides+as+potent+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmc.2015.07.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.068%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520N-%25284-aryl-5-aryloxy-thiazol-2-yl%2529-amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5293%26epage%3D5302%26doi%3D10.1016%2Fj.bmc.2015.07.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boenig, G. d. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Minor structural change to tertiary sulfonamide RORc ligands led to opposite mechanisms of action</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1021/ml500420y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500420y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=276-281&author=O.+Reneauthor=B.+P.+Fauberauthor=G.+d.+L.+Boenigauthor=B.+Burtonauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+R.+Johnsonauthor=J.+R.+Kieferauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=H.+A.+Wallweberauthor=H.+Wong&title=Minor+structural+change+to+tertiary+sulfonamide+RORc+ligands+led+to+opposite+mechanisms+of+action&doi=10.1021%2Fml500420y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml500420y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500420y%26sid%3Dliteratum%253Aachs%26aulast%3DRene%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBoenig%26aufirst%3DG.%2Bd.%2BL.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DMinor%2520structural%2520change%2520to%2520tertiary%2520sulfonamide%2520RORc%2520ligands%2520led%2520to%2520opposite%2520mechanisms%2520of%2520action%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D276%26epage%3D281%26doi%3D10.1021%2Fml500420y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aagaard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPheat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirholt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grindebacke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span> <span> </span><span class="NLM_article-title">Benzoxazepines achieve potent suppression of IL-17 release in human T-Helper 17 (TH 17) cells through an induced-fit binding mode to the nuclear receptor RORgamma</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1002%2Fcmdc.201500432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=26553345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=207-216&author=R.+I.+Olssonauthor=Y.+Xueauthor=S.+von+Bergauthor=A.+Aagaardauthor=J.+McPheatauthor=E.+L.+Hanssonauthor=J.+Bernstromauthor=P.+Hanssonauthor=J.+Jirholtauthor=H.+Grindebackeauthor=A.+Lefflerauthor=R.+Chenauthor=Y.+Xiongauthor=H.+Geauthor=T.+G.+Hanssonauthor=F.+Narjes&title=Benzoxazepines+achieve+potent+suppression+of+IL-17+release+in+human+T-Helper+17+%28TH+17%29+cells+through+an+induced-fit+binding+mode+to+the+nuclear+receptor+RORgamma&doi=10.1002%2Fcmdc.201500432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ</span></div><div class="casAuthors">Olsson, Roine I.; Xue, Yafeng; von Berg, Stefan; Aagaard, Anna; McPheat, Jane; Hansson, Eva L.; Bernstroem, Jenny; Hansson, Pia; Jirholt, Johan; Grindebacke, Hanna; Leffler, Agnes; Chen, Rongfeng; Xiong, Yao; Ge, Hongbin; Hansson, Thomas G.; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">RORγt, an isoform of the retinoic acid-related orphan receptor gamma (RORc, RORγ), has been identified as the master regulator of T-helper 17 (TH17) cell function and development, making it an attractive target for the treatment of autoimmune diseases.  Validation for this target comes from antibodies targeting interleukin-17 (IL-17), the signature cytokine produced by TH17 cells, which have shown impressive results in clin. trials.  Through focused screening of our compd. collection, we identified a series of N-sulfonylated benzoxazepines, which displayed micromolar affinity for the RORγ ligand-binding domain (LBD) in a radioligand binding assay.  Optimization of these initial hits resulted in potent binders, which dose-dependently decreased the ability of the RORγ-LBD to interact with a peptide derived from steroid receptor coactivator 1, and inhibited the release of IL-17 secretion from isolated and cultured human TH17 cells with nanomolar potency.  A cocrystal structure of inverse agonist 15 (2-chloro-6-fluoro-N-(4-{[3-(trifluoromethyl)phenyl]sulfonyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)benzamide) bound to the RORγ-LBD illustrated that both hydrophobic interactions, leading to an induced fit around the substituted benzamide moiety of 15, as well as a hydrogen bond from the amide NH to His479 seemed to be important for the mechanism of action.  This structure is compared with the structure of agonist 25 (N-(2-fluorophenyl)-4-[(4-fluorophenyl)sulfonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-6-amine ) and structures of other known RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorSpjXrs3zSrVg90H21EOLACvtfcHk0libiyzCw1kI0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N&md5=ed6fa69d887818da7acd4f9abbd2ff93</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500432%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DR.%2BI.%26aulast%3DXue%26aufirst%3DY.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DAagaard%26aufirst%3DA.%26aulast%3DMcPheat%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DE.%2BL.%26aulast%3DBernstrom%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJirholt%26aufirst%3DJ.%26aulast%3DGrindebacke%26aufirst%3DH.%26aulast%3DLeffler%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DH.%26aulast%3DHansson%26aufirst%3DT.%2BG.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DBenzoxazepines%2520achieve%2520potent%2520suppression%2520of%2520IL-17%2520release%2520in%2520human%2520T-Helper%252017%2520%2528TH%252017%2529%2520cells%2520through%2520an%2520induced-fit%2520binding%2520mode%2520to%2520the%2520nuclear%2520receptor%2520RORgamma%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D207%26epage%3D216%26doi%3D10.1002%2Fcmdc.201500432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildes, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chodaparambil, J. V.</span></span> <span> </span><span class="NLM_article-title">Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand</span>. <i>BMC Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">7</span>, <span class="refDoi"> DOI: 10.1186/s12900-016-0059-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1186%2Fs12900-016-0059-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27246200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVWrtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=7&author=D.+J.+Marcotteauthor=Y.+Liuauthor=K.+Littleauthor=J.+H.+Jonesauthor=N.+A.+Powellauthor=C.+P.+Wildesauthor=L.+F.+Silvianauthor=J.+V.+Chodaparambil&title=Structural+determinant+for+inducing+RORgamma+specific+inverse+agonism+triggered+by+a+synthetic+benzoxazinone+ligand&doi=10.1186%2Fs12900-016-0059-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand</span></div><div class="casAuthors">Marcotte, Douglas J.; Liu, Yu Ting; Little, Kevin; Jones, John H.; Powell, Noel A.; Wildes, Craig P.; Silvian, Laura F.; Chodaparambil, Jayanth V.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Structural Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7/1-7/9</span>CODEN:
                <span class="NLM_cas:coden">BSBMBB</span>;
        ISSN:<span class="NLM_cas:issn">1472-6807</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The nuclear hormone receptor RORγ regulates transcriptional genes involved in the prodn. of the pro-inflammatory interleukin IL-17 which has been linked to autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.  This transcriptional activity of RORγ is modulated through a protein-protein interaction involving the activation function 2 (AF2) helix on the ligand binding domain of RORγ and a conserved LXXLL helix motif on coactivator proteins.  Our goal was to develop a RORγ specific inverse agonist that would help down regulate pro-inflammatory gene transcription by disrupting the protein protein interaction with coactivator proteins as a therapeutic agent.  Results: We identified a novel series of synthetic benzoxazinone ligands having an agonist (BIO592) and inverse agonist (BIO399) mode of action in a FRET based assay.  We show that the AF2 helix of RORγ is proteolytically sensitive when inverse agonist BIO399 binds.  Using x-ray crystallog. we show how small modifications on the benzoxazinone agonist BIO592 trigger inverse agonism of RORγ.  Using an in vivo reporter assay, we show that the inverse agonist BIO599 displayed specificity for RORγ over ROR sub-family members α and β.  Conclusion: The synthetic benzoxazinone ligands identified in our FRET assay have an agonist (BIO592) or inverse agonist (BIO399) effect by stabilizing or destabilizing the agonist conformation of RORγ.  The proteolytic sensitivity of the AF2 helix of RORγ demonstrates that it destabilizes upon BIO399 inverse agonist binding perturbing the coactivator protein binding site.  Our structural investigation of the BIO592 agonist and BIO399 inverse agonist structures identified residue Met358 on RORγ as the trigger for RORγ specific inverse agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxW2sFawf8O7Vg90H21EOLACvtfcHk0liOtuhdKbTp9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWrtbvK&md5=1bd1b9a25ff0ce166d56a70e391691f3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1186%2Fs12900-016-0059-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12900-016-0059-3%26sid%3Dliteratum%253Aachs%26aulast%3DMarcotte%26aufirst%3DD.%2BJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLittle%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DWildes%26aufirst%3DC.%2BP.%26aulast%3DSilvian%26aufirst%3DL.%2BF.%26aulast%3DChodaparambil%26aufirst%3DJ.%2BV.%26atitle%3DStructural%2520determinant%2520for%2520inducing%2520RORgamma%2520specific%2520inverse%2520agonism%2520triggered%2520by%2520a%2520synthetic%2520benzoxazinone%2520ligand%26jtitle%3DBMC%2520Struct.%2520Biol.%26date%3D2016%26volume%3D16%26spage%3D7%26doi%3D10.1186%2Fs12900-016-0059-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doebelin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patouret, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmarajan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span> <span> </span><span class="NLM_article-title">N-Arylsulfonyl indolines as retinoic acid receptor-related orphan receptor gamma (RORgamma) agonists</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2607</span>– <span class="NLM_lpage">2620</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1002%2Fcmdc.201600491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27879053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSlsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2607-2620&author=C.+Doebelinauthor=R.+Patouretauthor=R.+D.+Garcia-Ordonezauthor=M.+R.+Changauthor=V.+Dharmarajanauthor=D.+S.+Kuruvillaauthor=S.+J.+Novickauthor=L.+Linauthor=M.+D.+Cameronauthor=P.+R.+Griffinauthor=T.+M.+Kamenecka&title=N-Arylsulfonyl+indolines+as+retinoic+acid+receptor-related+orphan+receptor+gamma+%28RORgamma%29+agonists&doi=10.1002%2Fcmdc.201600491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists</span></div><div class="casAuthors">Doebelin, Christelle; Patouret, Remi; Garcia-Ordonez, Ruben D.; Chang, Mi Ra; Dharmarajan, Venkatasubramanian; Kuruvilla, Dana S.; Novick, Scott J.; Lin, Li; Cameron, Michael D.; Griffin, Patrick R.; Kamenecka, Theodore M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2607-2620</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The nuclear retinoic acid receptor-related orphan receptor γ (RORγ; NR1F3) is a key regulator of inflammatory gene programs involved in T helper 17 (TH17) cell proliferation.  As such, synthetic small-mol. repressors (inverse agonists) targeting RORγ have been extensively studied for their potential as therapeutic agents for various autoimmune diseases.  Alternatively, enhancing TH17 cell proliferation through activation (agonism) of RORγ may boost an immune response, thereby offering a potentially new approach in cancer immunotherapy.  Herein the authors describe the development of N-arylsulfonyl indolines as RORγ agonists.  Structure-activity studies reveal a crit. linker region in these mols. as the major determinant for agonism.  Hydrogen/deuterium exchange coupled to mass spectrometry (HDX-MS) anal. of RORγ-ligand complexes help rationalize the obsd. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFUjlrkpRAz7Vg90H21EOLACvtfcHk0liOtuhdKbTp9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSlsbzP&md5=1dfb3c08077c18e8cda3e6a287bb8194</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600491%26sid%3Dliteratum%253Aachs%26aulast%3DDoebelin%26aufirst%3DC.%26aulast%3DPatouret%26aufirst%3DR.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DDharmarajan%26aufirst%3DV.%26aulast%3DKuruvilla%26aufirst%3DD.%2BS.%26aulast%3DNovick%26aufirst%3DS.%2BJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26atitle%3DN-Arylsulfonyl%2520indolines%2520as%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520gamma%2520%2528RORgamma%2529%2520agonists%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2607%26epage%3D2620%26doi%3D10.1002%2Fcmdc.201600491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span>; <span class="NLM_string-name">Toogood, P. L.</span>; <span class="NLM_string-name">Hu, X.</span>; <span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Celeste, L. L.</span>; <span class="NLM_string-name">Liu, X.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Adoptive cellular therapy using an agonist of retinoic acid recepor-related orphan receptor gamma & related therapeutic methods</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2015,131,035</span>, Mar 9, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=G.+D.+Glick&author=P.+L.+Toogood&author=X.+Hu&author=T.+D.+Aicher&author=L.+L.+Celeste&author=X.+Liu&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Adoptive+cellular+therapy+using+an+agonist+of+retinoic+acid+recepor-related+orphan+receptor+gamma+%26+related+therapeutic+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGlick%26aufirst%3DG.%2BD.%26atitle%3DAdoptive%2520cellular%2520therapy%2520using%2520an%2520agonist%2520of%2520retinoic%2520acid%2520recepor-related%2520orphan%2520receptor%2520gamma%2520%2526%2520related%2520therapeutic%2520methods%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2015,171,610</span>, May 17, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+D.+Aicher&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Tetrahydroquinoline+sulfonamide+and+related+compounds+for+use+as+agonists+of+ROR%CE%B3+and+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DTetrahydroquinoline%2520sulfonamide%2520and%2520related%2520compounds%2520for%2520use%2520as%2520agonists%2520of%2520ROR%25CE%25B3%2520and%2520the%2520treatment%2520of%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Skalitzky, D. J.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of Disease</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2015,171,558</span>, Jul 20, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=T.+D.+Aicher&author=D.+J.+Skalitzky&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Benzenesulfonamido+and+related+compounds+for+use+as+agonists+of+ROR%CE%B3+and+the+treatment+of+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DBenzenesulfonamido%2520and%2520related%2520compounds%2520for%2520use%2520as%2520agonists%2520of%2520ROR%25CE%25B3%2520and%2520the%2520treatment%2520of%2520Disease%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Aryl Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2016,201,225</span>, Dec 15, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+D.+Aicher&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Aryl+Dihydro-2H-benzo%5Bb%5D%5B1%2C4%5Doxazine+sulfonamide+and+related+compounds+for+use+as+agonists+of+ROR%CE%B3+and+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DAryl%2520Dihydro-2H-benzo%255Bb%255D%255B1%252C4%255Doxazine%2520sulfonamide%2520and%2520related%2520compounds%2520for%2520use%2520as%2520agonists%2520of%2520ROR%25CE%25B3%2520and%2520the%2520treatment%2520of%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Dihydro-2H-benzo[b][1,4]oxazine sulfomide and related compounds for use as agonists of RORγ and the treatment of disease</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2016,179,343</span>, Nov 10, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+D.+Aicher&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Dihydro-2H-benzo%5Bb%5D%5B1%2C4%5Doxazine+sulfomide+and+related+compounds+for+use+as+agonists+of+ROR%CE%B3+and+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DDihydro-2H-benzo%255Bb%255D%255B1%252C4%255Doxazine%2520sulfomide%2520and%2520related%2520compounds%2520for%2520use%2520as%2520agonists%2520of%2520ROR%25CE%25B3%2520and%2520the%2520treatment%2520of%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span>Cortellis,
Thomson Reuters Database: Search results for “retinoid Z receptor
gamma agonist”. <a href="https://cortellis.thomsonreuterslifesciences.com/" class="extLink">https://cortellis.thomsonreuterslifesciences.com/</a> (accessed Jun 23, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cortellis%2C%0AThomson+Reuters+Database%3A+Search+results+for+%E2%80%9Cretinoid+Z+receptor%0Agamma+agonist%E2%80%9D.+https%3A%2F%2Fcortellis.thomsonreuterslifesciences.com%2F+%28accessed+Jun+23%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span>News
on FierceBiotech. <a href="http://www.fiercebiotech.com/biotech/lycera-s-double-action-immuno-oncology-drug-starts-trials" class="extLink">http://www.fiercebiotech.com/biotech/lycera-s-double-action-immuno-oncology-drug-starts-trials</a> (accessed Jan 4, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=News%0Aon+FierceBiotech.+http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Flycera-s-double-action-immuno-oncology-drug-starts-trials+%28accessed+Jan+4%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span>U.S. National
Library of Medicine. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02929862" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02929862</a> (accessed June 23, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+National%0ALibrary+of+Medicine.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02929862+%28accessed+June+23%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowsky, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">488</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1038/nm.4070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnm.4070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27019329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFShurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=488-496&author=J.+Wangauthor=J.+X.+Zouauthor=X.+Xueauthor=D.+Caiauthor=Y.+Zhangauthor=Z.+Duanauthor=Q.+Xiangauthor=J.+C.+Yangauthor=M.+C.+Louieauthor=A.+D.+Borowskyauthor=A.+C.+Gaoauthor=C.+P.+Evansauthor=K.+S.+Lamauthor=J.+Xuauthor=H.+Kungauthor=R.+M.+Evansauthor=Y.+Xuauthor=H.+Chen&title=ROR-%CE%B3+drives+androgen+receptor+expression+and+represents+a+therapeutic+target+in+castration-resistant+prostate+cancer&doi=10.1038%2Fnm.4070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer</span></div><div class="casAuthors">Wang, Junjian; Zou, June X.; Xue, Xiaoqian; Cai, Demin; Zhang, Yan; Duan, Zhijian; Xiang, Qiuping; Yang, Joy C.; Louie, Maggie C.; Borowsky, Alexander D.; Gao, Allen C.; Evans, Christopher P.; Lam, Kit S.; Xu, Jianzhen; Kung, Hsing-Jien; Evans, Ronald M.; Xu, Yong; Chen, Hong-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The androgen receptor (AR) is overexpressed and hyperactivated in human castration-resistant prostate cancer (CRPC).  However, the determinants of AR overexpression in CRPC are poorly defined.  Here we show that retinoic acid receptor-related orphan receptor γ (ROR-γ) is overexpressed and amplified in metastatic CRPC tumors, and that ROR-γ drives AR expression in the tumors.  ROR-γ recruits nuclear receptor coactivator 1 and 3 (NCOA1 and NCOA3, also known as SRC-1 and SRC-3) to an AR-ROR response element (RORE) to stimulate AR gene transcription.  ROR-γ antagonists suppress the expression of both AR and its variant AR-V7 in prostate cancer (PCa) cell lines and tumors.  ROR-γ antagonists also markedly diminish genome-wide AR binding, H3K27ac abundance and expression of the AR target gene network.  Finally, ROR-γ antagonists suppressed tumor growth in multiple AR-expressing, but not AR-neg., xenograft PCa models, and they effectively sensitized CRPC tumors to enzalutamide, without overt toxicity, in mice.  Taken together, these results establish ROR-γ as a key player in CRPC by acting upstream of AR and as a potential therapeutic target for advanced PCa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX9ywlnlPbX7Vg90H21EOLACvtfcHk0lgPuKLuVw-IaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFShurY%253D&md5=3817be87b91c2f148987d35e2305365c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnm.4070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4070%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DJ.%2BX.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DJ.%2BC.%26aulast%3DLouie%26aufirst%3DM.%2BC.%26aulast%3DBorowsky%26aufirst%3DA.%2BD.%26aulast%3DGao%26aufirst%3DA.%2BC.%26aulast%3DEvans%26aufirst%3DC.%2BP.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DKung%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DROR-%25CE%25B3%2520drives%2520androgen%2520receptor%2520expression%2520and%2520represents%2520a%2520therapeutic%2520target%2520in%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D488%26epage%3D496%26doi%3D10.1038%2Fnm.4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spooner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawidzka, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majchrzak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kryczek, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Huis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalitzky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurd, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulos, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. L.</span></span> <span> </span><span class="NLM_article-title">Synthetic RORgamma agonists regulate multiple pathways to enhance antitumor immunity</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1254854</span>, <span class="refDoi"> DOI: 10.1080/2162402X.2016.1254854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1080%2F2162402X.2016.1254854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e1254854&author=X.+Huauthor=X.+Liuauthor=J.+Moisanauthor=Y.+Wangauthor=C.+A.+Leschauthor=C.+Spoonerauthor=R.+W.+Morganauthor=E.+M.+Zawidzkaauthor=D.+Mertzauthor=D.+Bousleyauthor=K.+Majchrzakauthor=I.+Kryczekauthor=C.+Taylorauthor=C.+Van+Huisauthor=D.+Skalitzkyauthor=A.+Hurdauthor=T.+D.+Aicherauthor=P.+L.+Toogoodauthor=G.+D.+Glickauthor=C.+M.+Paulosauthor=W.+Zouauthor=L.+L.+Carter&title=Synthetic+RORgamma+agonists+regulate+multiple+pathways+to+enhance+antitumor+immunity&doi=10.1080%2F2162402X.2016.1254854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F2162402X.2016.1254854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F2162402X.2016.1254854%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMoisan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLesch%26aufirst%3DC.%2BA.%26aulast%3DSpooner%26aufirst%3DC.%26aulast%3DMorgan%26aufirst%3DR.%2BW.%26aulast%3DZawidzka%26aufirst%3DE.%2BM.%26aulast%3DMertz%26aufirst%3DD.%26aulast%3DBousley%26aufirst%3DD.%26aulast%3DMajchrzak%26aufirst%3DK.%26aulast%3DKryczek%26aufirst%3DI.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DVan%2BHuis%26aufirst%3DC.%26aulast%3DSkalitzky%26aufirst%3DD.%26aulast%3DHurd%26aufirst%3DA.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DGlick%26aufirst%3DG.%2BD.%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26atitle%3DSynthetic%2520RORgamma%2520agonists%2520regulate%2520multiple%2520pathways%2520to%2520enhance%2520antitumor%2520immunity%26jtitle%3DOncoimmunology%26date%3D2016%26volume%3D5%26spage%3De1254854%26doi%3D10.1080%2F2162402X.2016.1254854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ryota Nakajima, Hiroyuki Oono, Sakae Sugiyama, Yohei Matsueda, Tomohide Ida, Shinji Kakuda, Jun Hirata, Atsushi Baba, Akito Makino, Ryo Matsuyama, Ryan D. White, Ryan Ρ. Wurz, Youngsook Shin, Xiaoshan Min, Angel Guzman-Perez, Zhulun Wang, Antony Symons, Sanjay K. Singh, Srinivasa Reddy Mothe, Sergei Belyakov, Anjan Chakrabarti, <span class="NLM_string-name hlFld-ContribAuthor">Satoshi Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of [1,2,4]Triazolo[1,5-a]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 528-534. <a href="https://doi.org/10.1021/acsmedchemlett.9b00649" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00649%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyridine%252BDerivatives%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BROR%2525CE%2525B3t%252BInverse%252BAgonists%26aulast%3DNakajima%26aufirst%3DRyota%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D24122019%26date%3D27022020%26date%3D03032020%26date%3D27022020%26volume%3D11%26issue%3D4%26spage%3D528%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan Zhang, Xishan Wu, Xiaoqian Xue, Chenchang Li, Junjian Wang, Rui Wang, Cheng Zhang, Chao Wang, Yudan Shi, Lingjiao Zou, Qiu Li, Zenghong Huang, Xiaojuan Hao, Kerry Loomes, Donghai Wu, Hong-Wu Chen, Jinxin Xu, <span class="NLM_string-name hlFld-ContribAuthor">Yong Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4716-4730. <a href="https://doi.org/10.1021/acs.jmedchem.9b00327" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BXY101%25252C%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BROR%2525CE%2525B3%252BInverse%252BAgonist%252Bfor%252BTreatment%252Bof%252BCastration-Resistant%252BProstate%252BCancer%26aulast%3DZhang%26aufirst%3DYan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20022019%26date%3D22042019%26date%3D09042019%26volume%3D62%26issue%3D9%26spage%3D4716%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jina Kim, Jaeyoung Song, Hyun Dong Ji, Eun Kyung Yoo, Jae-Eon Lee, Sang Bong Lee, Ji Min Oh, Seungmi Lee, Ji Sun Hwang, Heeseok Yoon, Dong-Su Kim, Su-Jeong Lee, Minseon Jeong, Sungwoo Lee, Kyung-Hee Kim, Hueng-Sik Choi, Sang Woo Lee, Keun-Gyu Park, In-Kyu Lee, Seong Heon Kim, Hayoung Hwang, Yong Hyun Jeon, Jungwook Chin, <span class="NLM_string-name hlFld-ContribAuthor">Sung Jin Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1837-1858. <a href="https://doi.org/10.1021/acs.jmedchem.8b01296" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BEstrogen-Related%252BReceptor-%2525CE%2525B3%252BInverse%252BAgonists%252BTo%252BRestore%252Bthe%252BSodium%252BIodide%252BSymporter%252BFunction%252Bin%252BAnaplastic%252BThyroid%252BCancer%26aulast%3DKim%26aufirst%3DJina%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D16082018%26date%3D04022019%26date%3D18012019%26volume%3D62%26issue%3D4%26spage%3D1837%26epage%3D1858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tomoya Yukawa, Yoshi Nara, Mitsunori Kono, Ayumu Sato, Tsuneo Oda, Terufumi Takagi, Takayuki Sato, Yoshihiro Banno, Naohiro Taya, Takashi Imada, Zenyu Shiokawa, Nobuyuki Negoro, Tetsuji Kawamoto, Ryokichi Koyama, Noriko Uchiyama, Robert Skene, Isaac Hoffman, Chien-Hung Chen, BiChing Sang, Gyorgy Snell, Ryosuke Katsuyama, Satoshi Yamamoto, <span class="NLM_string-name hlFld-ContribAuthor">Junya Shirai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt Agonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1167-1179. <a href="https://doi.org/10.1021/acs.jmedchem.8b01181" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01181%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BRetinoic%252BAcid-Related%252BOrphan%252BReceptor%252B%2525CE%2525B3t%252B%252528ROR%2525CE%2525B3t%252529%252BAgonist%252BStructure-Based%252BFunctionality%252BSwitching%252BApproach%252Bfrom%252BIn%252BHouse%252BROR%2525CE%2525B3t%252BInverse%252BAgonist%252Bto%252BROR%2525CE%2525B3t%252BAgonist%26aulast%3DYukawa%26aufirst%3DTomoya%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27072018%26date%3D04022019%26date%3D17012019%26volume%3D62%26issue%3D3%26spage%3D1167%26epage%3D1179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vrajesh B. Pandya, Sanjay Kumar, Sachchidanand, Rajiv Sharma, <span class="NLM_string-name hlFld-ContribAuthor">Ranjit C. Desai</span>. </span><span class="cited-content_cbyCitation_article-title">Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (24)
                                     , 10976-10995. <a href="https://doi.org/10.1021/acs.jmedchem.8b00588" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00588%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCombating%252BAutoimmune%252BDiseases%252BWith%252BRetinoic%252BAcid%252BReceptor-Related%252BOrphan%252BReceptor-%2525CE%2525B3%252B%252528ROR%2525CE%2525B3%252Bor%252BRORc%252529%252BInhibitors%25253A%252BHits%252Band%252BMisses%26aulast%3DPandya%26aufirst%3DVrajesh%2BB.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13042018%26date%3D30072018%26date%3D16072018%26volume%3D61%26issue%3D24%26spage%3D10976%26epage%3D10995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David A. Carcache, Anna Vulpetti, Joerg Kallen, Henri Mattes, David Orain, Rowan Stringer, Eric Vangrevelinghe, Romain M. Wolf, Klemens Kaupmann, Johannes Ottl, Janet Dawson, Nigel G. Cooke, Klemens Hoegenauer, Andreas Billich, Juergen Wagner, Christine Guntermann, <span class="NLM_string-name hlFld-ContribAuthor">Samuel Hintermann</span>. </span><span class="cited-content_cbyCitation_article-title">Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6724-6735. <a href="https://doi.org/10.1021/acs.jmedchem.8b00529" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00529%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimizing%252Ba%252BWeakly%252BBinding%252BFragment%252Binto%252Ba%252BPotent%252BROR%2525CE%2525B3t%252BInverse%252BAgonist%252Bwith%252BEfficacy%252Bin%252Ban%252Bin%252BVivo%252BInflammation%252BModel%26aulast%3DCarcache%26aufirst%3DDavid%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04042018%26date%3D24072018%26date%3D10072018%26volume%3D61%26issue%3D15%26spage%3D6724%26epage%3D6735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth  Cash</span>, <span class="hlFld-ContribAuthor ">Sandra  Sephton</span>, <span class="hlFld-ContribAuthor ">Cassandra  Woolley</span>, <span class="hlFld-ContribAuthor ">Attia M.  Elbehi</span>, <span class="hlFld-ContribAuthor ">Anu  R. I.</span>, <span class="hlFld-ContribAuthor ">Bene  Ekine-Afolabi</span>, <span class="hlFld-ContribAuthor ">Victor C.  Kok</span>. </span><span class="cited-content_cbyCitation_article-title">The role of the circadian clock in cancer hallmark acquisition and immune-based cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2021,</strong> <em>40 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-021-01919-5" title="DOI URL">https://doi.org/10.1186/s13046-021-01919-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-021-01919-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-021-01919-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DThe%252Brole%252Bof%252Bthe%252Bcircadian%252Bclock%252Bin%252Bcancer%252Bhallmark%252Bacquisition%252Band%252Bimmune-based%252Bcancer%252Btherapeutics%26aulast%3DCash%26aufirst%3DElizabeth%26date%3D2021%26date%3D2021%26volume%3D40%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojun  Ma</span>, <span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Xinwei  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel N-sulfonamide-tetrahydroisoquinolines as potent retinoic acid receptor-related orphan receptor γt agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113585. <a href="https://doi.org/10.1016/j.ejmech.2021.113585" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113585%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BN-sulfonamide-tetrahydroisoquinolines%252Bas%252Bpotent%252Bretinoic%252Bacid%252Breceptor-related%252Borphan%252Breceptor%252B%2525CE%2525B3t%252Bagonists%26aulast%3DMa%26aufirst%3DXiaojun%26date%3D2021%26volume%3D222%26spage%3D113585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Buesking</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Mayes</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Combs</span>. </span><span class="cited-content_cbyCitation_article-title">Immuno‐Oncology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-30. <a href="https://doi.org/10.1002/0471266949.bmc272" title="DOI URL">https://doi.org/10.1002/0471266949.bmc272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc272%26sid%3Dliteratum%253Aachs%26atitle%3DImmuno%2525E2%252580%252590Oncology%26aulast%3DBuesking%26aufirst%3DAndrew%2BW.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D30%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryota  Nakajima</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Oono</span>, <span class="hlFld-ContribAuthor ">Keiko  Kumazawa</span>, <span class="hlFld-ContribAuthor ">Tomohide  Ida</span>, <span class="hlFld-ContribAuthor ">Jun  Hirata</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Xiaoshan  Min</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Zhulun  Wang</span>, <span class="hlFld-ContribAuthor ">Antony  Symons</span>, <span class="hlFld-ContribAuthor ">Sanjay K.  Singh</span>, <span class="hlFld-ContribAuthor ">Srinivasa Reddy  Mothe</span>, <span class="hlFld-ContribAuthor ">Sergei  Belyakov</span>, <span class="hlFld-ContribAuthor ">Anjan  Chakrabarti</span>, <span class="hlFld-ContribAuthor ">Satoshi  Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 6-Oxo-4-phenyl-hexanoic acid derivatives as RORγt inverse agonists showing favorable ADME profile. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>36 </em>, 127786. <a href="https://doi.org/10.1016/j.bmcl.2021.127786" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127786%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B6-Oxo-4-phenyl-hexanoic%252Bacid%252Bderivatives%252Bas%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%252Bshowing%252Bfavorable%252BADME%252Bprofile%26aulast%3DNakajima%26aufirst%3DRyota%26date%3D2021%26volume%3D36%26spage%3D127786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuehan  Xia</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Yunpeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Li  Xia</span>, <span class="hlFld-ContribAuthor ">Yafei  Huang</span>, <span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Meiqi  Song</span>, <span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Yunyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Zhu</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of tetrahydroquinolines and benzomorpholines as novel potent RORγt agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113013. <a href="https://doi.org/10.1016/j.ejmech.2020.113013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Btetrahydroquinolines%252Band%252Bbenzomorpholines%252Bas%252Bnovel%252Bpotent%252BROR%2525CE%2525B3t%252Bagonists%26aulast%3DXia%26aufirst%3DYuehan%26date%3D2021%26volume%3D211%26spage%3D113013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tong  Li</span>, <span class="hlFld-ContribAuthor ">Bowen  Wu</span>, <span class="hlFld-ContribAuthor ">Tao  Yang</span>, <span class="hlFld-ContribAuthor ">Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Ke  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">The outstanding antitumor capacity of CD4+ T helper lymphocytes. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2020,</strong> <em>1874 </em>
                                    (2)
                                     , 188439. <a href="https://doi.org/10.1016/j.bbcan.2020.188439" title="DOI URL">https://doi.org/10.1016/j.bbcan.2020.188439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2020.188439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2020.188439%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DThe%252Boutstanding%252Bantitumor%252Bcapacity%252Bof%252BCD4%25252B%252BT%252Bhelper%252Blymphocytes%26aulast%3DLi%26aufirst%3DTong%26date%3D2020%26volume%3D1874%26issue%3D2%26spage%3D188439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-cheng  Yu</span>, <span class="hlFld-ContribAuthor ">Feng  Yang</span>, <span class="hlFld-ContribAuthor ">Xiao-yu  Ding</span>, <span class="hlFld-ContribAuthor ">Nan-nan  Sun</span>, <span class="hlFld-ContribAuthor ">Zheng-yuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Ya-fei  Huang</span>, <span class="hlFld-ContribAuthor ">Yu-rong  Yan</span>, <span class="hlFld-ContribAuthor ">Chen  Zhu</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Zhi-feng  Chen</span>, <span class="hlFld-ContribAuthor ">Si-qi  Guo</span>, <span class="hlFld-ContribAuthor ">Hua-liang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kai-xian  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiao-min  Luo</span>, <span class="hlFld-ContribAuthor ">Shi-jie  Chen</span>, <span class="hlFld-ContribAuthor ">Yong-hui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Crystallography-guided discovery of carbazole-based retinoic acid-related orphan receptor gamma-t (RORγt) modulators: insights into different protein behaviors with “short” and “long” inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>126 </em><a href="https://doi.org/10.1038/s41401-020-00552-w" title="DOI URL">https://doi.org/10.1038/s41401-020-00552-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-00552-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-00552-w%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DCrystallography-guided%252Bdiscovery%252Bof%252Bcarbazole-based%252Bretinoic%252Bacid-related%252Borphan%252Breceptor%252Bgamma-t%252B%252528ROR%2525CE%2525B3t%252529%252Bmodulators%25253A%252Binsights%252Binto%252Bdifferent%252Bprotein%252Bbehaviors%252Bwith%252B%2525E2%252580%25259Cshort%2525E2%252580%25259D%252Band%252B%2525E2%252580%25259Clong%2525E2%252580%25259D%252Binverse%252Bagonists%26aulast%3DYu%26aufirst%3DMing-cheng%26date%3D2020%26date%3D2020%26volume%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jina  Kim</span>, <span class="hlFld-ContribAuthor ">Hayoung  Hwang</span>, <span class="hlFld-ContribAuthor ">Heeseok  Yoon</span>, <span class="hlFld-ContribAuthor ">Jae-Eon  Lee</span>, <span class="hlFld-ContribAuthor ">Ji Min  Oh</span>, <span class="hlFld-ContribAuthor ">Hongchan  An</span>, <span class="hlFld-ContribAuthor ">Hyun Dong  Ji</span>, <span class="hlFld-ContribAuthor ">Seungmi  Lee</span>, <span class="hlFld-ContribAuthor ">Eunju  Cha</span>, <span class="hlFld-ContribAuthor ">Min Jung  Ma</span>, <span class="hlFld-ContribAuthor ">Dong-Su  Kim</span>, <span class="hlFld-ContribAuthor ">Su-Jeong  Lee</span>, <span class="hlFld-ContribAuthor ">Tara Man  Kadayat</span>, <span class="hlFld-ContribAuthor ">Jaeyoung  Song</span>, <span class="hlFld-ContribAuthor ">Sang Woo  Lee</span>, <span class="hlFld-ContribAuthor ">Jae-Han  Jeon</span>, <span class="hlFld-ContribAuthor ">Keun-Gyu  Park</span>, <span class="hlFld-ContribAuthor ">In-Kyu  Lee</span>, <span class="hlFld-ContribAuthor ">Yong Hyun  Jeon</span>, <span class="hlFld-ContribAuthor ">Jungwook  Chin</span>, <span class="hlFld-ContribAuthor ">Sung Jin  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>205 </em>, 112501. <a href="https://doi.org/10.1016/j.ejmech.2020.112501" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112501%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Borally%252Bavailable%252Binverse%252Bagonist%252Bof%252Bestrogen-related%252Breceptor%252Bgamma%252Bshowed%252Bexpanded%252Befficacy%252Bfor%252Bthe%252Bradioiodine%252Btherapy%252Bof%252Bpoorly%252Bdifferentiated%252Bthyroid%252Bcancer%26aulast%3DKim%26aufirst%3DJina%26date%3D2020%26volume%3D205%26spage%3D112501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Hu</span>, <span class="hlFld-ContribAuthor ">Qiuju  Han</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">STAT3: A key signaling molecule for converting cold to hot tumors. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2020,</strong> <em>489 </em>, 29-40. <a href="https://doi.org/10.1016/j.canlet.2020.05.035" title="DOI URL">https://doi.org/10.1016/j.canlet.2020.05.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2020.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2020.05.035%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DSTAT3%25253A%252BA%252Bkey%252Bsignaling%252Bmolecule%252Bfor%252Bconverting%252Bcold%252Bto%252Bhot%252Btumors%26aulast%3DHu%26aufirst%3DRui%26date%3D2020%26volume%3D489%26spage%3D29%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rens M. J. M.  Vries</span>, <span class="hlFld-ContribAuthor ">Richard G.  Doveston</span>, <span class="hlFld-ContribAuthor ">Femke A.  Meijer</span>, <span class="hlFld-ContribAuthor ">Luc  Brunsveld</span>. </span><span class="cited-content_cbyCitation_article-title">Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (7)
                                     , 561-565. <a href="https://doi.org/10.1002/cmdc.202000044" title="DOI URL">https://doi.org/10.1002/cmdc.202000044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000044%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DElucidation%252Bof%252Ban%252BAllosteric%252BMode%252Bof%252BAction%252Bfor%252Ba%252BThienopyrazole%252BROR%2525CE%2525B3t%252BInverse%252BAgonist%26aulast%3DVries%26aufirst%3DRens%2BM.%2BJ.%2BM.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D7%26spage%3D561%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shusuke  Suzuki</span>, <span class="hlFld-ContribAuthor ">Toshiya  Nakamura</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Saito</span>, <span class="hlFld-ContribAuthor ">Yuta  Terauchi</span>, <span class="hlFld-ContribAuthor ">Kentaro  Kawai</span>, <span class="hlFld-ContribAuthor ">Midori  Takimoto-Kamimura</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Kurita</span>. </span><span class="cited-content_cbyCitation_article-title">Structural change of retinoic-acid receptor-related orphan receptor induced by binding of inverse-agonist: Molecular dynamics and ab initio molecular orbital simulations. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2020,</strong> <em>18 </em>, 1676-1685. <a href="https://doi.org/10.1016/j.csbj.2020.06.034" title="DOI URL">https://doi.org/10.1016/j.csbj.2020.06.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2020.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2020.06.034%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DStructural%252Bchange%252Bof%252Bretinoic-acid%252Breceptor-related%252Borphan%252Breceptor%252Binduced%252Bby%252Bbinding%252Bof%252Binverse-agonist%25253A%252BMolecular%252Bdynamics%252Band%252Bab%252Binitio%252Bmolecular%252Borbital%252Bsimulations%26aulast%3DSuzuki%26aufirst%3DShusuke%26date%3D2020%26volume%3D18%26spage%3D1676%26epage%3D1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl-substituted indole and indoline derivatives as RORγt agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111589. <a href="https://doi.org/10.1016/j.ejmech.2019.111589" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111589%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Baryl-substituted%252Bindole%252Band%252Bindoline%252Bderivatives%252Bas%252BROR%2525CE%2525B3t%252Bagonists%26aulast%3DZhu%26aufirst%3DYan%26date%3D2019%26volume%3D182%26spage%3D111589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong-min  Yuan</span>, <span class="hlFld-ContribAuthor ">Hai-hong  Chen</span>, <span class="hlFld-ContribAuthor ">Nan-nan  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-jun  Ma</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulations on RORγt: insights into its functional agonism and inverse agonism. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2019,</strong> <em>40 </em>
                                    (11)
                                     , 1480-1489. <a href="https://doi.org/10.1038/s41401-019-0259-z" title="DOI URL">https://doi.org/10.1038/s41401-019-0259-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0259-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0259-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DMolecular%252Bdynamics%252Bsimulations%252Bon%252BROR%2525CE%2525B3t%25253A%252Binsights%252Binto%252Bits%252Bfunctional%252Bagonism%252Band%252Binverse%252Bagonism%26aulast%3DYuan%26aufirst%3DCong-min%26date%3D2019%26date%3D2019%26volume%3D40%26issue%3D11%26spage%3D1480%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaja  Karaś</span>, <span class="hlFld-ContribAuthor ">Anna  Sałkowska</span>, <span class="hlFld-ContribAuthor ">Iwona  Karwaciak</span>, <span class="hlFld-ContribAuthor ">Aurelia  Walczak-Drzewiecka</span>, <span class="hlFld-ContribAuthor ">Jarosław  Dastych</span>, <span class="hlFld-ContribAuthor ">Rafał A.  Bachorz</span>, <span class="hlFld-ContribAuthor ">Marcin  Ratajewski</span>. </span><span class="cited-content_cbyCitation_article-title">The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (22)
                                     , 5780. <a href="https://doi.org/10.3390/ijms20225780" title="DOI URL">https://doi.org/10.3390/ijms20225780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20225780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20225780%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BDichotomous%252BNature%252Bof%252BAZ5104%252B%252528an%252BEGFR%252BInhibitor%252529%252BTowards%252BROR%2525CE%2525B3%252Band%252BROR%2525CE%2525B3T%26aulast%3DKara%25C5%259B%26aufirst%3DKaja%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D22%26spage%3D5780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Yang</span>, <span class="hlFld-ContribAuthor ">Ruihan  Zhang</span>, <span class="hlFld-ContribAuthor ">Dongxuan  Ni</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Shijie  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Weilie  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of betulinaldehyde as a natural RORγt agonist. </span><span class="cited-content_cbyCitation_journal-name">Fitoterapia</span><span> <strong>2019,</strong> <em>137 </em>, 104200. <a href="https://doi.org/10.1016/j.fitote.2019.104200" title="DOI URL">https://doi.org/10.1016/j.fitote.2019.104200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fitote.2019.104200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fitote.2019.104200%26sid%3Dliteratum%253Aachs%26jtitle%3DFitoterapia%26atitle%3DDiscovery%252Bof%252Bbetulinaldehyde%252Bas%252Ba%252Bnatural%252BROR%2525CE%2525B3t%252Bagonist%26aulast%3DYang%26aufirst%3DFeng%26date%3D2019%26volume%3D137%26spage%3D104200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Congmin  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Ma</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Gu</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3181. <a href="https://doi.org/10.3390/molecules23123181" title="DOI URL">https://doi.org/10.3390/molecules23123181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123181%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BMechanism%252Bof%252BAction%252Bof%252BROR%2525CE%2525B3t%252BAgonists%252Band%252BInverse%252BAgonists%25253A%252BInsights%252Bfrom%252BMolecular%252BDynamics%252BSimulation%26aulast%3DSun%26aufirst%3DNannan%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. First reported RORγ natural ligands as RORγ agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) <b>4</b> with RORγ LBD. (B) overlay of <b>2</b> (gray), <b>3</b> (green), and <b>4</b> (blue). PDB codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KYT">3KYT</a> (RORγ/<b>2</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0J">3L0J</a> (RORγ/<b>3</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0L">3L0L</a> (RORγ/<b>4</b>). Blue dashes represent hydrogen bond interactions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Oxysterol RORγt agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Chemical structure of 4ACD8 (<b>9</b>); (B) RORγt-<b>9</b> cocrystal structure; (C) key interactions of RORγ LBD with <b>9</b> (blue dashes represent hydrogen bond interactions).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of <b>10</b> (zymosterol) and <b>11</b> (desmosterol).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of <b>12</b> (T0901317) and <b>13</b> (SR1078).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Aryl amides as RORγ agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Discovery of tertiary amines as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) RORγ cocrystal structure with agonist <b>18</b>; (B) key interactions of RORγ LBD with <b>18</b> (blue dashes represent hydrogen bond interactions, and pink dashes represent π–π stacking interactions).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Thiazole amides as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Co-crystal structure of RORγ LBD with <b>27</b>; (B) key interactions of RORγ LBD with <b>27</b> (blue dashes represent hydrogen bond interactions, and pink dashes represent π–π stacking interactions).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Sulfonamides as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Cocrystal structure inverse agonist <b>31</b> (purple) and agonist <b>33</b> (green) with RORγ LBD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Benzoxazepine benzamides as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (A) Superposition of soak-in crystal structures of <b>34</b> (purple) and <b>35</b> (green). (B) Superposition of cocrystal structure of <b>34</b> (red) and soak-in crystal structure of <b>35</b> (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Benzoxazinones as RORγt modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Overlay of inverse agonist <b>36</b> (BIO399, purple) and agonist <b>37</b> (BIO592, green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. <b>13</b> and its analog <b>38</b> (SR0987).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. <i>N-</i>Arylsulfonylindolines as RORγ agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Exemplary RORγt agonists in patent WO2015131035 A1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/medium/jm-2017-013142_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Representative RORγt agonists in Lycera’s patents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-14/acs.jmedchem.7b01314/20180719/images/large/jm-2017-013142_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01314&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i14">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balkwill, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Inflammation and cancer: back to Virchow?</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">539</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(00)04046-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2FS0140-6736%2800%2904046-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=11229684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsVKltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=539-545&author=F.+Balkwillauthor=A.+Mantovani&title=Inflammation+and+cancer%3A+back+to+Virchow%3F&doi=10.1016%2FS0140-6736%2800%2904046-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and cancer: back to Virchow?</span></div><div class="casAuthors">Balkwill, F.; Mantovani, A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9255</span>),
    <span class="NLM_cas:pages">539-545</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  The response of the body to a cancer is not a unique mechanism but has many parallels with inflammation and wound healing.  This article reviews the links between cancer and inflammation and discusses the implications of these links for cancer prevention and treatment.  We suggest that the inflammatory cells and cytokines found in tumors are more likely to contribute to tumor growth, progression, and immunosuppression than they are to mount an effective host anti-tumor response.  Moreover cancer susceptibility and severity may be assocd. with functional polymorphisms of inflammatory cytokine genes, and deletion or inhibition of inflammatory cytokines inhibits development of exptl. cancer.  If genetic damage is the "match that lights the fire" of cancer, some types of inflammation may provide the "fuel that feeds the flames".  Over the past 10 yr information about the cytokine and chemokine network has led to development of a range of cytokine/chemokine antagonists targeted at inflammatory and allergic diseases.  The first of these to enter the clinic, tumor necrosis factor antagonists, have shown encouraging efficacy.  In this article the authors have provided a rationale for the use of cytokine and chemokine blockade, and further investigation of non-steroidal anti-inflammatory drugs, in the chemoprevention and treatment of malignant diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIap2mRKsiZLVg90H21EOLACvtfcHk0li8ONlrQrfWbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsVKltb0%253D&md5=a3568a66d36e057bf811ac3dedbf0199</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2800%2904046-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252800%252904046-0%26sid%3Dliteratum%253Aachs%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DInflammation%2520and%2520cancer%253A%2520back%2520to%2520Virchow%253F%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D539%26epage%3D545%26doi%3D10.1016%2FS0140-6736%2800%2904046-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. S.</span></span> <i>A Commotion in the Blood: Life, Death, and the Immune System</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Henry Holt</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1997</span>; pp  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">14</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=14-14&author=S.+S.+Hall&title=A+Commotion+in+the+Blood%3A+Life%2C+Death%2C+and+the+Immune+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DS.%2BS.%26btitle%3DA%2520Commotion%2520in%2520the%2520Blood%253A%2520Life%252C%2520Death%252C%2520and%2520the%2520Immune%2520System%26pub%3DHenry%2520Holt%26date%3D1997%26spage%3D14%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coley, W. B.,  II</span></span> <span> </span><span class="NLM_article-title">Contribution to the knowledge of sarcoma</span>. <i>Ann. Surg.</i> <span class="NLM_year" style="font-weight: bold;">1891</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1097/00000658-189112000-00015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1097%2F00000658-189112000-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=17859590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A280%3ADC%252BD2srksVKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1891&pages=199-220&author=W.+B.+Coley&title=Contribution+to+the+knowledge+of+sarcoma&doi=10.1097%2F00000658-189112000-00015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">II. Contribution to the Knowledge of Sarcoma</span></div><div class="casAuthors">Coley W B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of surgery</span>
        (<span class="NLM_cas:date">1891</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-220</span>
        ISSN:<span class="NLM_cas:issn">0003-4932</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRo-f4FsyvzhTQLBVDQn4bCfW6udTcc2eZrETpjdB-ZtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srksVKlsg%253D%253D&md5=41f295141a7469993cfd74031506e71d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00000658-189112000-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00000658-189112000-00015%26sid%3Dliteratum%253Aachs%26aulast%3DColey%26aufirst%3DW.%2BB.%26atitle%3DContribution%2520to%2520the%2520knowledge%2520of%2520sarcoma%26jtitle%3DAnn.%2520Surg.%26date%3D1891%26volume%3D14%26spage%3D199%26epage%3D220%26doi%3D10.1097%2F00000658-189112000-00015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Couzin-Frankel, J.</span></span> <span> </span><span class="NLM_article-title">Breakthrough of the year 2013. cancer immunotherapy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>342</i></span>,  <span class="NLM_fpage">1432</span>– <span class="NLM_lpage">1433</span>, <span class="refDoi"> DOI: 10.1126/science.342.6165.1432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1126%2Fscience.342.6165.1432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=24357284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2013&pages=1432-1433&author=J.+Couzin-Frankel&title=Breakthrough+of+the+year+2013.+cancer+immunotherapy&doi=10.1126%2Fscience.342.6165.1432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer immunotherapy</span></div><div class="casAuthors">Couzin-Frankel, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">6165</span>),
    <span class="NLM_cas:pages">1432-1433</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxASV1j-6kL7Vg90H21EOLACvtfcHk0lgUTW0gmaonzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotF2qsg%253D%253D&md5=2e0995fd567c5b59f40c46981da0bef4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.342.6165.1432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.342.6165.1432%26sid%3Dliteratum%253Aachs%26aulast%3DCouzin-Frankel%26aufirst%3DJ.%26atitle%3DBreakthrough%2520of%2520the%2520year%25202013.%2520cancer%2520immunotherapy%26jtitle%3DScience%26date%3D2013%26volume%3D342%26spage%3D1432%26epage%3D1433%26doi%3D10.1126%2Fscience.342.6165.1432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahoney, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennert, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, G. J.</span></span> <span> </span><span class="NLM_article-title">Combination cancer immunotherapy and new immunomodulatory targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1038/nrd4591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnrd4591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=26228759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=561-584&author=K.+M.+Mahoneyauthor=P.+D.+Rennertauthor=G.+J.+Freeman&title=Combination+cancer+immunotherapy+and+new+immunomodulatory+targets&doi=10.1038%2Fnrd4591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Combination cancer immunotherapy and new immunomodulatory targets</span></div><div class="casAuthors">Mahoney, Kathleen M.; Rennert, Paul D.; Freeman, Gordon J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-584</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting immune checkpoints such as programmed cell death protein 1 (PD1), programmed cell death 1 ligand 1 (PDL1) and cytotoxic T lymphocyte antigen 4 (CTLA4) has achieved noteworthy benefit in multiple cancers by blocking immunoinhibitory signals and enabling patients to produce an effective antitumor response.  Inhibitors of CTLA4, PD1 or PDL1 administered as single agents have resulted in durable tumor regression in some patients, and combinations of PD1 and CTLA4 inhibitors may enhance antitumor benefit.  Numerous addnl. immunomodulatory pathways as well as inhibitory factors expressed or secreted by myeloid and stromal cells in the tumor microenvironment are potential targets for synergizing with immune checkpoint blockade.  Given the breadth of potential targets in the immune system, crit. questions to address include which combinations should move forward in development and which patients will benefit from these treatments.  This Review discusses the leading drug targets that are expressed on tumor cells and in the tumor microenvironment that allow enhancement of the antitumor immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwi7ChUpfjArVg90H21EOLACvtfcHk0lgUTW0gmaonzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KiurrJ&md5=b0b598b2a7c62794b4f03c4cea196a97</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4591%26sid%3Dliteratum%253Aachs%26aulast%3DMahoney%26aufirst%3DK.%2BM.%26aulast%3DRennert%26aufirst%3DP.%2BD.%26aulast%3DFreeman%26aufirst%3DG.%2BJ.%26atitle%3DCombination%2520cancer%2520immunotherapy%2520and%2520new%2520immunomodulatory%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D561%26epage%3D584%26doi%3D10.1038%2Fnrd4591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ishihara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pop, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyengar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannan, R.</span></span> <span> </span><span class="NLM_article-title">Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1007/s00262-016-1914-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1007%2Fs00262-016-1914-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27743027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yitbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=281-298&author=D.+Ishiharaauthor=L.+Popauthor=T.+Takeshimaauthor=P.+Iyengarauthor=R.+Hannan&title=Rationale+and+evidence+to+combine+radiation+therapy+and+immunotherapy+for+cancer+treatment&doi=10.1007%2Fs00262-016-1914-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment</span></div><div class="casAuthors">Ishihara, Dan; Pop, Laurentiu; Takeshima, Tsuguhide; Iyengar, Puneeth; Hannan, Raquibul</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-298</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Cancer immunotherapy exploits the immune system's ability to differentiate between tumor target cells and host cells.  Except for limited success against a few tumor types, most immunotherapies have not achieved the desired clin. efficacy until recently.  The field of cancer immunotherapy has flourished with a variety of new agents for clin. use, and remarkable progress has been made in the design of effective immunotherapeutic regimens.  Furthermore, the therapeutic outcome of these novel agents is enhanced when combined with conventional cancer treatment modalities including radiotherapy (RT).  An increasing no. of studies have demonstrated the abscopal effect, an immunol. response occurring in cancer sites distant from irradiated areas.  The present work reviews studies on the combination between RT and immunotherapy to induce synergistic and abscopal effects involved in cancer immunomodulation.  Further insight into the complex interactions between the immune system and cancer cells in the tumor microenvironment, and their modulation by RT, may reveal the abscopal effect as a clin. relevant and reproducible event leading to improved cancer outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7j6Vr1ziOIrVg90H21EOLACvtfcHk0ljsCCt0cpcJ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yitbjP&md5=e04b45ff25872d8794b712abf8606cc1</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00262-016-1914-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-016-1914-6%26sid%3Dliteratum%253Aachs%26aulast%3DIshihara%26aufirst%3DD.%26aulast%3DPop%26aufirst%3DL.%26aulast%3DTakeshima%26aufirst%3DT.%26aulast%3DIyengar%26aufirst%3DP.%26aulast%3DHannan%26aufirst%3DR.%26atitle%3DRationale%2520and%2520evidence%2520to%2520combine%2520radiation%2520therapy%2520and%2520immunotherapy%2520for%2520cancer%2520treatment%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2017%26volume%3D66%26spage%3D281%26epage%3D298%26doi%3D10.1007%2Fs00262-016-1914-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vilgelm, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, A.</span></span> <span> </span><span class="NLM_article-title">Combinatorial approach to cancer immunotherapy: strength in numbers</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1189/jlb.5RI0116-013RR</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1189%2Fjlb.5RI0116-013RR" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27256570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSks7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2016&pages=275-290&author=A.+E.+Vilgelmauthor=D.+B.+Johnsonauthor=A.+Richmond&title=Combinatorial+approach+to+cancer+immunotherapy%3A+strength+in+numbers&doi=10.1189%2Fjlb.5RI0116-013RR"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial approach to cancer immunotherapy: strength in numbers</span></div><div class="casAuthors">Vilgelm, Anna E.; Johnson, Douglas B.; Richmond, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-290</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Society for Leukocyte Biology</span>)
        </div><div class="casAbstract">Immune-checkpoint blockade therapy with antibodies targeting CTLA-4 and PD-1 has revolutionized melanoma treatment by eliciting responses that can be remarkably durable and is now advancing to other malignancies.  However, not all patients respond to immune-checkpoint inhibitors.  Extensive preclin. evidence suggests that combining immune-checkpoint inhibitors with other anticancer treatments can greatly improve the therapeutic benefit.  The first clin. success of the combinatorial approach to cancer immunotherapy was demonstrated using a dual-checkpoint blockade with CTLA-4 and PD-1 inhibitors, which resulted in accelerated FDA approval of this therapeutic regimen.  In this review, we discuss the combinations of current and emerging immunotherapeutic agents in clin. and preclin. development and summarize the insights into potential mechanisms of synergistic anti-tumor activity gained from animal studies.  These promising combinatorial partners for the immune-checkpoint blockade include therapeutics targeting addnl. inhibitory receptors of T cells, such as TIM-3, LAG-3, TIGIT, and BTLA, and agonists of T cell costimulatory receptors 4-1BB, OX40, and GITR, as well as agents that promote cancer cell recognition by the immune system, such as tumor vaccines, IDO inhibitors, and agonists of the CD40 receptor of APCs.  We also review the therapeutic potential of regimens combining the immune-checkpoint blockade with therapeutic interventions that have been shown to enhance immunogenicity of cancer cells, including oncolytic viruses, RT, epigenetic therapy, and senescence-inducing therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph3E1E6MXDzLVg90H21EOLACvtfcHk0ljsCCt0cpcJ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSks7zP&md5=ae79677e8207f81fa81cb99e619fc642</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1189%2Fjlb.5RI0116-013RR&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.5RI0116-013RR%26sid%3Dliteratum%253Aachs%26aulast%3DVilgelm%26aufirst%3DA.%2BE.%26aulast%3DJohnson%26aufirst%3DD.%2BB.%26aulast%3DRichmond%26aufirst%3DA.%26atitle%3DCombinatorial%2520approach%2520to%2520cancer%2520immunotherapy%253A%2520strength%2520in%2520numbers%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2016%26volume%3D100%26spage%3D275%26epage%3D290%26doi%3D10.1189%2Fjlb.5RI0116-013RR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teague, R. M.</span></span> <span> </span><span class="NLM_article-title">Targeting CD8<sup>+</sup> T-cell tolerance for cancer immunotherapy</span>. <i>Immunotherapy</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">852</span>, <span class="refDoi"> DOI: 10.2217/imt.14.51</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.2217%2Fimt.14.51" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=833-852&author=S.+R.+Jacksonauthor=J.+Yuanauthor=R.+M.+Teague&title=Targeting+CD8%2B+T-cell+tolerance+for+cancer+immunotherapy&doi=10.2217%2Fimt.14.51"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2217%2Fimt.14.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fimt.14.51%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DS.%2BR.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DTeague%26aufirst%3DR.%2BM.%26atitle%3DTargeting%2520CD8%252B%2520T-cell%2520tolerance%2520for%2520cancer%2520immunotherapy%26jtitle%3DImmunotherapy%26date%3D2014%26volume%3D6%26spage%3D833%26epage%3D852%26doi%3D10.2217%2Fimt.14.51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thor Straten, P.</span></span> <span> </span><span class="NLM_article-title">Immune-suppressive properties of the tumor microenvironment</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1137</span>– <span class="NLM_lpage">1148</span>, <span class="refDoi"> DOI: 10.1007/s00262-013-1434-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1007%2Fs00262-013-1434-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=23666510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVSmtbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=1137-1148&author=J.+C.+Beckerauthor=M.+H.+Andersenauthor=D.+Schramaauthor=P.+Thor+Straten&title=Immune-suppressive+properties+of+the+tumor+microenvironment&doi=10.1007%2Fs00262-013-1434-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Immune-suppressive properties of the tumor microenvironment</span></div><div class="casAuthors">Becker, Juergen C.; Andersen, Mads Hald; Schrama, David; thor Straten, Per</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1137-1148</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Solid tumors are more than an accumulation of cancer cells.  Indeed, cancerous cells create a permissive microenvironment by exploiting non-transformed host cells.  Thus, solid tumors rather resemble abnormal organs composed of the cancerous cells itself and the stroma providing the supportive framework.  The stroma can be divided into the extracellular matrix consisting of proteoglycans, hyaluronic acid, and fibrous proteins, as well as stromal cells including mesenchymal and immune cells; moreover, it contains various peptide factors and metabolites.  Here, we will focus on immune-modulating capacities of the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLtWHRmIPq_rVg90H21EOLACvtfcHk0lgir0S8tjZkfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVSmtbvM&md5=78f0a9179a7864d6be5153e99274d369</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00262-013-1434-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-013-1434-6%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DJ.%2BC.%26aulast%3DAndersen%26aufirst%3DM.%2BH.%26aulast%3DSchrama%26aufirst%3DD.%26aulast%3DThor%2BStraten%26aufirst%3DP.%26atitle%3DImmune-suppressive%2520properties%2520of%2520the%2520tumor%2520microenvironment%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2013%26volume%3D62%26spage%3D1137%26epage%3D1148%26doi%3D10.1007%2Fs00262-013-1434-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wayteck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breckpot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Smedt, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raemdonck, K.</span></span> <span> </span><span class="NLM_article-title">A personalized view on cancer immunotherapy</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2013.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.canlet.2013.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=24051308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOgsbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2014&pages=113-125&author=L.+Wayteckauthor=K.+Breckpotauthor=J.+Demeesterauthor=S.+C.+De+Smedtauthor=K.+Raemdonck&title=A+personalized+view+on+cancer+immunotherapy&doi=10.1016%2Fj.canlet.2013.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A personalized view on cancer immunotherapy</span></div><div class="casAuthors">Wayteck, Laura; Breckpot, Karine; Demeester, Jo; De Smedt, Stefaan C.; Raemdonck, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-125</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Recent progress in cancer immunotherapy has resulted in complete responses in patients refractory to current std. cancer therapies.  However, due to tumor heterogeneity and inter-individual variations in anti-tumor immunity, only subsets of patients experience clin. benefit.  This review highlights the implementation of a personalized approach to enhance treatment efficacy and reduce side effects, including the identification of tumor-specific antigens for cancer vaccination and adoptive T cell therapies.  Furthermore, together with the current advances and promising clin. outcomes of combination cancer (immuno-)therapies, the screening for predictive biomarkers in a patient-specific manner is emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtw-Tgp9wkh7Vg90H21EOLACvtfcHk0lgir0S8tjZkfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOgsbbF&md5=072e789986a14c4f74cdd0b52eed984a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2013.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2013.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DWayteck%26aufirst%3DL.%26aulast%3DBreckpot%26aufirst%3DK.%26aulast%3DDemeester%26aufirst%3DJ.%26aulast%3DDe%2BSmedt%26aufirst%3DS.%2BC.%26aulast%3DRaemdonck%26aufirst%3DK.%26atitle%3DA%2520personalized%2520view%2520on%2520cancer%2520immunotherapy%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D352%26spage%3D113%26epage%3D125%26doi%3D10.1016%2Fj.canlet.2013.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyman, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubinstein, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surh, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprent, J.</span></span> <span> </span><span class="NLM_article-title">Selective stimulation of T cell subsets with antibody-cytokine immune complexes</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">1924</span>– <span class="NLM_lpage">1927</span>, <span class="refDoi"> DOI: 10.1126/science.1122927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1126%2Fscience.1122927" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2006&pages=1924-1927&author=O.+Boymanauthor=M.+Kovarauthor=M.+P.+Rubinsteinauthor=C.+D.+Surhauthor=J.+Sprent&title=Selective+stimulation+of+T+cell+subsets+with+antibody-cytokine+immune+complexes&doi=10.1126%2Fscience.1122927"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1122927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1122927%26sid%3Dliteratum%253Aachs%26aulast%3DBoyman%26aufirst%3DO.%26aulast%3DKovar%26aufirst%3DM.%26aulast%3DRubinstein%26aufirst%3DM.%2BP.%26aulast%3DSurh%26aufirst%3DC.%2BD.%26aulast%3DSprent%26aufirst%3DJ.%26atitle%3DSelective%2520stimulation%2520of%2520T%2520cell%2520subsets%2520with%2520antibody-cytokine%2520immune%2520complexes%26jtitle%3DScience%26date%3D2006%26volume%3D311%26spage%3D1924%26epage%3D1927%26doi%3D10.1126%2Fscience.1122927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pardoll, D. M.</span></span> <span> </span><span class="NLM_article-title">The blockade of immune checkpoints in cancer immunotherapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">252</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1038/nrc3239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnrc3239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=22437870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVegtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=252-64&author=D.+M.+Pardoll&title=The+blockade+of+immune+checkpoints+in+cancer+immunotherapy&doi=10.1038%2Fnrc3239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The blockade of immune checkpoints in cancer immunotherapy</span></div><div class="casAuthors">Pardoll, Drew M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">252-264</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Among the most promising approaches to activating therapeutic antitumor immunity is the blockade of immune checkpoints.  Immune checkpoints refer to a plethora of inhibitory pathways hardwired into the immune system that are crucial for maintaining self-tolerance and modulating the duration and amplitude of physiol. immune responses in peripheral tissues in order to minimize collateral tissue damage.  It is now clear that tumors co-opt certain immune-checkpoint pathways as a major mechanism of immune resistance, particularly against T cells that are specific for tumor antigens.  Because many of the immune checkpoints are initiated by ligand-receptor interactions, they can be readily blocked by antibodies or modulated by recombinant forms of ligands or receptors.  Cytotoxic T-lymphocyte-assocd. antigen 4 (CTLA4) antibodies were the first of this class of immunotherapeutics to achieve US Food and Drug Administration (FDA) approval.  Preliminary clin. findings with blockers of addnl. immune-checkpoint proteins, such as programmed cell death protein 1 (PD1), indicate broad and diverse opportunities to enhance antitumor immunity with the potential to produce durable clin. responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosDPsOq8t6CrVg90H21EOLACvtfcHk0ljnnffy5cYbMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVegtrw%253D&md5=d278a058ffb1ccd3f678c1ae3ac0e55e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrc3239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3239%26sid%3Dliteratum%253Aachs%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26atitle%3DThe%2520blockade%2520of%2520immune%2520checkpoints%2520in%2520cancer%2520immunotherapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26spage%3D252%26epage%3D64%26doi%3D10.1038%2Fnrc3239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restifo, N. P.</span></span> <span> </span><span class="NLM_article-title">Adoptive cell transfer as personalized immunotherapy for human cancer</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1126/science.aaa4967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1126%2Fscience.aaa4967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=25838374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXls1Wmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=62-68&author=S.+A.+Rosenbergauthor=N.+P.+Restifo&title=Adoptive+cell+transfer+as+personalized+immunotherapy+for+human+cancer&doi=10.1126%2Fscience.aaa4967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Adoptive cell transfer as personalized immunotherapy for human cancer</span></div><div class="casAuthors">Rosenberg, Steven A.; Restifo, Nicholas P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6230</span>),
    <span class="NLM_cas:pages">62-68</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Adoptive cell therapy (ACT) is a highly personalized cancer therapy that involves administration to the cancer-bearing host of immune cells with direct anticancer activity.  ACT using naturally occurring tumor-reactive lymphocytes has mediated durable, complete regressions in patients with melanoma, probably by targeting somatic mutations exclusive to each cancer.  These results have expanded the reach of ACT to the treatment of common epithelial cancers.  In addn., the ability to genetically engineer lymphocytes to express conventional T cell receptors or chimeric antigen receptors has further extended the successful application of ACT for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbfkkwt9K57Vg90H21EOLACvtfcHk0ljnnffy5cYbMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXls1Wmurk%253D&md5=5e1f436aab5b0a6cf53eb4f50e3bb143</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaa4967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaa4967%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DS.%2BA.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26atitle%3DAdoptive%2520cell%2520transfer%2520as%2520personalized%2520immunotherapy%2520for%2520human%2520cancer%26jtitle%3DScience%26date%3D2015%26volume%3D348%26spage%3D62%26epage%3D68%26doi%3D10.1126%2Fscience.aaa4967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palucka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banchereau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span> <span> </span><span class="NLM_article-title">Designing vaccines based on biology of human dendritic cell subsets</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2010.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.immuni.2010.10.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=464-478&author=K.+Paluckaauthor=J.+Banchereauauthor=I.+Mellman&title=Designing+vaccines+based+on+biology+of+human+dendritic+cell+subsets&doi=10.1016%2Fj.immuni.2010.10.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2010.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2010.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DPalucka%26aufirst%3DK.%26aulast%3DBanchereau%26aufirst%3DJ.%26aulast%3DMellman%26aufirst%3DI.%26atitle%3DDesigning%2520vaccines%2520based%2520on%2520biology%2520of%2520human%2520dendritic%2520cell%2520subsets%26jtitle%3DImmunity%26date%3D2010%26volume%3D33%26spage%3D464%26epage%3D478%26doi%3D10.1016%2Fj.immuni.2010.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>Cortellis,
Thomson Reuters Database. <a href="https://cortellis.thomsonreuterslifesciences.com/" class="extLink">https://cortellis.thomsonreuterslifesciences.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cortellis%2C%0AThomson+Reuters+Database.+https%3A%2F%2Fcortellis.thomsonreuterslifesciences.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collin, M.</span></span> <span> </span><span class="NLM_article-title">Immune checkpoint inhibitors: a patent review (2010–2015)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1080/13543776.2016.1176150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1080%2F13543776.2016.1176150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27054314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1SlsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=555-564&author=M.+Collin&title=Immune+checkpoint+inhibitors%3A+a+patent+review+%282010%E2%80%932015%29&doi=10.1080%2F13543776.2016.1176150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Immune checkpoint inhibitors: a patent review (2010-2015)</span></div><div class="casAuthors">Collin, Matthieu</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-564</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Immune checkpoint inhibitors, like anti-PD-1/PD-L1 antibodies, are revolutionizing therapeutic concepts in the treatment of cancer.  Said class of drugs will represent a multi-billion dollar market over the coming decade.  Many companies have therefore developed important patent activities in the field.: The present review gives an overview of the patent literature during the period 2010-2015 in the field of immune checkpoint inhibitors.  In particular, the review presents a selection of international patent applications related to inhibitors of PD-1/PD-L1, CTLA-4, IDO, TIM3, LAG3, TIGIT, BTLA, VISTA, ICOS, KIRs and CD39.: Immune checkpoint inhibitors are now widely accepted as a key component of the therapeutic strategies in cancer.  This fervent activity creates a maze of third-party patents that pose considerable risks for both newcomers and established companies.  We can thus anticipate that the no. of patent conflicts and disputes will increase in the near future.  Treatments will involve combination therapy comprising at least one immune checkpoint inhibitor and companies will multiply patent filings in this field.  Finally, we can expect that patents related to biomarkers that will render a patient eligible to a treatment with an immune checkpoint inhibitor will have tremendous com. value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMoVL42Yd6VrVg90H21EOLACvtfcHk0li2cLAvXrXITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1SlsbY%253D&md5=a23ba11a0c4b42243e327dccb46259b5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F13543776.2016.1176150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2016.1176150%26sid%3Dliteratum%253Aachs%26aulast%3DCollin%26aufirst%3DM.%26atitle%3DImmune%2520checkpoint%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932015%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D555%26epage%3D564%26doi%3D10.1080%2F13543776.2016.1176150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smothers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivasan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoos, A.</span></span> <span> </span><span class="NLM_article-title">Big opportunities for small molecules in immuno-oncology</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">622</span>, <span class="refDoi"> DOI: 10.1038/nrd4596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnrd4596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=26228631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KiurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=603-622&author=J.+L.+Adamsauthor=J.+Smothersauthor=R.+Srinivasanauthor=A.+Hoos&title=Big+opportunities+for+small+molecules+in+immuno-oncology&doi=10.1038%2Fnrd4596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Big opportunities for small molecules in immuno-oncology</span></div><div class="casAuthors">Adams, Jerry L.; Smothers, James; Srinivasan, Roopa; Hoos, Axel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">603-622</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The regulatory approval of ipilimumab (Yervoy) in 2011 ushered in a new era of cancer immunotherapies with durable clin. effects.  Most of these breakthrough medicines are monoclonal antibodies that block protein-protein interactions between T cell checkpoint receptors and their cognate ligands.  In addn., genetically engineered autologous T cell therapies have also recently demonstrated significant clin. responses in haematol. cancers.  Conspicuously missing from this class of therapies are traditional small-mol. drugs, which have previously served as the backbone of targeted cancer therapies.  Modulating the immune system through a small-mol. approach offers several unique advantages that are complementary to, and potentially synergistic with, biol. modalities.  This Review highlights immuno-oncol. pathways and mechanisms that can be best or solely targeted by small-mol. medicines.  Agents aimed at these mechanisms - modulation of the immune response, trafficking to the tumor microenvironment and cellular infiltration - are poised to significantly extend the scope of immuno-oncol. applications and enhance the opportunities for combination with tumor-targeted agents and biol. immunotherapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBZyGzN4ec8bVg90H21EOLACvtfcHk0li2cLAvXrXITA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KiurvE&md5=b6c9d41ae81a8c504ee6aac209ea0509</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrd4596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4596%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DSmothers%26aufirst%3DJ.%26aulast%3DSrinivasan%26aufirst%3DR.%26aulast%3DHoos%26aufirst%3DA.%26atitle%3DBig%2520opportunities%2520for%2520small%2520molecules%2520in%2520immuno-oncology%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D603%26epage%3D622%26doi%3D10.1038%2Fnrd4596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weinmann, H.</span></span> <span> </span><span class="NLM_article-title">Cancer immunotherapy: selected targets and small-molecule modulators</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1002%2Fcmdc.201500566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=26836578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=450-466&author=H.+Weinmann&title=Cancer+immunotherapy%3A+selected+targets+and+small-molecule+modulators&doi=10.1002%2Fcmdc.201500566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators</span></div><div class="casAuthors">Weinmann, Hilmar</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">450-466</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">There is a significant amt. of excitement in the scientific community around cancer immunotherapy, as this approach has renewed hope for many cancer patients owing to some recent successes in the clinic.  Currently available immuno-oncol. therapeutics under clin. development and on the market are mostly biologics (antibodies, proteins, engineered cells, and oncolytic viruses).  However, modulation of the immune system with small mols. offers several advantages that may be complementary and potentially synergistic to the use of large biologicals.  Therefore, the discovery and development of novel small-mol. modulators is a rapidly growing research area for medicinal chemists working in cancer immunotherapy.  This review provides a brief introduction into recent trends related to selected targets and pathways for cancer immunotherapy and their small-mol. pharmacol. modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXRleizKnn77Vg90H21EOLACvtfcHk0ljX2dy77WmlYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSiurg%253D&md5=0cf24fb364c8f87d912da8267fa9eb98</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500566%26sid%3Dliteratum%253Aachs%26aulast%3DWeinmann%26aufirst%3DH.%26atitle%3DCancer%2520immunotherapy%253A%2520selected%2520targets%2520and%2520small-molecule%2520modulators%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D450%26epage%3D466%26doi%3D10.1002%2Fcmdc.201500566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatton, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangan, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C. T.</span></span> <span> </span><span class="NLM_article-title">Interleukin 17-producing CD4<sup>+</sup> effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1123</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1038/ni1254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fni1254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=16200070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFamsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1123-1132&author=L.+E.+Harringtonauthor=R.+D.+Hattonauthor=P.+R.+Manganauthor=H.+Turnerauthor=T.+L.+Murphyauthor=K.+M.+Murphyauthor=C.+T.+Weaver&title=Interleukin+17-producing+CD4%2B+effector+T+cells+develop+via+a+lineage+distinct+from+the+T+helper+type+1+and+2+lineages&doi=10.1038%2Fni1254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages</span></div><div class="casAuthors">Harrington, Laurie E.; Hatton, Robin D.; Mangan, Paul R.; Turner, Henrietta; Murphy, Theresa L.; Murphy, Kenneth M.; Weaver, Casey T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1123-1132</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CD4+ T cells producing interleukin 17 (IL-17) are assocd. with autoimmunity, although the precise mechanisms that control their development are undefined.  Here the authors present data that challenge the idea of a shared developmental pathway with T helper type 1 (TH1) or TH2 lineages and instead favor the idea of a distinct effector lineage the authors call 'TH-17'.  The development of TH-17 cells from naive precursor cells was potently inhibited by interferon-γ (IFN-γ) and IL-4, whereas committed TH-17 cells were resistant to suppression by TH1 or TH2 cytokines.  In the absence of IFN-γ and IL-4, IL-23 induced naive precursor cells to differentiate into TH-17 cells independently of the transcription factors STAT1, T-bet, STAT4 and STAT6.  These findings provide a basis for understanding how inhibition of IFN-γ signaling enhances development of pathogenic TH-17 effector cells that can exacerbate autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo6A2C_tQswLVg90H21EOLACvtfcHk0ljX2dy77WmlYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFamsb7J&md5=de4b453a239c0c221684e2c6227dd555</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fni1254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1254%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DL.%2BE.%26aulast%3DHatton%26aufirst%3DR.%2BD.%26aulast%3DMangan%26aufirst%3DP.%2BR.%26aulast%3DTurner%26aufirst%3DH.%26aulast%3DMurphy%26aufirst%3DT.%2BL.%26aulast%3DMurphy%26aufirst%3DK.%2BM.%26aulast%3DWeaver%26aufirst%3DC.%2BT.%26atitle%3DInterleukin%252017-producing%2520CD4%252B%2520effector%2520T%2520cells%2520develop%2520via%2520a%2520lineage%2520distinct%2520from%2520the%2520T%2520helper%2520type%25201%2520and%25202%2520lineages%26jtitle%3DNat.%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D1123%26epage%3D1132%26doi%3D10.1038%2Fni1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakae, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nambu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishigame, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakuta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakura, Y.</span></span> <span> </span><span class="NLM_article-title">IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">566</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.177.1.566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.4049%2Fjimmunol.177.1.566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=16785554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvV2ntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2006&pages=566-573&author=Y.+Komiyamaauthor=S.+Nakaeauthor=T.+Matsukiauthor=A.+Nambuauthor=H.+Ishigameauthor=S.+Kakutaauthor=K.+Sudoauthor=Y.+Iwakura&title=IL-17+plays+an+important+role+in+the+development+of+experimental+autoimmune+encephalomyelitis&doi=10.4049%2Fjimmunol.177.1.566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis</span></div><div class="casAuthors">Komiyama, Yutaka; Nakae, Susumu; Matsuki, Taizo; Nambu, Aya; Ishigame, Harumichi; Kakuta, Shigeru; Sudo, Katsuko; Iwakura, Yoichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">566-573</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">IL-17 is a proinflammatory cytokine that activates T cells and other immune cells to produce a variety of cytokines, chemokines, and cell adhesion mols.  This cytokine is augmented in the sera and/or tissues of patients with contact dermatitis, asthma, and rheumatoid arthritis.  The authors previously demonstrated that IL-17 is involved in the development of autoimmune arthritis and contact, delayed, and airway hypersensitivity in mice.  As the expression of IL-17 is also augmented in multiple sclerosis, the authors examd. the involvement of this cytokine in these diseases using IL-17-/- murine disease models.  They found that the development of exptl. autoimmune encephalomyelitis (EAE), the rodent model of multiple sclerosis, was suppressed in IL-17-/- mice; these animals exhibited delayed onset, reduced max. severity scores, ameliorated histol. changes, and early recovery.  T cell sensitization against myelin oligodendrocyte glycoprotein was reduced in IL-17-/- mice upon sensitization.  The major producer of IL-17 upon treatment with myelin oligodendrocyte glycoprotein were CD4+ T cells rather than CD8+ T cells, and adoptive transfer of IL-17-/- CD4+ T cells inefficiently induced EAE in recipient mice.  Notably, IL-17-producing T cells were increased in IFN-γ-/- cells, while IFN-γ-producing cells were increased in IL-17-/- cells, suggesting that IL-17 and IFN-γ mutually regulate IFN-γ and IL-17 prodn.  Thus, IL-17 rather than IFN-γ plays a crucial role in the development of EAE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP-YRfRiE4_rVg90H21EOLACvtfcHk0lgiOItLdmhNCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvV2ntbg%253D&md5=84f23ee506e146b036aeefc289dbdc33</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.177.1.566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.177.1.566%26sid%3Dliteratum%253Aachs%26aulast%3DKomiyama%26aufirst%3DY.%26aulast%3DNakae%26aufirst%3DS.%26aulast%3DMatsuki%26aufirst%3DT.%26aulast%3DNambu%26aufirst%3DA.%26aulast%3DIshigame%26aufirst%3DH.%26aulast%3DKakuta%26aufirst%3DS.%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DIwakura%26aufirst%3DY.%26atitle%3DIL-17%2520plays%2520an%2520important%2520role%2520in%2520the%2520development%2520of%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D177%26spage%3D566%26epage%3D573%26doi%3D10.4049%2Fjimmunol.177.1.566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tesmer, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundy, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. A.</span></span> <span> </span><span class="NLM_article-title">Th17 cells in human disease</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1111/j.1600-065X.2008.00628.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1111%2Fj.1600-065X.2008.00628.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=18613831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=87-113&author=L.+A.+Tesmerauthor=S.+K.+Lundyauthor=S.+Sarkarauthor=D.+A.+Fox&title=Th17+cells+in+human+disease&doi=10.1111%2Fj.1600-065X.2008.00628.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Th17 cells in human disease</span></div><div class="casAuthors">Tesmer, Laura A.; Lundy, Steven K.; Sarkar, Sujata; Fox, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87-113</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Our understanding of the role of T cells in human disease is undergoing revision as a result of the discovery of T-helper 17 (Th17) cells, a unique CD4+ T-cell subset characterized by prodn. of interleukin-17 (IL-17).  IL-17 is a highly inflammatory cytokine with robust effects on stromal cells in many tissues.  Recent data in humans and mice suggest that Th17 cells play an important role in the pathogenesis of a diverse group of immune-mediated diseases, including psoriasis, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and asthma.  Initial reports also propose a role for Th17 cells in tumorigenesis and transplant rejection.  Important differences, as well as many similarities, are emerging when the biol. of Th17 cells in the mouse is compared with corresponding phenomena in humans.  As our understanding of human Th17 biol. grows, the mechanisms underlying many diseases are becoming more apparent, resulting in a new appreciation for both previously known and more recently discovered cytokines, chemokines, and feedback mechanisms.  Given the strong assocn. between excessive Th17 activity and human disease, new therapeutic approaches targeting Th17 cells are highly promising, but the potential safety of such treatments may be limited by the role of these cells in normal host defenses against infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1z_YfE_Dmz7Vg90H21EOLACvtfcHk0lgiOItLdmhNCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGls7s%253D&md5=f8a6314e2868e3be4f072bda3a038697</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00628.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00628.x%26sid%3Dliteratum%253Aachs%26aulast%3DTesmer%26aufirst%3DL.%2BA.%26aulast%3DLundy%26aufirst%3DS.%2BK.%26aulast%3DSarkar%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DD.%2BA.%26atitle%3DTh17%2520cells%2520in%2520human%2520disease%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D87%26epage%3D113%26doi%3D10.1111%2Fj.1600-065X.2008.00628.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kryczek, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altuwaijri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeliga, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolls, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span> <span> </span><span class="NLM_article-title">Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">6730</span>– <span class="NLM_lpage">6733</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.178.11.6730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.4049%2Fjimmunol.178.11.6730" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=6730-6733&author=I.+Kryczekauthor=S.+Weiauthor=L.+Zouauthor=S.+Altuwaijriauthor=W.+Szeligaauthor=J.+Kollsauthor=A.+Changauthor=W.+Zou&title=Cutting+edge%3A+Th17+and+regulatory+T+cell+dynamics+and+the+regulation+by+IL-2+in+the+tumor+microenvironment&doi=10.4049%2Fjimmunol.178.11.6730"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.178.11.6730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.178.11.6730%26sid%3Dliteratum%253Aachs%26aulast%3DKryczek%26aufirst%3DI.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DZou%26aufirst%3DL.%26aulast%3DAltuwaijri%26aufirst%3DS.%26aulast%3DSzeliga%26aufirst%3DW.%26aulast%3DKolls%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DZou%26aufirst%3DW.%26atitle%3DCutting%2520edge%253A%2520Th17%2520and%2520regulatory%2520T%2520cell%2520dynamics%2520and%2520the%2520regulation%2520by%2520IL-2%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DJ.%2520Immunol.%26date%3D2007%26volume%3D178%26spage%3D6730%26epage%3D6733%26doi%3D10.4049%2Fjimmunol.178.11.6730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kryczek, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vatan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeliga, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlayson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeone, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welling, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coukos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span> <span> </span><span class="NLM_article-title">Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">1141</span>– <span class="NLM_lpage">1149</span>, <span class="refDoi"> DOI: 10.1182/blood-2009-03-208249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1182%2Fblood-2009-03-208249" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=1141-1149&author=I.+Kryczekauthor=M.+Banerjeeauthor=P.+Chengauthor=L.+Vatanauthor=W.+Szeligaauthor=S.+Weiauthor=E.+Huangauthor=E.+Finlaysonauthor=D.+Simeoneauthor=T.+H.+Wellingauthor=A.+Changauthor=G.+Coukosauthor=R.+Liuauthor=W.+Zou&title=Phenotype%2C+distribution%2C+generation%2C+and+functional+and+clinical+relevance+of+Th17+cells+in+the+human+tumor+environments&doi=10.1182%2Fblood-2009-03-208249"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-03-208249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-03-208249%26sid%3Dliteratum%253Aachs%26aulast%3DKryczek%26aufirst%3DI.%26aulast%3DBanerjee%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DP.%26aulast%3DVatan%26aufirst%3DL.%26aulast%3DSzeliga%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DFinlayson%26aufirst%3DE.%26aulast%3DSimeone%26aufirst%3DD.%26aulast%3DWelling%26aufirst%3DT.%2BH.%26aulast%3DChang%26aufirst%3DA.%26aulast%3DCoukos%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DW.%26atitle%3DPhenotype%252C%2520distribution%252C%2520generation%252C%2520and%2520functional%2520and%2520clinical%2520relevance%2520of%2520Th17%2520cells%2520in%2520the%2520human%2520tumor%2520environments%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D1141%26epage%3D1149%26doi%3D10.1182%2Fblood-2009-03-208249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muranski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antony, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulos, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touloukian, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gattinoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrzesinski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerstann, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feigenbaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restifo, N. P.</span></span> <span> </span><span class="NLM_article-title">Tumor-specific Th17-polarized cells eradicate large established melanoma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">373</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-11-120998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1182%2Fblood-2007-11-120998" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=362-373&author=P.+Muranskiauthor=A.+Boniauthor=P.+A.+Antonyauthor=L.+Cassardauthor=K.+R.+Irvineauthor=A.+Kaiserauthor=C.+M.+Paulosauthor=D.+C.+Palmerauthor=C.+E.+Touloukianauthor=K.+Ptakauthor=L.+Gattinoniauthor=C.+Wrzesinskiauthor=C.+S.+Hinrichsauthor=K.+W.+Kerstannauthor=L.+Feigenbaumauthor=C.+C.+Chanauthor=N.+P.+Restifo&title=Tumor-specific+Th17-polarized+cells+eradicate+large+established+melanoma&doi=10.1182%2Fblood-2007-11-120998"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-11-120998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-11-120998%26sid%3Dliteratum%253Aachs%26aulast%3DMuranski%26aufirst%3DP.%26aulast%3DBoni%26aufirst%3DA.%26aulast%3DAntony%26aufirst%3DP.%2BA.%26aulast%3DCassard%26aufirst%3DL.%26aulast%3DIrvine%26aufirst%3DK.%2BR.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DPalmer%26aufirst%3DD.%2BC.%26aulast%3DTouloukian%26aufirst%3DC.%2BE.%26aulast%3DPtak%26aufirst%3DK.%26aulast%3DGattinoni%26aufirst%3DL.%26aulast%3DWrzesinski%26aufirst%3DC.%26aulast%3DHinrichs%26aufirst%3DC.%2BS.%26aulast%3DKerstann%26aufirst%3DK.%2BW.%26aulast%3DFeigenbaum%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DC.%2BC.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26atitle%3DTumor-specific%2520Th17-polarized%2520cells%2520eradicate%2520large%2520established%2520melanoma%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D362%26epage%3D373%26doi%3D10.1182%2Fblood-2007-11-120998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odunsi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. F.</span></span> <span> </span><span class="NLM_article-title">Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">15505</span>– <span class="NLM_lpage">15510</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710686105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1073%2Fpnas.0710686105" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=15505-15510&author=Y.+Miyaharaauthor=K.+Odunsiauthor=W.+Chenauthor=G.+Pengauthor=J.+Matsuzakiauthor=R.+F.+Wang&title=Generation+and+regulation+of+human+CD4%2B+IL-17-producing+T+cells+in+ovarian+cancer&doi=10.1073%2Fpnas.0710686105"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710686105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710686105%26sid%3Dliteratum%253Aachs%26aulast%3DMiyahara%26aufirst%3DY.%26aulast%3DOdunsi%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DG.%26aulast%3DMatsuzaki%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.%2BF.%26atitle%3DGeneration%2520and%2520regulation%2520of%2520human%2520CD4%252B%2520IL-17-producing%2520T%2520cells%2520in%2520ovarian%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D15505%26epage%3D15510%26doi%3D10.1073%2Fpnas.0710686105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Orozco, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muranski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restifo, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overwijk, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, C.</span></span> <span> </span><span class="NLM_article-title">T helper 17 cells promote cytotoxic T cell activation in tumor immunity</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2009.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.immuni.2009.09.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=787-798&author=N.+Martin-Orozcoauthor=P.+Muranskiauthor=Y.+Chungauthor=X.+O.+Yangauthor=T.+Yamazakiauthor=S.+Luauthor=P.+Hwuauthor=N.+P.+Restifoauthor=W.+W.+Overwijkauthor=C.+Dong&title=T+helper+17+cells+promote+cytotoxic+T+cell+activation+in+tumor+immunity&doi=10.1016%2Fj.immuni.2009.09.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2009.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2009.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Orozco%26aufirst%3DN.%26aulast%3DMuranski%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%2BO.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHwu%26aufirst%3DP.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26aulast%3DOverwijk%26aufirst%3DW.%2BW.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DT%2520helper%252017%2520cells%2520promote%2520cytotoxic%2520T%2520cell%2520activation%2520in%2520tumor%2520immunity%26jtitle%3DImmunity%26date%3D2009%26volume%3D31%26spage%3D787%26epage%3D798%26doi%3D10.1016%2Fj.immuni.2009.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulos, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heemskerk, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrzesinski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borman, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muranski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restifo, N. P.</span></span> <span> </span><span class="NLM_article-title">Type 17 CD8<sup>+</sup> T cells display enhanced antitumor immunity</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1182/blood-2009-02-203935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1182%2Fblood-2009-02-203935" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=596-599&author=C.+S.+Hinrichsauthor=A.+Kaiserauthor=C.+M.+Paulosauthor=L.+Cassardauthor=L.+Sanchez-Perezauthor=B.+Heemskerkauthor=C.+Wrzesinskiauthor=Z.+A.+Bormanauthor=P.+Muranskiauthor=N.+P.+Restifo&title=Type+17+CD8%2B+T+cells+display+enhanced+antitumor+immunity&doi=10.1182%2Fblood-2009-02-203935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2009-02-203935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2009-02-203935%26sid%3Dliteratum%253Aachs%26aulast%3DHinrichs%26aufirst%3DC.%2BS.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DCassard%26aufirst%3DL.%26aulast%3DSanchez-Perez%26aufirst%3DL.%26aulast%3DHeemskerk%26aufirst%3DB.%26aulast%3DWrzesinski%26aufirst%3DC.%26aulast%3DBorman%26aufirst%3DZ.%2BA.%26aulast%3DMuranski%26aufirst%3DP.%26aulast%3DRestifo%26aufirst%3DN.%2BP.%26atitle%3DType%252017%2520CD8%252B%2520T%2520cells%2520display%2520enhanced%2520antitumor%2520immunity%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D596%26epage%3D599%26doi%3D10.1182%2Fblood-2009-02-203935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maglich, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, L.</span></span> <span> </span><span class="NLM_article-title">The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">4051</span>– <span class="NLM_lpage">4058</span>, <span class="refDoi"> DOI: 10.1093/nar/gkg444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1093%2Fnar%2Fgkg444" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=4051-4058&author=J.+M.+Maglichauthor=J.+A.+Caravellaauthor=M.+H.+Lambertauthor=T.+M.+Willsonauthor=J.+T.+Mooreauthor=L.+Ramamurthy&title=The+first+completed+genome+sequence+from+a+teleost+fish+%28Fugu+rubripes%29+adds+significant+diversity+to+the+nuclear+receptor+superfamily&doi=10.1093%2Fnar%2Fgkg444"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkg444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkg444%26sid%3Dliteratum%253Aachs%26aulast%3DMaglich%26aufirst%3DJ.%2BM.%26aulast%3DCaravella%26aufirst%3DJ.%2BA.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DMoore%26aufirst%3DJ.%2BT.%26aulast%3DRamamurthy%26aufirst%3DL.%26atitle%3DThe%2520first%2520completed%2520genome%2520sequence%2520from%2520a%2520teleost%2520fish%2520%2528Fugu%2520rubripes%2529%2520adds%2520significant%2520diversity%2520to%2520the%2520nuclear%2520receptor%2520superfamily%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2003%26volume%3D31%26spage%3D4051%26epage%3D4058%26doi%3D10.1093%2Fnar%2Fgkg444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov,  II</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepelley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17<sup>+</sup> T helper cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.cell.2006.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=16990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1121-1133&author=+Ivanovauthor=B.+S.+McKenzieauthor=L.+Zhouauthor=C.+E.+Tadokoroauthor=A.+Lepelleyauthor=J.+J.+Lafailleauthor=D.+J.+Cuaauthor=D.+R.+Littman&title=The+orphan+nuclear+receptor+RORgammat+directs+the+differentiation+program+of+proinflammatory+IL-17%2B+T+helper+cells&doi=10.1016%2Fj.cell.2006.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span></div><div class="casAuthors">Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease.  The authors show here that the orphan nuclear receptor RORγt is the key transcription factor that orchestrates the differentiation of this effector cell lineage.  RORγt induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4+ T helper cells and is required for their expression in response to IL-6 and TGF-β, the cytokines known to induce IL-17.  Th17 cells are constitutively present throughout the intestinal lamina propria, express RORγt, and are absent in mice deficient for RORγt or IL-6.  Mice with RORγt-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells.  Together, these studies suggest that RORγt is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsJd6RyFqWrVg90H21EOLACvtfcHk0lilVQX8e2dXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE&md5=4f5693603c30dca4f6a2d0994aeaf9b0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DLepelley%26aufirst%3DA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520RORgammat%2520directs%2520the%2520differentiation%2520program%2520of%2520proinflammatory%2520IL-17%252B%2520T%2520helper%2520cells%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D1121%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2006.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmarajan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebelin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Synthetic RORgammat agonists enhance protective immunity</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1012</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00899</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00899" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1012-1018&author=M.+R.+Changauthor=V.+Dharmarajanauthor=C.+Doebelinauthor=R.+D.+Garcia-Ordonezauthor=S.+J.+Novickauthor=D.+S.+Kuruvillaauthor=T.+M.+Kameneckaauthor=P.+R.+Griffin&title=Synthetic+RORgammat+agonists+enhance+protective+immunity&doi=10.1021%2Facschembio.5b00899"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00899%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DDharmarajan%26aufirst%3DV.%26aulast%3DDoebelin%26aufirst%3DC.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DNovick%26aufirst%3DS.%2BJ.%26aulast%3DKuruvilla%26aufirst%3DD.%2BS.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DSynthetic%2520RORgammat%2520agonists%2520enhance%2520protective%2520immunity%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D1012%26epage%3D1018%26doi%3D10.1021%2Facschembio.5b00899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crumbley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundasen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojetin, D. J.</span></span> <span> </span><span class="NLM_article-title">Nuclear receptors and their selective pharmacologic modulators</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">710</span>– <span class="NLM_lpage">778</span>, <span class="refDoi"> DOI: 10.1124/pr.112.006833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1124%2Fpr.112.006833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=23457206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslCisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=710-778&author=T.+P.+Burrisauthor=L.+A.+Soltauthor=Y.+Wangauthor=C.+Crumbleyauthor=S.+Banerjeeauthor=K.+Griffettauthor=T.+Lundasenauthor=T.+Hughesauthor=D.+J.+Kojetin&title=Nuclear+receptors+and+their+selective+pharmacologic+modulators&doi=10.1124%2Fpr.112.006833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear receptors and their selective pharmacologic modulators</span></div><div class="casAuthors">Burris, Thomas P.; Solt, Laura A.; Wang, Yongjun; Crumbley, Christine; Banerjee, Subhashis; Griffett, Kristine; Lundasen, Thomas; Hughes, Travis; Kojetin, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">710-778, 69 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors are ligand-activated transcription factors and include the receptors for steroid hormones, lipophilic vitamins, sterols, and bile acids.  These receptors serve as targets for development of myriad drugs that target a range of disorders.  Classically defined ligands that bind to the ligand-binding domain of nuclear receptors, whether they are endogenous or synthetic, either activate receptor activity (agonists) or block activation (antagonists) and due to the ability to alter activity of the receptors are often termed receptor "modulators".  The complex pharmacol. of nuclear receptors has provided a class of ligands distinct from these simple modulators where ligands display agonist/partial agonist/antagonist function in a tissue or gene selective manner.  This class of ligands is defined as selective modulators.  Here, we review the development and pharmacol. of a range of selective nuclear receptor modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodFD-Tf1vBUrVg90H21EOLACvtfcHk0lilVQX8e2dXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslCisrY%253D&md5=33c34757a837d2a80674fbe5c1660fe2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.006833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.006833%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCrumbley%26aufirst%3DC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DGriffett%26aufirst%3DK.%26aulast%3DLundasen%26aufirst%3DT.%26aulast%3DHughes%26aufirst%3DT.%26aulast%3DKojetin%26aufirst%3DD.%2BJ.%26atitle%3DNuclear%2520receptors%2520and%2520their%2520selective%2520pharmacologic%2520modulators%26jtitle%3DPharmacol.%2520Rev.%26date%3D2013%26volume%3D65%26spage%3D710%26epage%3D778%26doi%3D10.1124%2Fpr.112.006833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Germain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staels, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dacquet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, V.</span></span> <span> </span><span class="NLM_article-title">Overview of nomenclature of nuclear receptors</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.1124/pr.58.4.2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1124%2Fpr.58.4.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=17132848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1ajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=685-704&author=P.+Germainauthor=B.+Staelsauthor=C.+Dacquetauthor=M.+Speddingauthor=V.+Laudet&title=Overview+of+nomenclature+of+nuclear+receptors&doi=10.1124%2Fpr.58.4.2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of nomenclature of nuclear receptors</span></div><div class="casAuthors">Germain, Pierre; Staels, Bart; Dacquet, Catherine; Spedding, Michael; Laudet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-704</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Nuclear receptor pharmacol. has, to a certain extent, led the way, compared with other receptor systems, in the appreciation that ligands may exert very diverse pharmacol., based on their individual chem. structure and the allosteric changes induced in the receptor/accessory protein complex.  This can lead to very selective pharmacol. effects, which may not necessarily be predicted from the experience with other agonists/partial agonists/antagonists.  If this is the case, then drug discovery may be back to drug-specific pharmacol. (where each drug may have an original profile), rather than specific-drug pharmacol. (where agents specific for a receptor have a distinct profile).  As functional selectivity is indeed a crucial mechanism to be considered when going through the drug discovery development process, then initial screens using reconstituted systems may not show the appropriate pharmacol., simply because the required stoichiometry of corepressors and coactivators may not be present to select the best compds.; therefore, multiple effector systems are necessary to screen for differential activation, and, even then, screening with in vivo pathophysiol. models may ultimately be required for the selection process-a massive but necessary task for pharmacologists.  Thus, the characterization of nuclear receptors and their assocd. proteins and the ligands that interact with them will remain a challenge to pharmacologists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosXeD8Bz5rVrVg90H21EOLACvtfcHk0lgMAnkL26WaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1ajtA%253D%253D&md5=264d69bdcd7b9f01f2d6ef3b73b78c60</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.4.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.4.2%26sid%3Dliteratum%253Aachs%26aulast%3DGermain%26aufirst%3DP.%26aulast%3DStaels%26aufirst%3DB.%26aulast%3DDacquet%26aufirst%3DC.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DLaudet%26aufirst%3DV.%26atitle%3DOverview%2520of%2520nomenclature%2520of%2520nuclear%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D685%26epage%3D704%26doi%3D10.1124%2Fpr.58.4.2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORgamma or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.%0AP.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+nuclear+receptor+retinoic+acid+receptor-related+orphan+receptor-gamma+%28RORgamma+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520nuclear%2520receptor%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-gamma%2520%2528RORgamma%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T.
P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busby, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.chembiol.2011.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=22284354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=51-59&author=T.%0AP.+Burrisauthor=S.+A.+Busbyauthor=P.+R.+Griffin&title=Targeting+orphan+nuclear+receptors+for+treatment+of+metabolic+diseases+and+autoimmunity&doi=10.1016%2Fj.chembiol.2011.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity</span></div><div class="casAuthors">Burris, Thomas P.; Busby, Scott A.; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-59</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The nuclear receptor (NR) superfamily is composed of 48 members in humans and includes receptors for steroid hormones, thyroid hormone, various lipids and oxysterols.  This superfamily has been a rich source of drug targets for myriad diseases including inflammation, cancer, and metabolic disorders.  Approx. half of the superfamily have well characterized natural ligands whereas the remaining receptors are considered orphan receptors and remain a focus of a no. of investigators assessing their ability to be regulated by ligands.  Here, we review recent discoveries that yield important insight into the druggability of three orphan nuclear receptors: the retinoic acid receptor-like orphan receptors (RORs), peroxisome proliferator-activated receptor γ (PPARγ), and liver receptor homolog-1 (LRH-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWjganOqGf87Vg90H21EOLACvtfcHk0lgMAnkL26WaUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GjtLY%253D&md5=d110458f889d2faccd4a9c6f0c5fcf0d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DBusby%26aufirst%3DS.%2BA.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DTargeting%2520orphan%2520nuclear%2520receptors%2520for%2520treatment%2520of%2520metabolic%2520diseases%2520and%2520autoimmunity%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D51%26epage%3D59%26doi%3D10.1016%2Fj.chembiol.2011.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Action of RORs and their ligands in (patho)physiology</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.tem.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=22789990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWgur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=619-627&author=L.+A.+Soltauthor=T.+P.+Burris&title=Action+of+RORs+and+their+ligands+in+%28patho%29physiology&doi=10.1016%2Fj.tem.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Action of RORs and their ligands in (patho)physiology</span></div><div class="casAuthors">Solt, Laura A.; Burris, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">619-627</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The retinoic-acid-receptor-related orphan receptors (RORs) are members of the nuclear receptor (NR) superfamily whose activity has been implicated in several physiol. and pathol. processes.  The RORs, specifically RORα and RORγ, are considered to be master regulators of TH17 cells, a recently described subset of CD4+ T helper cells that have been demonstrated to have a pathol. role in autoimmune disease.  As with most members of the NR superfamily, RORs are ligand-regulated, suggesting that their activity can be modulated by synthetic ligands.  Recent advances in the field have established that selective inhibition of the RORs is a viable therapeutic approach for not only the treatment of autoimmune disorders but also ROR-mediated metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU_NvOEtj6cbVg90H21EOLACvtfcHk0ljkweLvV8hOKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWgur%252FJ&md5=a1d5b61ffa1b224265d1cd90d60e9620</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DAction%2520of%2520RORs%2520and%2520their%2520ligands%2520in%2520%2528patho%2529physiology%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D23%26spage%3D619%26epage%3D627%26doi%3D10.1016%2Fj.tem.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerrebrock, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">FitzHugh, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Berkel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birren, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruglyak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span> <span> </span><span class="NLM_article-title">Disruption of the nuclear hormone receptor RORalpha in staggerer mice</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1038/379736a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2F379736a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=736-739&author=B.+A.+Hamiltonauthor=W.+N.+Frankelauthor=A.+W.+Kerrebrockauthor=T.+L.+Hawkinsauthor=W.+FitzHughauthor=K.+Kusumiauthor=L.+B.+Russellauthor=K.+L.+Muellerauthor=V.+van+Berkelauthor=B.+W.+Birrenauthor=L.+Kruglyakauthor=E.+S.+Lander&title=Disruption+of+the+nuclear+hormone+receptor+RORalpha+in+staggerer+mice&doi=10.1038%2F379736a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2F379736a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379736a0%26sid%3Dliteratum%253Aachs%26aulast%3DHamilton%26aufirst%3DB.%2BA.%26aulast%3DFrankel%26aufirst%3DW.%2BN.%26aulast%3DKerrebrock%26aufirst%3DA.%2BW.%26aulast%3DHawkins%26aufirst%3DT.%2BL.%26aulast%3DFitzHugh%26aufirst%3DW.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DRussell%26aufirst%3DL.%2BB.%26aulast%3DMueller%26aufirst%3DK.%2BL.%26aulast%3Dvan%2BBerkel%26aufirst%3DV.%26aulast%3DBirren%26aufirst%3DB.%2BW.%26aulast%3DKruglyak%26aufirst%3DL.%26aulast%3DLander%26aufirst%3DE.%2BS.%26atitle%3DDisruption%2520of%2520the%2520nuclear%2520hormone%2520receptor%2520RORalpha%2520in%2520staggerer%2520mice%26jtitle%3DNature%26date%3D1996%26volume%3D379%26spage%3D736%26epage%3D739%26doi%3D10.1038%2F379736a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steinmayr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conquet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondi-Reig, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhaye-Bouchaud, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auclair, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crepel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotelo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Andre, M.</span></span> <span> </span><span class="NLM_article-title">Staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">3960</span>– <span class="NLM_lpage">3965</span>, <span class="refDoi"> DOI: 10.1073/pnas.95.7.3960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1073%2Fpnas.95.7.3960" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3960-3965&author=M.+Steinmayrauthor=E.+Andreauthor=F.+Conquetauthor=L.+Rondi-Reigauthor=N.+Delhaye-Bouchaudauthor=N.+Auclairauthor=H.+Danielauthor=F.+Crepelauthor=J.+Marianiauthor=C.+Soteloauthor=M.+Becker-Andre&title=Staggerer+phenotype+in+retinoid-related+orphan+receptor+alpha-deficient+mice&doi=10.1073%2Fpnas.95.7.3960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.7.3960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.7.3960%26sid%3Dliteratum%253Aachs%26aulast%3DSteinmayr%26aufirst%3DM.%26aulast%3DAndre%26aufirst%3DE.%26aulast%3DConquet%26aufirst%3DF.%26aulast%3DRondi-Reig%26aufirst%3DL.%26aulast%3DDelhaye-Bouchaud%26aufirst%3DN.%26aulast%3DAuclair%26aufirst%3DN.%26aulast%3DDaniel%26aufirst%3DH.%26aulast%3DCrepel%26aufirst%3DF.%26aulast%3DMariani%26aufirst%3DJ.%26aulast%3DSotelo%26aufirst%3DC.%26aulast%3DBecker-Andre%26aufirst%3DM.%26atitle%3DStaggerer%2520phenotype%2520in%2520retinoid-related%2520orphan%2520receptor%2520alpha-deficient%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D3960%26epage%3D3965%26doi%3D10.1073%2Fpnas.95.7.3960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gawlas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmayr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker-Andre, M.</span></span> <span> </span><span class="NLM_article-title">A novel isoform of the orphan nuclear receptor RORbeta is specifically expressed in pineal gland and retina</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1016/S0378-1119(98)00348-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2FS0378-1119%2898%2900348-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1998&pages=277-283&author=E.+Andreauthor=K.+Gawlasauthor=M.+Steinmayrauthor=M.+Becker-Andre&title=A+novel+isoform+of+the+orphan+nuclear+receptor+RORbeta+is+specifically+expressed+in+pineal+gland+and+retina&doi=10.1016%2FS0378-1119%2898%2900348-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0378-1119%2898%2900348-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0378-1119%252898%252900348-5%26sid%3Dliteratum%253Aachs%26aulast%3DAndre%26aufirst%3DE.%26aulast%3DGawlas%26aufirst%3DK.%26aulast%3DSteinmayr%26aufirst%3DM.%26aulast%3DBecker-Andre%26aufirst%3DM.%26atitle%3DA%2520novel%2520isoform%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520RORbeta%2520is%2520specifically%2520expressed%2520in%2520pineal%2520gland%2520and%2520retina%26jtitle%3DGene%26date%3D1998%26volume%3D216%26spage%3D277%26epage%3D283%26doi%3D10.1016%2FS0378-1119%2898%2900348-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer’s patches</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1034/j.1600-065X.2003.00074.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1034%2Fj.1600-065X.2003.00074.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=12969312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFyrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2003&pages=81-90&author=G.+Eberlauthor=D.+R.+Littman&title=The+role+of+the+nuclear+hormone+receptor+RORgammat+in+the+development+of+lymph+nodes+and+Peyer%E2%80%99s+patches&doi=10.1034%2Fj.1600-065X.2003.00074.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches</span></div><div class="casAuthors">Eberl, Gerard; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-90</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The nuclear hormone receptor retinoic acid-related orphan receptor (ROR)γt is required for the development of lymph nodes (LNs) and Peyer's patches (PPs), as these organs are absent in RORγt-deficient mice.  During fetal life, RORγt is expressed exclusively in lymphoid tissue-inducer (LTi) cells, a cell type that localizes in developing LNs and PPs.  LTi cells express surface lymphotoxin α1β2 that activates specialized mesenchymal cells to produce chemokines, upregulate adhesion mols. and induce further maturation of lymphoid organs.  RORγt inhibits nuclear factor of activated T-cell (NFAT) function in cell lines and induces the expression of Bcl-xL and p27kip1 in the adult thymus, suggesting that RORγt prevents cell activation, cell-cycle progression, and apoptosis.  We propose that RORγt, together with the inhibitor of basic helix-loop-helix transcription factor Id2, ensures generation and survival of fetal LTi cells necessary for the development of LNs and PPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQF5WmEPV1QbVg90H21EOLACvtfcHk0lgCnRGJpCCLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFyrt7k%253D&md5=7a1566b2570a0ae10edd9ff06160f298</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1034%2Fj.1600-065X.2003.00074.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1600-065X.2003.00074.x%26sid%3Dliteratum%253Aachs%26aulast%3DEberl%26aufirst%3DG.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520role%2520of%2520the%2520nuclear%2520hormone%2520receptor%2520RORgammat%2520in%2520the%2520development%2520of%2520lymph%2520nodes%2520and%2520Peyer%25E2%2580%2599s%2520patches%26jtitle%3DImmunol.%2520Rev.%26date%3D2003%26volume%3D195%26spage%3D81%26epage%3D90%26doi%3D10.1034%2Fj.1600-065X.2003.00074.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isono, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita-Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span> <span> </span><span class="NLM_article-title">Inhibiting RORgammat/Th17 axis for autoimmune disorders</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.drudis.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=24792721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1205-1211&author=F.+Isonoauthor=S.+Fujita-Satoauthor=S.+Ito&title=Inhibiting+RORgammat%2FTh17+axis+for+autoimmune+disorders&doi=10.1016%2Fj.drudis.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting RORγt/Th17 axis for autoimmune disorders</span></div><div class="casAuthors">Isono, Fujio; Fujita-Sato, Saori; Ito, Shuichiro</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1205-1211</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent success reported in late-stage clin. trials for the treatment of psoriasis by antibodies directed against interleukin (IL)-17 or its receptor has validated and strongly supports the development of inhibitors of the IL-17 pathway as a new therapeutic modality in chronic inflammation and autoimmunity.  These results also encourage the drug discovery of orally available small mols. that can modulate down the prodn. of IL-17 by Th17 cells (the major IL-17 producers) or the downstream signaling of the IL-17 receptor.  Here, we review these strategies with an emphasis on inhibiting the retinoic-acid-related orphan nuclear receptor RORγt, which is the master regulator of Th17 cells and a promising therapeutic target for the treatment of multiple autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQi4K-X9vSobVg90H21EOLACvtfcHk0lgCnRGJpCCLng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D&md5=aaa82e8d21bcd0c879b0219a7b84e126</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DIsono%26aufirst%3DF.%26aulast%3DFujita-Sato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DS.%26atitle%3DInhibiting%2520RORgammat%252FTh17%2520axis%2520for%2520autoimmune%2520disorders%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1205%26epage%3D1211%26doi%3D10.1016%2Fj.drudis.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennert, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1038/ni1022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fni1022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=14691482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWhtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=64-73&author=G.+Eberlauthor=S.+Marmonauthor=M.+J.+Sunshineauthor=P.+D.+Rennertauthor=Y.+Choiauthor=D.+R.+Littman&title=An+essential+function+for+the+nuclear+receptor+RORgamma%28t%29+in+the+generation+of+fetal+lymphoid+tissue+inducer+cells&doi=10.1038%2Fni1022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells</span></div><div class="casAuthors">Eberl, Gerard; Marmon, Shana; Sunshine, Mary-Jean; Rennert, Paul D.; Choi, Yongwon; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-73</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lymphoid tissue inducer (LTi) cells are assocd. with early development of lymph nodes and Peyer's patches.  The authors show here that during fetal life the nuclear hormone receptor RORγt is expressed exclusively in and is required for the generation of LTi cells.  RORγt+ LTi cells provide essential factors, among which lymphotoxin-α1β2 is necessary but not sufficient for activation of the mesenchyma in lymph node and Peyer's patch anlagen.  This early LTi cell-mediated activation of lymph node and Peyer's patch mesenchyma forms the necessary platform for the subsequent development of mature lymphoid tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5WJaoOUVHLVg90H21EOLACvtfcHk0lil8JNsohIPFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWhtr3N&md5=537f5f89b071b5b5a710d80a476d1b52</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fni1022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1022%26sid%3Dliteratum%253Aachs%26aulast%3DEberl%26aufirst%3DG.%26aulast%3DMarmon%26aufirst%3DS.%26aulast%3DSunshine%26aufirst%3DM.%2BJ.%26aulast%3DRennert%26aufirst%3DP.%2BD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DAn%2520essential%2520function%2520for%2520the%2520nuclear%2520receptor%2520RORgamma%2528t%2529%2520in%2520the%2520generation%2520of%2520fetal%2520lymphoid%2520tissue%2520inducer%2520cells%26jtitle%3DNat.%2520Immunol.%26date%3D2004%26volume%3D5%26spage%3D64%26epage%3D73%26doi%3D10.1038%2Fni1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huh, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of RORgammat: targeting Th17 cells and other applications</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">2232</span>– <span class="NLM_lpage">2237</span>, <span class="refDoi"> DOI: 10.1002/eji.201242740</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1002%2Feji.201242740" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=2232-2237&author=J.+R.+Huhauthor=D.+R.+Littman&title=Small+molecule+inhibitors+of+RORgammat%3A+targeting+Th17+cells+and+other+applications&doi=10.1002%2Feji.201242740"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Feji.201242740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.201242740%26sid%3Dliteratum%253Aachs%26aulast%3DHuh%26aufirst%3DJ.%2BR.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520RORgammat%253A%2520targeting%2520Th17%2520cells%2520and%2520other%2520applications%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2012%26volume%3D42%26spage%3D2232%26epage%3D2237%26doi%3D10.1002%2Feji.201242740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martynowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1210%2Fme.2009-0507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=20203100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=923-929&author=L.+Jinauthor=D.+Martynowskiauthor=S.+Zhengauthor=T.+Wadaauthor=W.+Xieauthor=Y.+Li&title=Structural+basis+for+hydroxycholesterols+as+natural+ligands+of+orphan+nuclear+receptor+RORgamma&doi=10.1210%2Fme.2009-0507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ</span></div><div class="casAuthors">Jin, Lihua; Martynowski, Dariusz; Zheng, Songyang; Wada, Taira; Xie, Wen; Li, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The retinoic acid-related orphan receptor γ (RORγ) has important roles in development and metabolic homeostasis.  Although the biol. functions of RORγ have been studied extensively, no ligands for RORγ have been identified, and no structure of RORγ has been reported.  In this study, we showed that hydroxycholesterols promote the recruitment of coactivators by RORγ using biochem. assays.  We also report the crystal structures of the RORγ ligand-binding domain bound with hydroxycholesterols.  The structures reveal the binding modes of various hydroxycholesterols in the RORγ pocket, with the receptors all adopting the canonical active conformation.  Mutations that disrupt the binding of hydroxycholesterols abolish the constitutive activity of RORγ.  Our observations suggest an important role for the endogenous hydroxycholesterols in modulating RORγ-dependent biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-ndP3ZSYebVg90H21EOLACvtfcHk0lil8JNsohIPFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D&md5=1651fa21702f2a06451377fa11aa80bc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0507%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMartynowski%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520for%2520hydroxycholesterols%2520as%2520natural%2520ligands%2520of%2520orphan%2520nuclear%2520receptor%2520RORgamma%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D923%26epage%3D929%26doi%3D10.1210%2Fme.2009-0507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandridge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tootoonchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milla, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12163</span>– <span class="NLM_lpage">12168</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322807111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1073%2Fpnas.1322807111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12163-12168&author=P.+Sorooshauthor=J.+Wuauthor=X.+Xueauthor=J.+Songauthor=S.+W.+Suttonauthor=M.+Sabladauthor=J.+Yuauthor=M.+I.+Nelenauthor=X.+Liuauthor=G.+Castroauthor=R.+Lunaauthor=S.+Crawfordauthor=H.+Banieauthor=R.+A.+Dandridgeauthor=X.+Dengauthor=A.+Bittnerauthor=C.+Kueiauthor=M.+Tootoonchiauthor=N.+Rozenkrantsauthor=K.+Hermanauthor=J.+Gaoauthor=X.+V.+Yangauthor=K.+Sachenauthor=K.+Ngoauthor=W.+P.+Fung-Leungauthor=S.+Nguyenauthor=A.+de+Leon-Tabaldoauthor=J.+Blevittauthor=Y.+Zhangauthor=M.+D.+Cummingsauthor=T.+Raoauthor=N.+S.+Maniauthor=C.+Liuauthor=M.+McKinnonauthor=M.+E.+Millaauthor=A.+M.+Fourieauthor=S.+Sun&title=Oxysterols+are+agonist+ligands+of+RORgammat+and+drive+Th17+cell+differentiation&doi=10.1073%2Fpnas.1322807111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322807111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322807111%26sid%3Dliteratum%253Aachs%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DLuna%26aufirst%3DR.%26aulast%3DCrawford%26aufirst%3DS.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DDandridge%26aufirst%3DR.%2BA.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DBittner%26aufirst%3DA.%26aulast%3DKuei%26aufirst%3DC.%26aulast%3DTootoonchi%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DHerman%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%2BV.%26aulast%3DSachen%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DFung-Leung%26aufirst%3DW.%2BP.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3Dde%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DBlevitt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DRao%26aufirst%3DT.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DMilla%26aufirst%3DM.%2BE.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DOxysterols%2520are%2520agonist%2520ligands%2520of%2520RORgammat%2520and%2520drive%2520Th17%2520cell%2520differentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12163%26epage%3D12168%26doi%3D10.1073%2Fpnas.1322807111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santori, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Pavert, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglass, E. F.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leaver, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haubrich, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorbek, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konijn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosales, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mebius, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nes, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">Identification of natural RORgamma ligands that regulate the development of lymphoid cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">286</span>– <span class="NLM_lpage">297</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2015.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.cmet.2015.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=25651181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFals7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=286-297&author=F.+R.+Santoriauthor=P.+Huangauthor=S.+A.+van+de+Pavertauthor=E.+F.+Douglassauthor=D.+J.+Leaverauthor=B.+A.+Haubrichauthor=R.+Keberauthor=G.+Lorbekauthor=T.+Konijnauthor=B.+N.+Rosalesauthor=D.+Rozmanauthor=S.+Horvatauthor=A.+Rahierauthor=R.+E.+Mebiusauthor=F.+Rastinejadauthor=W.+D.+Nesauthor=D.+R.+Littman&title=Identification+of+natural+RORgamma+ligands+that+regulate+the+development+of+lymphoid+cells&doi=10.1016%2Fj.cmet.2015.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Natural RORγ Ligands that Regulate the Development of Lymphoid Cells</span></div><div class="casAuthors">Santori, Fabio R.; Huang, Pengxiang; van de Pavert, Serge A.; Douglass, Eugene F.; Leaver, David J.; Haubrich, Brad A.; Keber, Rok; Lorbek, Gregor; Konijn, Tanja; Rosales, Brittany N.; Rozman, Damjana; Horvat, Simon; Rahier, Alain; Mebius, Reina E.; Rastinejad, Fraydoon; Nes, W. David; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">286-297</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mice deficient in the nuclear hormone receptor RORγt have defective development of thymocytes, lymphoid organs, Th17 cells, and type 3 innate lymphoid cells.  RORγt binds to oxysterols derived from cholesterol catabolism, but it is not clear whether these are its natural ligands.  Here, we show that sterol lipids are necessary and sufficient to drive RORγt-dependent transcription.  We combined overexpression, RNAi, and genetic deletion of metabolic enzymes to study RORγ-dependent transcription.  Our results are consistent with the RORγt ligand(s) being a cholesterol biosynthetic intermediate (CBI) downstream of lanosterol and upstream of zymosterol.  Anal. of lipids bound to RORγ identified mols. with mol. wts. consistent with CBIs.  Furthermore, CBIs stabilized the RORγ ligand-binding domain and induced coactivator recruitment.  Genetic deletion of metabolic enzymes upstream of the RORγt-ligand(s) affected the development of lymph nodes and Th17 cells.  Our data suggest that CBIs play a role in lymphocyte development potentially through regulation of RORγt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxQ633DcL_x7Vg90H21EOLACvtfcHk0ljdfDqRZ1Twgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFals7Y%253D&md5=6a4dbea10a38202f6e2253964f8f244e</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2015.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2015.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DSantori%26aufirst%3DF.%2BR.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3Dvan%2Bde%2BPavert%26aufirst%3DS.%2BA.%26aulast%3DDouglass%26aufirst%3DE.%2BF.%26aulast%3DLeaver%26aufirst%3DD.%2BJ.%26aulast%3DHaubrich%26aufirst%3DB.%2BA.%26aulast%3DKeber%26aufirst%3DR.%26aulast%3DLorbek%26aufirst%3DG.%26aulast%3DKonijn%26aufirst%3DT.%26aulast%3DRosales%26aufirst%3DB.%2BN.%26aulast%3DRozman%26aufirst%3DD.%26aulast%3DHorvat%26aufirst%3DS.%26aulast%3DRahier%26aufirst%3DA.%26aulast%3DMebius%26aufirst%3DR.%2BE.%26aulast%3DRastinejad%26aufirst%3DF.%26aulast%3DNes%26aufirst%3DW.%2BD.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DIdentification%2520of%2520natural%2520RORgamma%2520ligands%2520that%2520regulate%2520the%2520development%2520of%2520lymphoid%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2015%26volume%3D21%26spage%3D286%26epage%3D297%26doi%3D10.1016%2Fj.cmet.2015.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendling, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span></span> <span> </span><span class="NLM_article-title">Sterol metabolism controls T(H)17 differentiation by generating endogenous RORgamma agonists</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnchembio.1714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=25558972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=141-147&author=X.+Huauthor=Y.+Wangauthor=L.+Y.+Haoauthor=X.+Liuauthor=C.+A.+Leschauthor=B.+M.+Sanchezauthor=J.+M.+Wendlingauthor=R.+W.+Morganauthor=T.+D.+Aicherauthor=L.+L.+Carterauthor=P.+L.+Toogoodauthor=G.+D.+Glick&title=Sterol+metabolism+controls+T%28H%2917+differentiation+by+generating+endogenous+RORgamma+agonists&doi=10.1038%2Fnchembio.1714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists</span></div><div class="casAuthors">Hu, Xiao; Wang, Yahong; Hao, Ling-Yang; Liu, Xikui; Lesch, Chuck A.; Sanchez, Brian M.; Wendling, Jay M.; Morgan, Rodney W.; Aicher, Tom D.; Carter, Laura L.; Toogood, Peter L.; Glick, Gary D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-147</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor γ (RORγt) controls the differentiation of naive CD4+ T cells into the TH17 lineage, which are crit. cells in the pathogenesis of autoimmune diseases.  Here the authors report that during TH17 differentiation, cholesterol biosynthesis and uptake programs are induced, whereas their metab. and efflux programs are suppressed.  These changes result in the accumulation of the cholesterol precursor, desmosterol, which functions as a potent endogenous RORγ agonist.  Generation of cholesterol precursors is essential for TH17 differentiation as blocking cholesterol synthesis with chem. inhibitors at steps before the formation of active precursors reduces differentiation.  Upon activation, metabolic changes also lead to prodn. of specific sterol-sulfate conjugates that favor activation of RORγ over the TH17-inhibiting sterol receptor LXR.  Thus, TH17 differentiation is orchestrated by coordinated sterol synthesis, mobilization and metab. to selectively activate RORγ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKonRBn05nmbVg90H21EOLACvtfcHk0ljRb6WFiVaC2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislOltQ%253D%253D&md5=e82af9d561a1e4683a86b815cb734971</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1714%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DL.%2BY.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLesch%26aufirst%3DC.%2BA.%26aulast%3DSanchez%26aufirst%3DB.%2BM.%26aulast%3DWendling%26aufirst%3DJ.%2BM.%26aulast%3DMorgan%26aufirst%3DR.%2BW.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DGlick%26aufirst%3DG.%2BD.%26atitle%3DSterol%2520metabolism%2520controls%2520T%2528H%252917%2520differentiation%2520by%2520generating%2520endogenous%2520RORgamma%2520agonists%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D141%26epage%3D147%26doi%3D10.1038%2Fnchembio.1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuhant, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istrate, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORalpha and RORgamma</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1029</span>– <span class="NLM_lpage">1034</span>, <span class="refDoi"> DOI: 10.1021/cb100223d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100223d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1029-1034&author=Y.+Wangauthor=N.+Kumarauthor=P.+Nuhantauthor=M.+D.+Cameronauthor=M.+A.+Istrateauthor=W.+R.+Roushauthor=P.+R.+Griffinauthor=T.+P.+Burris&title=Identification+of+SR1078%2C+a+synthetic+agonist+for+the+orphan+nuclear+receptors+RORalpha+and+RORgamma&doi=10.1021%2Fcb100223d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcb100223d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100223d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DNuhant%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DIstrate%26aufirst%3DM.%2BA.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DIdentification%2520of%2520SR1078%252C%2520a%2520synthetic%2520agonist%2520for%2520the%2520orphan%2520nuclear%2520receptors%2520RORalpha%2520and%2520RORgamma%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1029%26epage%3D1034%26doi%3D10.1021%2Fcb100223d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisely, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span> <span> </span><span class="NLM_article-title">Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor gamma (RORgamma) by a class of aryl amide compounds</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1124/mol.112.078667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1124%2Fmol.112.078667" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=583-590&author=W.+Zhangauthor=J.+Zhangauthor=L.+Fangauthor=L.+Zhouauthor=S.+Wangauthor=Z.+Xiangauthor=Y.+Liauthor=B.+Wiselyauthor=G.+Zhangauthor=G.+Anauthor=Y.+Wangauthor=S.+Leungauthor=Z.+Zhong&title=Increasing+human+Th17+differentiation+through+activation+of+orphan+nuclear+receptor+retinoid+acid-related+orphan+receptor+gamma+%28RORgamma%29+by+a+class+of+aryl+amide+compounds&doi=10.1124%2Fmol.112.078667"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.078667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.078667%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWisely%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DAn%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DZ.%26atitle%3DIncreasing%2520human%2520Th17%2520differentiation%2520through%2520activation%2520of%2520orphan%2520nuclear%2520receptor%2520retinoid%2520acid-related%2520orphan%2520receptor%2520gamma%2520%2528RORgamma%2529%2520by%2520a%2520class%2520of%2520aryl%2520amide%2520compounds%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D583%26epage%3D590%26doi%3D10.1124%2Fmol.112.078667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxdorf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of tertiary amine and indole derivatives as potent RORγt inverse agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1021/ml4003875</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4003875" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=65-68&author=T.+Yangauthor=Q.+Liuauthor=Y.+Chengauthor=W.+Caiauthor=Y.+Maauthor=L.+Yangauthor=Q.+Wuauthor=L.+A.+Orband-Millerauthor=L.+Zhouauthor=Z.+Xiangauthor=M.+Huxdorfauthor=W.+Zhangauthor=J.+Zhangauthor=J.+N.+Xiangauthor=S.+Leungauthor=Y.+Qiuauthor=Z.+Zhongauthor=J.+D.+Elliottauthor=X.+Linauthor=Y.+Wang&title=Discovery+of+tertiary+amine+and+indole+derivatives+as+potent+ROR%CE%B3t+inverse+agonists&doi=10.1021%2Fml4003875"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fml4003875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4003875%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DHuxdorf%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520tertiary%2520amine%2520and%2520indole%2520derivatives%2520as%2520potent%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D65%26epage%3D68%26doi%3D10.1021%2Fml4003875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5293</span>– <span class="NLM_lpage">5302</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1016%2Fj.bmc.2015.07.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5293-5302&author=Y.+Wangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Maauthor=L.+Yangauthor=L.+Zhouauthor=Z.+Xiangauthor=Z.+Chengauthor=S.+Luauthor=L.+A.+Orband-Millerauthor=W.+Zhangauthor=Q.+Wuauthor=K.+Zhangauthor=Y.+Liauthor=J.+N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+N-%284-aryl-5-aryloxy-thiazol-2-yl%29-amides+as+potent+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmc.2015.07.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.068%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520N-%25284-aryl-5-aryloxy-thiazol-2-yl%2529-amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5293%26epage%3D5302%26doi%3D10.1016%2Fj.bmc.2015.07.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rene, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boenig, G. d. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Minor structural change to tertiary sulfonamide RORc ligands led to opposite mechanisms of action</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1021/ml500420y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500420y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=276-281&author=O.+Reneauthor=B.+P.+Fauberauthor=G.+d.+L.+Boenigauthor=B.+Burtonauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+R.+Johnsonauthor=J.+R.+Kieferauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=H.+A.+Wallweberauthor=H.+Wong&title=Minor+structural+change+to+tertiary+sulfonamide+RORc+ligands+led+to+opposite+mechanisms+of+action&doi=10.1021%2Fml500420y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml500420y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500420y%26sid%3Dliteratum%253Aachs%26aulast%3DRene%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBoenig%26aufirst%3DG.%2Bd.%2BL.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DMinor%2520structural%2520change%2520to%2520tertiary%2520sulfonamide%2520RORc%2520ligands%2520led%2520to%2520opposite%2520mechanisms%2520of%2520action%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D276%26epage%3D281%26doi%3D10.1021%2Fml500420y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aagaard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPheat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirholt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grindebacke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span> <span> </span><span class="NLM_article-title">Benzoxazepines achieve potent suppression of IL-17 release in human T-Helper 17 (TH 17) cells through an induced-fit binding mode to the nuclear receptor RORgamma</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1002%2Fcmdc.201500432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=26553345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=207-216&author=R.+I.+Olssonauthor=Y.+Xueauthor=S.+von+Bergauthor=A.+Aagaardauthor=J.+McPheatauthor=E.+L.+Hanssonauthor=J.+Bernstromauthor=P.+Hanssonauthor=J.+Jirholtauthor=H.+Grindebackeauthor=A.+Lefflerauthor=R.+Chenauthor=Y.+Xiongauthor=H.+Geauthor=T.+G.+Hanssonauthor=F.+Narjes&title=Benzoxazepines+achieve+potent+suppression+of+IL-17+release+in+human+T-Helper+17+%28TH+17%29+cells+through+an+induced-fit+binding+mode+to+the+nuclear+receptor+RORgamma&doi=10.1002%2Fcmdc.201500432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ</span></div><div class="casAuthors">Olsson, Roine I.; Xue, Yafeng; von Berg, Stefan; Aagaard, Anna; McPheat, Jane; Hansson, Eva L.; Bernstroem, Jenny; Hansson, Pia; Jirholt, Johan; Grindebacke, Hanna; Leffler, Agnes; Chen, Rongfeng; Xiong, Yao; Ge, Hongbin; Hansson, Thomas G.; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">RORγt, an isoform of the retinoic acid-related orphan receptor gamma (RORc, RORγ), has been identified as the master regulator of T-helper 17 (TH17) cell function and development, making it an attractive target for the treatment of autoimmune diseases.  Validation for this target comes from antibodies targeting interleukin-17 (IL-17), the signature cytokine produced by TH17 cells, which have shown impressive results in clin. trials.  Through focused screening of our compd. collection, we identified a series of N-sulfonylated benzoxazepines, which displayed micromolar affinity for the RORγ ligand-binding domain (LBD) in a radioligand binding assay.  Optimization of these initial hits resulted in potent binders, which dose-dependently decreased the ability of the RORγ-LBD to interact with a peptide derived from steroid receptor coactivator 1, and inhibited the release of IL-17 secretion from isolated and cultured human TH17 cells with nanomolar potency.  A cocrystal structure of inverse agonist 15 (2-chloro-6-fluoro-N-(4-{[3-(trifluoromethyl)phenyl]sulfonyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)benzamide) bound to the RORγ-LBD illustrated that both hydrophobic interactions, leading to an induced fit around the substituted benzamide moiety of 15, as well as a hydrogen bond from the amide NH to His479 seemed to be important for the mechanism of action.  This structure is compared with the structure of agonist 25 (N-(2-fluorophenyl)-4-[(4-fluorophenyl)sulfonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-6-amine ) and structures of other known RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorSpjXrs3zSrVg90H21EOLACvtfcHk0ljuJ3WYfEiHbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N&md5=ed6fa69d887818da7acd4f9abbd2ff93</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500432%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DR.%2BI.%26aulast%3DXue%26aufirst%3DY.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DAagaard%26aufirst%3DA.%26aulast%3DMcPheat%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DE.%2BL.%26aulast%3DBernstrom%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJirholt%26aufirst%3DJ.%26aulast%3DGrindebacke%26aufirst%3DH.%26aulast%3DLeffler%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DH.%26aulast%3DHansson%26aufirst%3DT.%2BG.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DBenzoxazepines%2520achieve%2520potent%2520suppression%2520of%2520IL-17%2520release%2520in%2520human%2520T-Helper%252017%2520%2528TH%252017%2529%2520cells%2520through%2520an%2520induced-fit%2520binding%2520mode%2520to%2520the%2520nuclear%2520receptor%2520RORgamma%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D207%26epage%3D216%26doi%3D10.1002%2Fcmdc.201500432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildes, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chodaparambil, J. V.</span></span> <span> </span><span class="NLM_article-title">Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand</span>. <i>BMC Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">7</span>, <span class="refDoi"> DOI: 10.1186/s12900-016-0059-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1186%2Fs12900-016-0059-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27246200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVWrtbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=7&author=D.+J.+Marcotteauthor=Y.+Liuauthor=K.+Littleauthor=J.+H.+Jonesauthor=N.+A.+Powellauthor=C.+P.+Wildesauthor=L.+F.+Silvianauthor=J.+V.+Chodaparambil&title=Structural+determinant+for+inducing+RORgamma+specific+inverse+agonism+triggered+by+a+synthetic+benzoxazinone+ligand&doi=10.1186%2Fs12900-016-0059-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand</span></div><div class="casAuthors">Marcotte, Douglas J.; Liu, Yu Ting; Little, Kevin; Jones, John H.; Powell, Noel A.; Wildes, Craig P.; Silvian, Laura F.; Chodaparambil, Jayanth V.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Structural Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7/1-7/9</span>CODEN:
                <span class="NLM_cas:coden">BSBMBB</span>;
        ISSN:<span class="NLM_cas:issn">1472-6807</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The nuclear hormone receptor RORγ regulates transcriptional genes involved in the prodn. of the pro-inflammatory interleukin IL-17 which has been linked to autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.  This transcriptional activity of RORγ is modulated through a protein-protein interaction involving the activation function 2 (AF2) helix on the ligand binding domain of RORγ and a conserved LXXLL helix motif on coactivator proteins.  Our goal was to develop a RORγ specific inverse agonist that would help down regulate pro-inflammatory gene transcription by disrupting the protein protein interaction with coactivator proteins as a therapeutic agent.  Results: We identified a novel series of synthetic benzoxazinone ligands having an agonist (BIO592) and inverse agonist (BIO399) mode of action in a FRET based assay.  We show that the AF2 helix of RORγ is proteolytically sensitive when inverse agonist BIO399 binds.  Using x-ray crystallog. we show how small modifications on the benzoxazinone agonist BIO592 trigger inverse agonism of RORγ.  Using an in vivo reporter assay, we show that the inverse agonist BIO599 displayed specificity for RORγ over ROR sub-family members α and β.  Conclusion: The synthetic benzoxazinone ligands identified in our FRET assay have an agonist (BIO592) or inverse agonist (BIO399) effect by stabilizing or destabilizing the agonist conformation of RORγ.  The proteolytic sensitivity of the AF2 helix of RORγ demonstrates that it destabilizes upon BIO399 inverse agonist binding perturbing the coactivator protein binding site.  Our structural investigation of the BIO592 agonist and BIO399 inverse agonist structures identified residue Met358 on RORγ as the trigger for RORγ specific inverse agonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxW2sFawf8O7Vg90H21EOLACvtfcHk0lgkW43X3jHq0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWrtbvK&md5=1bd1b9a25ff0ce166d56a70e391691f3</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1186%2Fs12900-016-0059-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12900-016-0059-3%26sid%3Dliteratum%253Aachs%26aulast%3DMarcotte%26aufirst%3DD.%2BJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLittle%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DPowell%26aufirst%3DN.%2BA.%26aulast%3DWildes%26aufirst%3DC.%2BP.%26aulast%3DSilvian%26aufirst%3DL.%2BF.%26aulast%3DChodaparambil%26aufirst%3DJ.%2BV.%26atitle%3DStructural%2520determinant%2520for%2520inducing%2520RORgamma%2520specific%2520inverse%2520agonism%2520triggered%2520by%2520a%2520synthetic%2520benzoxazinone%2520ligand%26jtitle%3DBMC%2520Struct.%2520Biol.%26date%3D2016%26volume%3D16%26spage%3D7%26doi%3D10.1186%2Fs12900-016-0059-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doebelin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patouret, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dharmarajan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span> <span> </span><span class="NLM_article-title">N-Arylsulfonyl indolines as retinoic acid receptor-related orphan receptor gamma (RORgamma) agonists</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2607</span>– <span class="NLM_lpage">2620</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1002%2Fcmdc.201600491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27879053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSlsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2607-2620&author=C.+Doebelinauthor=R.+Patouretauthor=R.+D.+Garcia-Ordonezauthor=M.+R.+Changauthor=V.+Dharmarajanauthor=D.+S.+Kuruvillaauthor=S.+J.+Novickauthor=L.+Linauthor=M.+D.+Cameronauthor=P.+R.+Griffinauthor=T.+M.+Kamenecka&title=N-Arylsulfonyl+indolines+as+retinoic+acid+receptor-related+orphan+receptor+gamma+%28RORgamma%29+agonists&doi=10.1002%2Fcmdc.201600491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists</span></div><div class="casAuthors">Doebelin, Christelle; Patouret, Remi; Garcia-Ordonez, Ruben D.; Chang, Mi Ra; Dharmarajan, Venkatasubramanian; Kuruvilla, Dana S.; Novick, Scott J.; Lin, Li; Cameron, Michael D.; Griffin, Patrick R.; Kamenecka, Theodore M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2607-2620</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The nuclear retinoic acid receptor-related orphan receptor γ (RORγ; NR1F3) is a key regulator of inflammatory gene programs involved in T helper 17 (TH17) cell proliferation.  As such, synthetic small-mol. repressors (inverse agonists) targeting RORγ have been extensively studied for their potential as therapeutic agents for various autoimmune diseases.  Alternatively, enhancing TH17 cell proliferation through activation (agonism) of RORγ may boost an immune response, thereby offering a potentially new approach in cancer immunotherapy.  Herein the authors describe the development of N-arylsulfonyl indolines as RORγ agonists.  Structure-activity studies reveal a crit. linker region in these mols. as the major determinant for agonism.  Hydrogen/deuterium exchange coupled to mass spectrometry (HDX-MS) anal. of RORγ-ligand complexes help rationalize the obsd. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFUjlrkpRAz7Vg90H21EOLACvtfcHk0lgkW43X3jHq0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSlsbzP&md5=1dfb3c08077c18e8cda3e6a287bb8194</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600491%26sid%3Dliteratum%253Aachs%26aulast%3DDoebelin%26aufirst%3DC.%26aulast%3DPatouret%26aufirst%3DR.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DDharmarajan%26aufirst%3DV.%26aulast%3DKuruvilla%26aufirst%3DD.%2BS.%26aulast%3DNovick%26aufirst%3DS.%2BJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26atitle%3DN-Arylsulfonyl%2520indolines%2520as%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520gamma%2520%2528RORgamma%2529%2520agonists%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2607%26epage%3D2620%26doi%3D10.1002%2Fcmdc.201600491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span>; <span class="NLM_string-name">Toogood, P. L.</span>; <span class="NLM_string-name">Hu, X.</span>; <span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Celeste, L. L.</span>; <span class="NLM_string-name">Liu, X.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Adoptive cellular therapy using an agonist of retinoic acid recepor-related orphan receptor gamma & related therapeutic methods</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2015,131,035</span>, Mar 9, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=G.+D.+Glick&author=P.+L.+Toogood&author=X.+Hu&author=T.+D.+Aicher&author=L.+L.+Celeste&author=X.+Liu&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Adoptive+cellular+therapy+using+an+agonist+of+retinoic+acid+recepor-related+orphan+receptor+gamma+%26+related+therapeutic+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGlick%26aufirst%3DG.%2BD.%26atitle%3DAdoptive%2520cellular%2520therapy%2520using%2520an%2520agonist%2520of%2520retinoic%2520acid%2520recepor-related%2520orphan%2520receptor%2520gamma%2520%2526%2520related%2520therapeutic%2520methods%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2015,171,610</span>, May 17, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+D.+Aicher&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Tetrahydroquinoline+sulfonamide+and+related+compounds+for+use+as+agonists+of+ROR%CE%B3+and+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DTetrahydroquinoline%2520sulfonamide%2520and%2520related%2520compounds%2520for%2520use%2520as%2520agonists%2520of%2520ROR%25CE%25B3%2520and%2520the%2520treatment%2520of%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Skalitzky, D. J.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of Disease</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2015,171,558</span>, Jul 20, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=T.+D.+Aicher&author=D.+J.+Skalitzky&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Benzenesulfonamido+and+related+compounds+for+use+as+agonists+of+ROR%CE%B3+and+the+treatment+of+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DBenzenesulfonamido%2520and%2520related%2520compounds%2520for%2520use%2520as%2520agonists%2520of%2520ROR%25CE%25B3%2520and%2520the%2520treatment%2520of%2520Disease%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Aryl Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2016,201,225</span>, Dec 15, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+D.+Aicher&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Aryl+Dihydro-2H-benzo%5Bb%5D%5B1%2C4%5Doxazine+sulfonamide+and+related+compounds+for+use+as+agonists+of+ROR%CE%B3+and+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DAryl%2520Dihydro-2H-benzo%255Bb%255D%255B1%252C4%255Doxazine%2520sulfonamide%2520and%2520related%2520compounds%2520for%2520use%2520as%2520agonists%2520of%2520ROR%25CE%25B3%2520and%2520the%2520treatment%2520of%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span>; <span class="NLM_string-name">Taylor, C. B.</span>; <span class="NLM_string-name">Vanhuis, C. A.</span></span> <span> </span><span class="NLM_article-title">Dihydro-2H-benzo[b][1,4]oxazine sulfomide and related compounds for use as agonists of RORγ and the treatment of disease</span>. World Intellectual Property Organization Patent <span class="NLM_patent">2016,179,343</span>, Nov 10, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+D.+Aicher&author=C.+B.+Taylor&author=C.+A.+Vanhuis&title=Dihydro-2H-benzo%5Bb%5D%5B1%2C4%5Doxazine+sulfomide+and+related+compounds+for+use+as+agonists+of+ROR%CE%B3+and+the+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAicher%26aufirst%3DT.%2BD.%26atitle%3DDihydro-2H-benzo%255Bb%255D%255B1%252C4%255Doxazine%2520sulfomide%2520and%2520related%2520compounds%2520for%2520use%2520as%2520agonists%2520of%2520ROR%25CE%25B3%2520and%2520the%2520treatment%2520of%2520disease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span>Cortellis,
Thomson Reuters Database: Search results for “retinoid Z receptor
gamma agonist”. <a href="https://cortellis.thomsonreuterslifesciences.com/" class="extLink">https://cortellis.thomsonreuterslifesciences.com/</a> (accessed Jun 23, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Cortellis%2C%0AThomson+Reuters+Database%3A+Search+results+for+%E2%80%9Cretinoid+Z+receptor%0Agamma+agonist%E2%80%9D.+https%3A%2F%2Fcortellis.thomsonreuterslifesciences.com%2F+%28accessed+Jun+23%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span>News
on FierceBiotech. <a href="http://www.fiercebiotech.com/biotech/lycera-s-double-action-immuno-oncology-drug-starts-trials" class="extLink">http://www.fiercebiotech.com/biotech/lycera-s-double-action-immuno-oncology-drug-starts-trials</a> (accessed Jan 4, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=News%0Aon+FierceBiotech.+http%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Flycera-s-double-action-immuno-oncology-drug-starts-trials+%28accessed+Jan+4%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span>U.S. National
Library of Medicine. ClinicalTrials.gov. <a href="https://clinicaltrials.gov/ct2/show/NCT02929862" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02929862</a> (accessed June 23, <span class="NLM_year">2017</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+National%0ALibrary+of+Medicine.+ClinicalTrials.gov.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02929862+%28accessed+June+23%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louie, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowsky, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">488</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1038/nm.4070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1038%2Fnm.4070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=27019329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFShurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=488-496&author=J.+Wangauthor=J.+X.+Zouauthor=X.+Xueauthor=D.+Caiauthor=Y.+Zhangauthor=Z.+Duanauthor=Q.+Xiangauthor=J.+C.+Yangauthor=M.+C.+Louieauthor=A.+D.+Borowskyauthor=A.+C.+Gaoauthor=C.+P.+Evansauthor=K.+S.+Lamauthor=J.+Xuauthor=H.+Kungauthor=R.+M.+Evansauthor=Y.+Xuauthor=H.+Chen&title=ROR-%CE%B3+drives+androgen+receptor+expression+and+represents+a+therapeutic+target+in+castration-resistant+prostate+cancer&doi=10.1038%2Fnm.4070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer</span></div><div class="casAuthors">Wang, Junjian; Zou, June X.; Xue, Xiaoqian; Cai, Demin; Zhang, Yan; Duan, Zhijian; Xiang, Qiuping; Yang, Joy C.; Louie, Maggie C.; Borowsky, Alexander D.; Gao, Allen C.; Evans, Christopher P.; Lam, Kit S.; Xu, Jianzhen; Kung, Hsing-Jien; Evans, Ronald M.; Xu, Yong; Chen, Hong-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">488-496</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The androgen receptor (AR) is overexpressed and hyperactivated in human castration-resistant prostate cancer (CRPC).  However, the determinants of AR overexpression in CRPC are poorly defined.  Here we show that retinoic acid receptor-related orphan receptor γ (ROR-γ) is overexpressed and amplified in metastatic CRPC tumors, and that ROR-γ drives AR expression in the tumors.  ROR-γ recruits nuclear receptor coactivator 1 and 3 (NCOA1 and NCOA3, also known as SRC-1 and SRC-3) to an AR-ROR response element (RORE) to stimulate AR gene transcription.  ROR-γ antagonists suppress the expression of both AR and its variant AR-V7 in prostate cancer (PCa) cell lines and tumors.  ROR-γ antagonists also markedly diminish genome-wide AR binding, H3K27ac abundance and expression of the AR target gene network.  Finally, ROR-γ antagonists suppressed tumor growth in multiple AR-expressing, but not AR-neg., xenograft PCa models, and they effectively sensitized CRPC tumors to enzalutamide, without overt toxicity, in mice.  Taken together, these results establish ROR-γ as a key player in CRPC by acting upstream of AR and as a potential therapeutic target for advanced PCa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX9ywlnlPbX7Vg90H21EOLACvtfcHk0liJvXzVQjBVcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFShurY%253D&md5=3817be87b91c2f148987d35e2305365c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1038%2Fnm.4070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4070%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DJ.%2BX.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DJ.%2BC.%26aulast%3DLouie%26aufirst%3DM.%2BC.%26aulast%3DBorowsky%26aufirst%3DA.%2BD.%26aulast%3DGao%26aufirst%3DA.%2BC.%26aulast%3DEvans%26aufirst%3DC.%2BP.%26aulast%3DLam%26aufirst%3DK.%2BS.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DKung%26aufirst%3DH.%26aulast%3DEvans%26aufirst%3DR.%2BM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DROR-%25CE%25B3%2520drives%2520androgen%2520receptor%2520expression%2520and%2520represents%2520a%2520therapeutic%2520target%2520in%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D488%26epage%3D496%26doi%3D10.1038%2Fnm.4070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spooner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawidzka, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majchrzak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kryczek, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Huis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skalitzky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurd, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toogood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulos, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. L.</span></span> <span> </span><span class="NLM_article-title">Synthetic RORgamma agonists regulate multiple pathways to enhance antitumor immunity</span>. <i>Oncoimmunology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1254854</span>, <span class="refDoi"> DOI: 10.1080/2162402X.2016.1254854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;key=10.1080%2F2162402X.2016.1254854" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e1254854&author=X.+Huauthor=X.+Liuauthor=J.+Moisanauthor=Y.+Wangauthor=C.+A.+Leschauthor=C.+Spoonerauthor=R.+W.+Morganauthor=E.+M.+Zawidzkaauthor=D.+Mertzauthor=D.+Bousleyauthor=K.+Majchrzakauthor=I.+Kryczekauthor=C.+Taylorauthor=C.+Van+Huisauthor=D.+Skalitzkyauthor=A.+Hurdauthor=T.+D.+Aicherauthor=P.+L.+Toogoodauthor=G.+D.+Glickauthor=C.+M.+Paulosauthor=W.+Zouauthor=L.+L.+Carter&title=Synthetic+RORgamma+agonists+regulate+multiple+pathways+to+enhance+antitumor+immunity&doi=10.1080%2F2162402X.2016.1254854"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1080%2F2162402X.2016.1254854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F2162402X.2016.1254854%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMoisan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLesch%26aufirst%3DC.%2BA.%26aulast%3DSpooner%26aufirst%3DC.%26aulast%3DMorgan%26aufirst%3DR.%2BW.%26aulast%3DZawidzka%26aufirst%3DE.%2BM.%26aulast%3DMertz%26aufirst%3DD.%26aulast%3DBousley%26aufirst%3DD.%26aulast%3DMajchrzak%26aufirst%3DK.%26aulast%3DKryczek%26aufirst%3DI.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DVan%2BHuis%26aufirst%3DC.%26aulast%3DSkalitzky%26aufirst%3DD.%26aulast%3DHurd%26aufirst%3DA.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DGlick%26aufirst%3DG.%2BD.%26aulast%3DPaulos%26aufirst%3DC.%2BM.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26atitle%3DSynthetic%2520RORgamma%2520agonists%2520regulate%2520multiple%2520pathways%2520to%2520enhance%2520antitumor%2520immunity%26jtitle%3DOncoimmunology%26date%3D2016%26volume%3D5%26spage%3De1254854%26doi%3D10.1080%2F2162402X.2016.1254854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KYT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KYT','PDB','3KYT'); return false;">PDB: 3KYT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0J','PDB','3L0J'); return false;">PDB: 3L0J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0L','PDB','3L0L'); return false;">PDB: 3L0L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4S14" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4S14','PDB','4S14'); return false;">PDB: 4S14</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NIE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NIE','PDB','4NIE'); return false;">PDB: 4NIE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XT9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XT9','PDB','4XT9'); return false;">PDB: 4XT9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WQP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WQP','PDB','4WQP'); return false;">PDB: 4WQP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WPF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WPF','PDB','4WPF'); return false;">PDB: 4WPF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APJ','PDB','5APJ'); return false;">PDB: 5APJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APH','PDB','5APH'); return false;">PDB: 5APH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APK','PDB','5APK'); return false;">PDB: 5APK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IXK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IXK','PDB','5IXK'); return false;">PDB: 5IXK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IZ0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IZ0','PDB','5IZ0'); return false;">PDB: 5IZ0</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01314%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01314" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0f347fb533291","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
